<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE Publisher PUBLIC "-//Springer-Verlag//DTD A++ V2.4//EN" "http://devel.springer.de/A++/V2.4/DTD/A++V2.4.dtd">
<Publisher>
  <PublisherInfo>
    <PublisherName>Springer-Verlag</PublisherName>
    <PublisherLocation>New York</PublisherLocation>
  </PublisherInfo>
  <Journal>
    <JournalInfo JournalProductType="ArchiveJournal" NumberingStyle="Unnumbered">
      <JournalID>12248</JournalID>
      <JournalElectronicISSN>1550-7416</JournalElectronicISSN>
      <JournalTitle>The AAPS Journal</JournalTitle>
      <JournalAbbreviatedTitle>AAPS J</JournalAbbreviatedTitle>
      <JournalSubjectGroup>
        <JournalSubject Code="F" Type="Primary">Pharmacy</JournalSubject>
        <JournalSubject Code="F00008" Priority="1" Type="Secondary">Pharmacy</JournalSubject>
        <JournalSubject Code="B21007" Priority="2" Type="Secondary">Pharmacology/Toxicology</JournalSubject>
        <JournalSubject Code="C12002" Priority="3" Type="Secondary">Biotechnology</JournalSubject>
      </JournalSubjectGroup>
    </JournalInfo>
    <Volume>
      <VolumeInfo TocLevels="0" VolumeType="Regular">
        <VolumeIDStart>7</VolumeIDStart>
        <VolumeIDEnd>7</VolumeIDEnd>
        <VolumeIssueCount>4</VolumeIssueCount>
      </VolumeInfo>
      <Issue IssueType="Regular">
        <IssueInfo TocLevels="0">
          <IssueIDStart>3</IssueIDStart>
          <IssueIDEnd>3</IssueIDEnd>
          <IssueArticleCount>25</IssueArticleCount>
          <IssueHistory>
            <CoverDate>
              <Year>2005</Year>
              <Month>9</Month>
            </CoverDate>
          </IssueHistory>
          <IssueCopyright>
            <CopyrightHolderName>American Association of Pharmaceutical Scientists</CopyrightHolderName>
            <CopyrightYear>2005</CopyrightYear>
          </IssueCopyright>
        </IssueInfo>
        <Article ID="Art14">
          <ArticleInfo ArticleType="OriginalPaper" ContainsESM="No" Language="En" NumberingStyle="Unnumbered" TocLevels="0">
            <ArticleID>73625</ArticleID>
            <ArticleDOI>10.1208/aapsj070364</ArticleDOI>
            <ArticleSequenceNumber>14</ArticleSequenceNumber>
            <ArticleTitle Language="En">The therapeutic potential of drugs that target cannabinoid receptors or modulate the tissue levels or actions of endocannabinoids</ArticleTitle>
            <ArticleFirstPage>E625</ArticleFirstPage>
            <ArticleLastPage>E654</ArticleLastPage>
            <ArticleHistory>
              <RegistrationDate>
                <Year>2008</Year>
                <Month>1</Month>
                <Day>23</Day>
              </RegistrationDate>
              <Received>
                <Year>2005</Year>
                <Month>5</Month>
                <Day>31</Day>
              </Received>
              <Accepted>
                <Year>2005</Year>
                <Month>7</Month>
                <Day>21</Day>
              </Accepted>
            </ArticleHistory>
            <ArticleCopyright>
              <CopyrightHolderName>American Association of Pharmaceutical Scientists</CopyrightHolderName>
              <CopyrightYear>2005</CopyrightYear>
            </ArticleCopyright>
            <ArticleGrants Type="Regular">
              <MetadataGrant Grant="OpenAccess"/>
              <AbstractGrant Grant="OpenAccess"/>
              <BodyPDFGrant Grant="Restricted"/>
              <BodyHTMLGrant Grant="Restricted"/>
              <BibliographyGrant Grant="Restricted"/>
              <ESMGrant Grant="Restricted"/>
            </ArticleGrants>
            <ArticleContext>
              <JournalID>12248</JournalID>
              <VolumeIDStart>7</VolumeIDStart>
              <VolumeIDEnd>7</VolumeIDEnd>
              <IssueIDStart>3</IssueIDStart>
              <IssueIDEnd>3</IssueIDEnd>
            </ArticleContext>
          </ArticleInfo>
          <ArticleHeader>
            <AuthorGroup>
              <Author AffiliationIDS="Aff1" CorrespondingAffiliationID="Aff1">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Roger</GivenName>
                  <GivenName>G.</GivenName>
                  <FamilyName>Pertwee</FamilyName>
                </AuthorName>
                <Contact>
                  <Phone>+44-1224-555740</Phone>
                  <Fax>+44-1224-555844</Fax>
                  <Email>rgp@abdn.ac.uk</Email>
                </Contact>
              </Author>
              <Affiliation ID="Aff1">
                <OrgDivision>School of Medical Sciences, Institute of Medical Sciences</OrgDivision>
                <OrgName>University of Aberdeen</OrgName>
                <OrgAddress>
                  <Street>Foresterhill</Street>
                  <Postcode>AB25 2ZD</Postcode>
                  <City>Aberdeen</City>
                  <Country>Scotland, UK</Country>
                </OrgAddress>
              </Affiliation>
            </AuthorGroup>
            <Abstract ID="Abs1" Language="En">
              <Heading>Abstract</Heading>
              <Para>There are at least 2 types of cannabinoid receptor, CB<Subscript>1</Subscript> and CB<Subscript>2</Subscript>, both G protein coupled. CB<Subscript>1</Subscript> receptors are expressed predominantly at nerve terminals and mediate inhibition of transmitter release, whereas CB<Subscript>2</Subscript> receptors are found mainly on immune cells, their roles including the modulation of cytokine release and of immune cell migration. Endogenous agonists for cannabinoid receptors also exist. These “endocannabinoids” are synthesized on demand and removed from their sites of action by cellular uptake and intracellular enzymic hydrolysis. Endocannabinoids and their receptors together constitute the endocannabinoid system. This review summarizes evidence that there are certain central and peripheral disorders in which increases take place in the release of endocannabinoids onto their receptors and/or in the density or coupling efficiency of these receptors and that this upregulation is protective in some disorders but can have undesirable consequences in others. It also considers therapeutic strategies by which this upregulation might be modulated to clinical advantage. These strategies include the administration of (1) a CB<Subscript>1</Subscript> and/or CB<Subscript>2</Subscript> receptor agonist or antagonist that does or does not readily cross the blood brain barrier; (2) a CB<Subscript>1</Subscript> and/or CB<Subscript>2</Subscript> receptor agonist intrathecally or directly to some other site outside the brain; (3) a partial CB<Subscript>1</Subscript> and/or CB<Subscript>2</Subscript> receptor agonist rather than a full agonist; (4) a CB<Subscript>1</Subscript> and/or CB<Subscript>2</Subscript> receptor agonist together with a noncannabinoid, for example, morphine or codeine; (5) an inhibitor or activator of endocannabinoid biosynthesis, cellular uptake, or metabolism; (6) an allosteric modulator of the CB<Subscript>1</Subscript> receptor; and (7) a CB<Subscript>2</Subscript> receptor inverse agonist.</Para>
            </Abstract>
            <KeywordGroup Language="En">
              <Heading>KeyWords</Heading>
              <Keyword>cannabinoid receptors</Keyword>
              <Keyword>endocannabinoids</Keyword>
              <Keyword>fatty acid amide hydrolase inhibitors</Keyword>
              <Keyword>autoprotection</Keyword>
              <Keyword>therapeutic strategies</Keyword>
            </KeywordGroup>
            <ArticleNote Type="Misc">
              <SimplePara>Published: October 24, 2005</SimplePara>
            </ArticleNote>
          </ArticleHeader>
          <BodyRef FileRef="BodyRef/PDF/12248_2008_Article_73625.pdf" TargetType="OnlinePDF"/>
          <ArticleBackmatter>
            <Bibliography ID="Bib1">
              <Heading>References</Heading>
              <Citation ID="CR1">
                <CitationNumber>1.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>AC</Initials>
                    <FamilyName>Howlett</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>F</Initials>
                    <FamilyName>Barth</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>TI</Initials>
                    <FamilyName>Bonner</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">International Union of Pharmacology. XXVII. Classification of cannabinoid receptors</ArticleTitle>
                  <JournalTitle>Pharmacol Rev.</JournalTitle>
                  <VolumeID>54</VolumeID>
                  <FirstPage>161</FirstPage>
                  <LastPage>202</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12037135</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD38XltVOiuro%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1124/pr.54.2.161</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Howlett AC, Barth F, Bonner TI, et al. International Union of Pharmacology. XXVII. Classification of cannabinoid receptors.<Emphasis Type="Italic">Pharmacol Rev.</Emphasis> 2002;54:161–202.</BibUnstructured>
              </Citation>
              <Citation ID="CR2">
                <CitationNumber>2.</CitationNumber>
                <BibChapter>
                  <BibAuthorName>
                    <Initials>RG</Initials>
                    <FamilyName>Pertwee</FamilyName>
                  </BibAuthorName>
                  <Year>2005</Year>
                  <ChapterTitle Language="En">Pharmacological actions of cannabinoids</ChapterTitle>
                  <BibEditorName>
                    <Initials>RG</Initials>
                    <FamilyName>Pertwee</FamilyName>
                  </BibEditorName>
                  <Eds/>
                  <BookTitle>Cannabinoids, Handbook of Experimental Pharmacology</BookTitle>
                  <PublisherName>Springer-Verlag</PublisherName>
                  <PublisherLocation>Heidelberg, Germany</PublisherLocation>
                  <FirstPage>1</FirstPage>
                  <LastPage>51</LastPage>
                </BibChapter>
                <BibUnstructured>Pertwee RG. Pharmacological actions of cannabinoids. In: Pertwee RG, ed.<Emphasis Type="Italic">Cannabinoids, Handbook of Experimental Pharmacology</Emphasis>. Heidelberg, Germany: Springer-Verlag; 2005;168:1–51.</BibUnstructured>
              </Citation>
              <Citation ID="CR3">
                <CitationNumber>3.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>LA</Initials>
                    <FamilyName>Matsuda</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>SJ</Initials>
                    <FamilyName>Lolait</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>MJ</Initials>
                    <FamilyName>Brownstein</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>AC</Initials>
                    <FamilyName>Young</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>TI</Initials>
                    <FamilyName>Bonner</FamilyName>
                  </BibAuthorName>
                  <Year>1990</Year>
                  <ArticleTitle Language="En">Structure of a cannabinoid receptor and functional expression of the cloned cDNA</ArticleTitle>
                  <JournalTitle>Nature</JournalTitle>
                  <VolumeID>346</VolumeID>
                  <FirstPage>561</FirstPage>
                  <LastPage>564</LastPage>
                  <Occurrence Type="PID">
                    <Handle>2165569</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK3cXls1Ghu7w%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1038/346561a0</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Matsuda LA, Lolait SJ, Brownstein MJ, Young AC, Bonner TI. Structure of a cannabinoid receptor and functional expression of the cloned cDNA.<Emphasis Type="Italic">Nature</Emphasis>. 1990;346:561–564.</BibUnstructured>
              </Citation>
              <Citation ID="CR4">
                <CitationNumber>4.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Munro</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>KL</Initials>
                    <FamilyName>Thomas</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Abu-Shaar</FamilyName>
                  </BibAuthorName>
                  <Year>1993</Year>
                  <ArticleTitle Language="En">Molecular characterization of a peripheral receptor for cannabinoids</ArticleTitle>
                  <JournalTitle>Nature</JournalTitle>
                  <VolumeID>365</VolumeID>
                  <FirstPage>61</FirstPage>
                  <LastPage>65</LastPage>
                  <Occurrence Type="PID">
                    <Handle>7689702</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK3sXmsVWiurk%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1038/365061a0</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Munro S, Thomas KL, Abu-Shaar M. Molecular characterization of a peripheral receptor for cannabinoids.<Emphasis Type="Italic">Nature</Emphasis>. 1993;365:61–65.</BibUnstructured>
              </Citation>
              <Citation ID="CR5">
                <CitationNumber>5.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>RG</Initials>
                    <FamilyName>Pertwee</FamilyName>
                  </BibAuthorName>
                  <Year>1999</Year>
                  <ArticleTitle Language="En">Pharmacology of cannabinoid receptor ligands</ArticleTitle>
                  <JournalTitle>Curr Med Chem</JournalTitle>
                  <VolumeID>6</VolumeID>
                  <FirstPage>635</FirstPage>
                  <LastPage>664</LastPage>
                  <Occurrence Type="PID">
                    <Handle>10469884</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK1MXltlKkurg%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Pertwee RG. Pharmacology of cannabinoid receptor ligands.<Emphasis Type="Italic">Curr Med Chem</Emphasis>. 1999;6:635–664.</BibUnstructured>
              </Citation>
              <Citation ID="CR6">
                <CitationNumber>6.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>RG</Initials>
                    <FamilyName>Pertwee</FamilyName>
                  </BibAuthorName>
                  <Year>2005</Year>
                  <ArticleTitle Language="En">Inverse agonism and neutral antagonism at cannabinoid CB<Subscript>1</Subscript> receptors</ArticleTitle>
                  <JournalTitle>Life Sci.</JournalTitle>
                  <VolumeID>76</VolumeID>
                  <FirstPage>1307</FirstPage>
                  <LastPage>1324</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15670612</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2MXntVSksQ%3D%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/j.lfs.2004.10.025</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Pertwee RG. Inverse agonism and neutral antagonism at cannabinoid CB<Subscript>1</Subscript> receptors.<Emphasis Type="Italic">Life Sci.</Emphasis> 2005;76:1307–1324.</BibUnstructured>
              </Citation>
              <Citation ID="CR7">
                <CitationNumber>7.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>RG</Initials>
                    <FamilyName>Pertwee</FamilyName>
                  </BibAuthorName>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">Novel pharmacological targets for cannabinoids</ArticleTitle>
                  <JournalTitle>Curr Neuropharmacol</JournalTitle>
                  <VolumeID>2</VolumeID>
                  <FirstPage>9</FirstPage>
                  <LastPage>29</LastPage>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2cXlsFWmtQ%3D%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.2174/1570159043476927</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Pertwee RG. Novel pharmacological targets for cannabinoids.<Emphasis Type="Italic">Curr Neuropharmacol</Emphasis>. 2004;2:9–29.</BibUnstructured>
              </Citation>
              <Citation ID="CR8">
                <CitationNumber>8.</CitationNumber>
                <BibUnstructured>Price MRBaillie GThomas A. Allosteric modulation of the cannabinoid CB<Subscript>1</Subscript> receptor.<Emphasis Type="Italic">Mol Pharmacol</Emphasis>. In press.</BibUnstructured>
              </Citation>
              <Citation ID="CR9">
                <CitationNumber>9.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>HB</Initials>
                    <FamilyName>Bradshaw</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JM</Initials>
                    <FamilyName>Walker</FamilyName>
                  </BibAuthorName>
                  <Year>2005</Year>
                  <ArticleTitle Language="En">The expanding field of cannabimimetic and related lipid mediators</ArticleTitle>
                  <JournalTitle>Br J Pharmacol</JournalTitle>
                  <VolumeID>144</VolumeID>
                  <FirstPage>459</FirstPage>
                  <LastPage>465</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15655504</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2MXhsVOmtr8%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1038/sj.bjp.0706093</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Bradshaw HB, Walker JM. The expanding field of cannabimimetic and related lipid mediators.<Emphasis Type="Italic">Br J Pharmacol</Emphasis>. 2005;144:459–465.</BibUnstructured>
              </Citation>
              <Citation ID="CR10">
                <CitationNumber>10.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Steffens</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Zentner</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Honegger</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>TJ</Initials>
                    <FamilyName>Feuerstein</FamilyName>
                  </BibAuthorName>
                  <Year>2005</Year>
                  <ArticleTitle Language="En">Binding affinity and agonist activity of putative endogenous cannabinoids at the human neocortical CB<Subscript>1</Subscript> receptor</ArticleTitle>
                  <JournalTitle>Biochem Pharmacol</JournalTitle>
                  <VolumeID>69</VolumeID>
                  <FirstPage>169</FirstPage>
                  <LastPage>178</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15588725</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2cXhtVGgtbnJ</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/j.bcp.2004.08.033</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Steffens M, Zentner J, Honegger J, Feuerstein TJ. Binding affinity and agonist activity of putative endogenous cannabinoids at the human neocortical CB<Subscript>1</Subscript> receptor.<Emphasis Type="Italic">Biochem Pharmacol</Emphasis>. 2005;69:169–178.</BibUnstructured>
              </Citation>
              <Citation ID="CR11">
                <CitationNumber>11.</CitationNumber>
                <BibChapter>
                  <BibAuthorName>
                    <Initials>GA</Initials>
                    <FamilyName>Cabral</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Staab</FamilyName>
                  </BibAuthorName>
                  <Year>2005</Year>
                  <ChapterTitle Language="En">Effects on the immune system</ChapterTitle>
                  <BibEditorName>
                    <Initials>RG</Initials>
                    <FamilyName>Pertwee</FamilyName>
                  </BibEditorName>
                  <Eds/>
                  <BookTitle>Cannabinoids, Handbook of Experimental Pharmacology</BookTitle>
                  <PublisherName>Springer-Verlag</PublisherName>
                  <PublisherLocation>Heidelberg, Germany</PublisherLocation>
                  <FirstPage>385</FirstPage>
                  <LastPage>423</LastPage>
                </BibChapter>
                <BibUnstructured>Cabral GA, Staab A. Effects on the immune system. In: Pertwee RG, ed.<Emphasis Type="Italic">Cannabinoids, Handbook of Experimental Pharmacology</Emphasis>. Heidelberg, Germany: Springer-Verlag; 2005;168:385–423.</BibUnstructured>
              </Citation>
              <Citation ID="CR12">
                <CitationNumber>12.</CitationNumber>
                <BibChapter>
                  <BibAuthorName>
                    <Initials>B</Initials>
                    <FamilyName>Szabo</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>E</Initials>
                    <FamilyName>Schlicker</FamilyName>
                  </BibAuthorName>
                  <Year>2005</Year>
                  <ChapterTitle Language="En">Effects of cannabinoids on neurotransmission</ChapterTitle>
                  <BibEditorName>
                    <Initials>RG</Initials>
                    <FamilyName>Pertwee</FamilyName>
                  </BibEditorName>
                  <Eds/>
                  <BookTitle>Cannabinoids, Handbook of Experimental Pharmacology</BookTitle>
                  <PublisherName>Springer-Verlag</PublisherName>
                  <PublisherLocation>Heidelberg, Germany</PublisherLocation>
                  <FirstPage>327</FirstPage>
                  <LastPage>365</LastPage>
                </BibChapter>
                <BibUnstructured>Szabo B, Schlicker E. Effects of cannabinoids on neurotransmission. In: Pertwee RG, ed.<Emphasis Type="Italic">Cannabinoids, Handbook of Experimental Pharmacology</Emphasis>. Heidelberg, Germany: Springer-Verlag; 2005;168:327–365.</BibUnstructured>
              </Citation>
              <Citation ID="CR13">
                <CitationNumber>13.</CitationNumber>
                <BibChapter>
                  <BibAuthorName>
                    <Initials>CW</Initials>
                    <FamilyName>Vaughan</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>MJ</Initials>
                    <FamilyName>Christie</FamilyName>
                  </BibAuthorName>
                  <Year>2005</Year>
                  <ChapterTitle Language="En">Retrograde signalling by endocannabinoids</ChapterTitle>
                  <BibEditorName>
                    <Initials>RG</Initials>
                    <FamilyName>Pertwee</FamilyName>
                  </BibEditorName>
                  <Eds/>
                  <BookTitle>Cannabinoids, Handbook of Experimental Pharmacology</BookTitle>
                  <PublisherName>Springer-Verlag</PublisherName>
                  <PublisherLocation>Heidelberg, Germany</PublisherLocation>
                  <FirstPage>367</FirstPage>
                  <LastPage>383</LastPage>
                </BibChapter>
                <BibUnstructured>Vaughan CW, Christie MJ. Retrograde signalling by endocannabinoids. In: Pertwee RG, ed.<Emphasis Type="Italic">Cannabinoids, Handbook of Experimental Pharmacology</Emphasis>. Heidelberg, Germany: Springer-Verlag; 2005;168:367–383.</BibUnstructured>
              </Citation>
              <Citation ID="CR14">
                <CitationNumber>14.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>TJ</Initials>
                    <FamilyName>Price</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Patwardhan</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>AN</Initials>
                    <FamilyName>Akopian</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>KM</Initials>
                    <FamilyName>Hargreaves</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>CM</Initials>
                    <FamilyName>Flores</FamilyName>
                  </BibAuthorName>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">Modulation of trigeminal sensory neuron activity by the dual cannabinoid-vanilloid agonists anandamide,<Emphasis Type="Italic">N</Emphasis>-arachidonoyl-dopamine and arachidonyl-2-chloroethylamide</ArticleTitle>
                  <JournalTitle>Br J Pharmacol</JournalTitle>
                  <VolumeID>141</VolumeID>
                  <FirstPage>1118</FirstPage>
                  <LastPage>1130</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15006899</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2cXjs1yhtro%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1038/sj.bjp.0705711</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Price TJ, Patwardhan A, Akopian AN, Hargreaves KM, Flores CM. Modulation of trigeminal sensory neuron activity by the dual cannabinoid-vanilloid agonists anandamide,<Emphasis Type="Italic">N</Emphasis>-arachidonoyl-dopamine and arachidonyl-2-chloroethylamide.<Emphasis Type="Italic">Br J Pharmacol</Emphasis>. 2004;141:1118–1130.</BibUnstructured>
              </Citation>
              <Citation ID="CR15">
                <CitationNumber>15.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>CL</Initials>
                    <FamilyName>Baker</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JJ</Initials>
                    <FamilyName>McDougall</FamilyName>
                  </BibAuthorName>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">The cannabinomimetic arachidonyl-2-chloroethylamide (ACEA) acts on capsaicin-sensitive TRPV1 receptors but not cannabinoid receptors in rat joints</ArticleTitle>
                  <JournalTitle>Br J Pharmacol</JournalTitle>
                  <VolumeID>142</VolumeID>
                  <FirstPage>1361</FirstPage>
                  <LastPage>1367</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15277316</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2cXntlCrt7g%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1038/sj.bjp.0705902</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Baker CL, McDougall JJ. The cannabinomimetic arachidonyl-2-chloroethylamide (ACEA) acts on capsaicin-sensitive TRPV1 receptors but not cannabinoid receptors in rat joints.<Emphasis Type="Italic">Br J Pharmacol</Emphasis>. 2004;142:1361–1367.</BibUnstructured>
              </Citation>
              <Citation ID="CR16">
                <CitationNumber>16.</CitationNumber>
                <BibChapter>
                  <BibAuthorName>
                    <Initials>V</Initials>
                    <FamilyName>Marzo</FamilyName>
                    <Particle>Di</Particle>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>L</Initials>
                    <FamilyName>Petrocellis</FamilyName>
                    <Particle>De</Particle>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>T</Initials>
                    <FamilyName>Bisogno</FamilyName>
                  </BibAuthorName>
                  <Year>2005</Year>
                  <ChapterTitle Language="En">The biosynthesis, fate and pharmacological properties of endocannabinoids</ChapterTitle>
                  <BibEditorName>
                    <Initials>RG</Initials>
                    <FamilyName>Pertwee</FamilyName>
                  </BibEditorName>
                  <Eds/>
                  <BookTitle>Camabinoids, Handbook of Experimental Pharmacology</BookTitle>
                  <PublisherName>Springer-Verlag</PublisherName>
                  <PublisherLocation>Heidelberg, Germany</PublisherLocation>
                  <FirstPage>147</FirstPage>
                  <LastPage>185</LastPage>
                </BibChapter>
                <BibUnstructured>Di Marzo V, De Petrocellis L, Bisogno T. The biosynthesis, fate and pharmacological properties of endocannabinoids. In: Pertwee RG, ed.<Emphasis Type="Italic">Camabinoids, Handbook of Experimental Pharmacology</Emphasis>. Heidelberg, Germany: Springer-Verlag; 2005;168:147–185.</BibUnstructured>
              </Citation>
              <Citation ID="CR17">
                <CitationNumber>17.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>T</Initials>
                    <FamilyName>Bisogno</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>D</Initials>
                    <FamilyName>Melck</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>MY</Initials>
                    <FamilyName>Bobrov</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2000</Year>
                  <ArticleTitle Language="En">
                    <Emphasis Type="Italic">N</Emphasis>-acyl-dopamines: novel synthetic CB<Subscript>1</Subscript> cannabinoid-receptor ligands and inhibitors of anandamide inactivation with cannabimimetic activity<Emphasis Type="Italic">in vitro</Emphasis> and<Emphasis Type="Italic">in vivo</Emphasis>
                  </ArticleTitle>
                  <JournalTitle>Biochem J.</JournalTitle>
                  <VolumeID>351</VolumeID>
                  <FirstPage>817</FirstPage>
                  <LastPage>824</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11042139</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3cXotF2qsLc%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1042/0264-6021:3510817</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Bisogno T, Melck D, Bobrov MY, et al.<Emphasis Type="Italic">N</Emphasis>-acyl-dopamines: novel synthetic CB<Subscript>1</Subscript> cannabinoid-receptor ligands and inhibitors of anandamide inactivation with cannabimimetic activity<Emphasis Type="Italic">in vitro</Emphasis> and<Emphasis Type="Italic">in vivo</Emphasis>.<Emphasis Type="Italic">Biochem J.</Emphasis> 2000;351:817–824.</BibUnstructured>
              </Citation>
              <Citation ID="CR18">
                <CitationNumber>18.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>JD</Initials>
                    <FamilyName>Leggett</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Aspley</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>SRG</Initials>
                    <FamilyName>Beckett</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>AM</Initials>
                    <FamilyName>D’Antona</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>DA</Initials>
                    <FamilyName>Kendall</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>DA</Initials>
                    <FamilyName>Kendall</FamilyName>
                  </BibAuthorName>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">Oleamide is a selective endogenous agonist of rat and human CB<Subscript>1</Subscript> cannabinoid receptors</ArticleTitle>
                  <JournalTitle>Br J Pharmacol</JournalTitle>
                  <VolumeID>141</VolumeID>
                  <FirstPage>253</FirstPage>
                  <LastPage>262</LastPage>
                  <Occurrence Type="PID">
                    <Handle>14707029</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2cXhsFOis7Y%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1038/sj.bjp.0705607</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Leggett JD, Aspley S, Beckett SRG, D’Antona AM, Kendall DA, Kendall DA. Oleamide is a selective endogenous agonist of rat and human CB<Subscript>1</Subscript> cannabinoid receptors.<Emphasis Type="Italic">Br J Pharmacol</Emphasis>. 2004;141:253–262.</BibUnstructured>
              </Citation>
              <Citation ID="CR19">
                <CitationNumber>19.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>AC</Initials>
                    <FamilyName>Porter</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J-M</Initials>
                    <FamilyName>Sauer</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>MD</Initials>
                    <FamilyName>Knierman</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">Characterization of a novel endocannabinoid, virodhamine, with antagonist activity at the CB<Subscript>1</Subscript> receptor</ArticleTitle>
                  <JournalTitle>J Pharmacol Exp Ther</JournalTitle>
                  <VolumeID>301</VolumeID>
                  <FirstPage>1020</FirstPage>
                  <LastPage>1024</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12023533</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD38XktlGjsLc%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1124/jpet.301.3.1020</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Porter AC, Sauer J-M, Knierman MD, et al. Characterization of a novel endocannabinoid, virodhamine, with antagonist activity at the CB<Subscript>1</Subscript> receptor.<Emphasis Type="Italic">J Pharmacol Exp Ther</Emphasis>. 2002;301:1020–1024.</BibUnstructured>
              </Citation>
              <Citation ID="CR20">
                <CitationNumber>20.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>BF</Initials>
                    <FamilyName>Cravatt</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>AH</Initials>
                    <FamilyName>Lichtman</FamilyName>
                  </BibAuthorName>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">The endogenous cannabinoid system and its role in nociceptive behavior</ArticleTitle>
                  <JournalTitle>J Neurobiol</JournalTitle>
                  <VolumeID>61</VolumeID>
                  <FirstPage>149</FirstPage>
                  <LastPage>160</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15362158</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2cXovVajtrs%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1002/neu.20080</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Cravatt BF, Lichtman AH. The endogenous cannabinoid system and its role in nociceptive behavior.<Emphasis Type="Italic">J Neurobiol</Emphasis>. 2004;61:149–160.</BibUnstructured>
              </Citation>
              <Citation ID="CR21">
                <CitationNumber>21.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>CJ</Initials>
                    <FamilyName>Hillard</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Jarrahian</FamilyName>
                  </BibAuthorName>
                  <Year>2003</Year>
                  <ArticleTitle Language="En">Cellular accumulation of anandamide: consensus and controversy</ArticleTitle>
                  <JournalTitle>Br J Pharmacol</JournalTitle>
                  <VolumeID>140</VolumeID>
                  <FirstPage>802</FirstPage>
                  <LastPage>808</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12970089</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3sXps1eksr8%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1038/sj.bjp.0705468</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Hillard CJ, Jarrahian A. Cellular accumulation of anandamide: consensus and controversy.<Emphasis Type="Italic">Br J Pharmacol</Emphasis>. 2003;140:802–808.</BibUnstructured>
              </Citation>
              <Citation ID="CR22">
                <CitationNumber>22.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>N</Initials>
                    <FamilyName>Ueda</FamilyName>
                  </BibAuthorName>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">Endocannabinoid hydrolases</ArticleTitle>
                  <JournalTitle>Prostaglandins Other Lipid Mediat</JournalTitle>
                  <VolumeID>68–9</VolumeID>
                  <FirstPage>521</FirstPage>
                  <LastPage>534</LastPage>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0090-6980(02)00053-9</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Ueda N. Endocannabinoid hydrolases.<Emphasis Type="Italic">Prostaglandins Other Lipid Mediat</Emphasis>. 2002;68–9:521–534.</BibUnstructured>
              </Citation>
              <Citation ID="CR23">
                <CitationNumber>23.</CitationNumber>
                <BibChapter>
                  <BibAuthorName>
                    <Initials>W-SV</Initials>
                    <FamilyName>Ho</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>CJ</Initials>
                    <FamilyName>Hillard</FamilyName>
                  </BibAuthorName>
                  <Year>2005</Year>
                  <ChapterTitle Language="En">Modulators of endocannabinoid enzymic hydrolysis and membrane transport</ChapterTitle>
                  <BibEditorName>
                    <Initials>RG</Initials>
                    <FamilyName>Pertwee</FamilyName>
                  </BibEditorName>
                  <Eds/>
                  <BookTitle>Cannabinoids, Handbook of Experimental Pharmacology</BookTitle>
                  <PublisherName>Springer-Verlag</PublisherName>
                  <PublisherLocation>Heidelberg, Germany</PublisherLocation>
                  <FirstPage>187</FirstPage>
                  <LastPage>207</LastPage>
                </BibChapter>
                <BibUnstructured>Ho W-SV, Hillard CJ. Modulators of endocannabinoid enzymic hydrolysis and membrane transport. In: Pertwee RG, ed.<Emphasis Type="Italic">Cannabinoids, Handbook of Experimental Pharmacology</Emphasis>. Heidelberg, Germany: Springer-Verlag; 2005;168:187–207.</BibUnstructured>
              </Citation>
              <Citation ID="CR24">
                <CitationNumber>24.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>AI</Initials>
                    <FamilyName>Gulyas</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>BF</Initials>
                    <FamilyName>Cravatt</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>MH</Initials>
                    <FamilyName>Bracey</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">Segregation of 2 endocannabinoid-hydrolyzing enzymes into pre- and postsynaptic compartments in the rat hippocampus, cerebellum and amygdala</ArticleTitle>
                  <JournalTitle>Eur J Neurosci</JournalTitle>
                  <VolumeID>20</VolumeID>
                  <FirstPage>441</FirstPage>
                  <LastPage>458</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15233753</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:DC%2BD2czjt1Gntg%3D%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1111/j.1460-9568.2004.03428.x</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Gulyas AI, Cravatt BF, Bracey MH, et al. Segregation of 2 endocannabinoid-hydrolyzing enzymes into pre- and postsynaptic compartments in the rat hippocampus, cerebellum and amygdala.<Emphasis Type="Italic">Eur J Neurosci</Emphasis>. 2004;20:441–458.</BibUnstructured>
              </Citation>
              <Citation ID="CR25">
                <CitationNumber>25.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>N</Initials>
                    <FamilyName>Ueda</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>K</Initials>
                    <FamilyName>Yamanaka</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Yamamoto</FamilyName>
                  </BibAuthorName>
                  <Year>2001</Year>
                  <ArticleTitle Language="En">Purification and characterization of an acid amidase selective for<Emphasis Type="Italic">N</Emphasis>-palmitoylethanolamine, a putative endogenous anti-inflammatory substance</ArticleTitle>
                  <JournalTitle>J Biol Chem</JournalTitle>
                  <VolumeID>276</VolumeID>
                  <FirstPage>35552</FirstPage>
                  <LastPage>35557</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11463796</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3MXntFahs7g%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1074/jbc.M106261200</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Ueda N, Yamanaka K, Yamamoto S. Purification and characterization of an acid amidase selective for<Emphasis Type="Italic">N</Emphasis>-palmitoylethanolamine, a putative endogenous anti-inflammatory substance.<Emphasis Type="Italic">J Biol Chem</Emphasis>. 2001;276:35552–35557.</BibUnstructured>
              </Citation>
              <Citation ID="CR26">
                <CitationNumber>26.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Verme</FamilyName>
                    <Particle>Lo</Particle>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Gaetani</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Fu</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>F</Initials>
                    <FamilyName>Oveisi</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>K</Initials>
                    <FamilyName>Burton</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>D</Initials>
                    <FamilyName>Piomelli</FamilyName>
                  </BibAuthorName>
                  <Year>2005</Year>
                  <ArticleTitle Language="En">Regulation of food intake by oleoylethanolamide</ArticleTitle>
                  <JournalTitle>Cell Mol Life Sci</JournalTitle>
                  <VolumeID>62</VolumeID>
                  <FirstPage>708</FirstPage>
                  <LastPage>716</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15770421</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1007/s00018-004-4494-0</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2MXktlymt70%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Lo Verme J, Gaetani S, Fu J, Oveisi F, Burton K, Piomelli D. Regulation of food intake by oleoylethanolamide.<Emphasis Type="Italic">Cell Mol Life Sci</Emphasis>. 2005;62:708–716.</BibUnstructured>
              </Citation>
              <Citation ID="CR27">
                <CitationNumber>27.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>D</Initials>
                    <FamilyName>Fegley</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Gaetani</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Duranti</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2005</Year>
                  <ArticleTitle Language="En">Characterization of the fatty acid amide hydrolase inhibitor cyclohexyl carbamic acid 3′-carbamoyl-biphenyl-3-yl ester (URB597): effects on anandamide and oleoylethanolamide deactivation</ArticleTitle>
                  <JournalTitle>J Pharmacol Exp Ther</JournalTitle>
                  <VolumeID>313</VolumeID>
                  <FirstPage>352</FirstPage>
                  <LastPage>358</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15579492</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2MXjtlSntro%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1124/jpet.104.078980</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Fegley D, Gaetani S, Duranti A, et al. Characterization of the fatty acid amide hydrolase inhibitor cyclohexyl carbamic acid 3′-carbamoyl-biphenyl-3-yl ester (URB597): effects on anandamide and oleoylethanolamide deactivation.<Emphasis Type="Italic">J Pharmacol Exp Ther</Emphasis>. 2005;313:352–358.</BibUnstructured>
              </Citation>
              <Citation ID="CR28">
                <CitationNumber>28.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>KR</Initials>
                    <FamilyName>Kozak</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>LJ</Initials>
                    <FamilyName>Marnett</FamilyName>
                  </BibAuthorName>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">Oxidative metabolism of endocannabinoids</ArticleTitle>
                  <JournalTitle>Prostaglandins Leukot Essent Fatty Acids</JournalTitle>
                  <VolumeID>66</VolumeID>
                  <FirstPage>211</FirstPage>
                  <LastPage>220</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12052037</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD38Xlt1Kksro%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1054/plef.2001.0359</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Kozak KR, Marnett LJ. Oxidative metabolism of endocannabinoids.<Emphasis Type="Italic">Prostaglandins Leukot Essent Fatty Acids</Emphasis>. 2002;66:211–220.</BibUnstructured>
              </Citation>
              <Citation ID="CR29">
                <CitationNumber>29.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>SM</Initials>
                    <FamilyName>Saario</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JR</Initials>
                    <FamilyName>Savinainen</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JT</Initials>
                    <FamilyName>Laitinen</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>T</Initials>
                    <FamilyName>Järvinen</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>R</Initials>
                    <FamilyName>Niemi</FamilyName>
                  </BibAuthorName>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">Monoglyceride lipase-like enzymatic activity is responsible for hydrolysis of 2-arachidonoylglycerol in rat cerebellar membranes</ArticleTitle>
                  <JournalTitle>Biochem Pharmacol</JournalTitle>
                  <VolumeID>67</VolumeID>
                  <FirstPage>1381</FirstPage>
                  <LastPage>1387</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15013854</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2cXhvVyhsLw%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/j.bcp.2003.12.003</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Saario SM, Savinainen JR, Laitinen JT, Järvinen T, Niemi R. Monoglyceride lipase-like enzymatic activity is responsible for hydrolysis of 2-arachidonoylglycerol in rat cerebellar membranes.<Emphasis Type="Italic">Biochem Pharmacol</Emphasis>. 2004;67:1381–1387.</BibUnstructured>
              </Citation>
              <Citation ID="CR30">
                <CitationNumber>30.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>TP</Initials>
                    <FamilyName>Dinh</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Kathuria</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>D</Initials>
                    <FamilyName>Piomelli</FamilyName>
                  </BibAuthorName>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">RNA interference suggests a primary role for monoacylglycerol lipase in the degradation of the endocannabinoid 2-arachidonoylglycerol</ArticleTitle>
                  <JournalTitle>Mol Pharmacol</JournalTitle>
                  <VolumeID>66</VolumeID>
                  <FirstPage>1260</FirstPage>
                  <LastPage>1264</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15272052</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2cXptVKmtLk%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1124/mol.104.002071</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Dinh TP, Kathuria S, Piomelli D. RNA interference suggests a primary role for monoacylglycerol lipase in the degradation of the endocannabinoid 2-arachidonoylglycerol.<Emphasis Type="Italic">Mol Pharmacol</Emphasis>. 2004;66:1260–1264.</BibUnstructured>
              </Citation>
              <Citation ID="CR31">
                <CitationNumber>31.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>F</Initials>
                    <FamilyName>Fezza</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>T</Initials>
                    <FamilyName>Bisogno</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Minassi</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>G</Initials>
                    <FamilyName>Appendino</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>R</Initials>
                    <FamilyName>Mechoulam</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>V</Initials>
                    <FamilyName>Marzo</FamilyName>
                    <Particle>Di</Particle>
                  </BibAuthorName>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">Noladin ether, a putative novel endocannabinoid: inactivation mechanisms and a sensitive method for its quantification in rat tissues</ArticleTitle>
                  <JournalTitle>FEBS Lett</JournalTitle>
                  <VolumeID>513</VolumeID>
                  <FirstPage>294</FirstPage>
                  <LastPage>298</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11904167</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD38XitFejsb4%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0014-5793(02)02341-4</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Fezza F, Bisogno T, Minassi A, Appendino G, Mechoulam R, Di Marzo V. Noladin ether, a putative novel endocannabinoid: inactivation mechanisms and a sensitive method for its quantification in rat tissues.<Emphasis Type="Italic">FEBS Lett</Emphasis>. 2002;513:294–298.</BibUnstructured>
              </Citation>
              <Citation ID="CR32">
                <CitationNumber>32.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>L</Initials>
                    <FamilyName>Petrocellis</FamilyName>
                    <Particle>De</Particle>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JB</Initials>
                    <FamilyName>Davis</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>V</Initials>
                    <FamilyName>Marzo</FamilyName>
                    <Particle>Di</Particle>
                  </BibAuthorName>
                  <Year>2001</Year>
                  <ArticleTitle Language="En">Palmitoylethanolamide enhances anandamide stimulation of human vanilloid VR1 receptors</ArticleTitle>
                  <JournalTitle>FEBS Lett</JournalTitle>
                  <VolumeID>506</VolumeID>
                  <FirstPage>253</FirstPage>
                  <LastPage>256</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11602256</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0014-5793(01)02934-9</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>De Petrocellis L, Davis JB, Di Marzo V. Palmitoylethanolamide enhances anandamide stimulation of human vanilloid VR1 receptors.<Emphasis Type="Italic">FEBS Lett</Emphasis>. 2001;506:253–256.</BibUnstructured>
              </Citation>
              <Citation ID="CR33">
                <CitationNumber>33.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>T</Initials>
                    <FamilyName>Sheskin</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>L</Initials>
                    <FamilyName>Hanus</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Slager</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>Z</Initials>
                    <FamilyName>Vogel</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>R</Initials>
                    <FamilyName>Mechoulam</FamilyName>
                  </BibAuthorName>
                  <Year>1997</Year>
                  <ArticleTitle Language="En">Structural requirements for binding of anandamide-type compounds to the brain cannabinoid receptor</ArticleTitle>
                  <JournalTitle>J Med Chem</JournalTitle>
                  <VolumeID>40</VolumeID>
                  <FirstPage>659</FirstPage>
                  <LastPage>667</LastPage>
                  <Occurrence Type="PID">
                    <Handle>9057852</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK2sXhsFWns7k%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1021/jm960752x</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Sheskin T, Hanus L, Slager J, Vogel Z, Mechoulam R. Structural requirements for binding of anandamide-type compounds to the brain cannabinoid receptor.<Emphasis Type="Italic">J Med Chem</Emphasis>. 1997;40:659–667.</BibUnstructured>
              </Citation>
              <Citation ID="CR34">
                <CitationNumber>34.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>SR</Initials>
                    <FamilyName>Fernando</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>RG</Initials>
                    <FamilyName>Pertwee</FamilyName>
                  </BibAuthorName>
                  <Year>1997</Year>
                  <ArticleTitle Language="En">Evidence that methyl arachidonyl fluorophosphonate is an irreversible cannabinoid receptor antagonist</ArticleTitle>
                  <JournalTitle>Br J Pharmacol</JournalTitle>
                  <VolumeID>121</VolumeID>
                  <FirstPage>1716</FirstPage>
                  <LastPage>1720</LastPage>
                  <Occurrence Type="PID">
                    <Handle>9283708</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK2sXlslKjtrs%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1038/sj.bjp.0701303</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Fernando SR, Pertwee RG. Evidence that methyl arachidonyl fluorophosphonate is an irreversible cannabinoid receptor antagonist.<Emphasis Type="Italic">Br J Pharmacol</Emphasis>. 1997;121:1716–1720.</BibUnstructured>
              </Citation>
              <Citation ID="CR35">
                <CitationNumber>35.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>JR</Initials>
                    <FamilyName>Savinainen</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>SM</Initials>
                    <FamilyName>Saario</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>R</Initials>
                    <FamilyName>Niemi</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>T</Initials>
                    <FamilyName>Järvinen</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JT</Initials>
                    <FamilyName>Laitinen</FamilyName>
                  </BibAuthorName>
                  <Year>2003</Year>
                  <ArticleTitle Language="En">An optimized approach to study endocannabinoid signaling: evidence against constitutive activity of rat brain adenosine A<Subscript>1</Subscript> and cannabinoid CB<Subscript>1</Subscript> receptors</ArticleTitle>
                  <JournalTitle>Br J Pharmacol</JournalTitle>
                  <VolumeID>140</VolumeID>
                  <FirstPage>1451</FirstPage>
                  <LastPage>1459</LastPage>
                  <Occurrence Type="PID">
                    <Handle>14623770</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2cXhsV2qtw%3D%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1038/sj.bjp.0705577</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Savinainen JR, Saario SM, Niemi R, Järvinen T, Laitinen JT. An optimized approach to study endocannabinoid signaling: evidence against constitutive activity of rat brain adenosine A<Subscript>1</Subscript> and cannabinoid CB<Subscript>1</Subscript> receptors.<Emphasis Type="Italic">Br J Pharmacol</Emphasis>. 2003;140:1451–1459.</BibUnstructured>
              </Citation>
              <Citation ID="CR36">
                <CitationNumber>36.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>K</Initials>
                    <FamilyName>Nithipatikom</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>MP</Initials>
                    <FamilyName>Endsley</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>MA</Initials>
                    <FamilyName>Isbell</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">2-Arachidonoylglycerol: a novel inhibitor of androgen-independent prostate cancer cell invasion</ArticleTitle>
                  <JournalTitle>Cancer Res</JournalTitle>
                  <VolumeID>64</VolumeID>
                  <FirstPage>8826</FirstPage>
                  <LastPage>8830</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15604240</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2cXhtVOmsL7O</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1158/0008-5472.CAN-04-3136</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Nithipatikom K, Endsley MP, Isbell MA, et al. 2-Arachidonoylglycerol: a novel inhibitor of androgen-independent prostate cancer cell invasion.<Emphasis Type="Italic">Cancer Res</Emphasis>. 2004;64:8826–8830.</BibUnstructured>
              </Citation>
              <Citation ID="CR37">
                <CitationNumber>37.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Kathuria</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Gaetani</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>D</Initials>
                    <FamilyName>Fegley</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2003</Year>
                  <ArticleTitle Language="En">Modulation of anxiety through blockade of anandamide hyyrolysis</ArticleTitle>
                  <JournalTitle>Nat Med</JournalTitle>
                  <VolumeID>9</VolumeID>
                  <FirstPage>76</FirstPage>
                  <LastPage>81</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12461523</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3sXivF2l</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1038/nm803</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Kathuria S, Gaetani S, Fegley D, et al. Modulation of anxiety through blockade of anandamide hyyrolysis.<Emphasis Type="Italic">Nat Med</Emphasis>. 2003;9:76–81.</BibUnstructured>
              </Citation>
              <Citation ID="CR38">
                <CitationNumber>38.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>AH</Initials>
                    <FamilyName>Lichtman</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>D</Initials>
                    <FamilyName>Leung</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>CC</Initials>
                    <FamilyName>Shelton</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">Reversible inhibitors of fatty acid amide hydrolase that promote analgesia: evidence for an unprecedented combination of potency and selectivity</ArticleTitle>
                  <JournalTitle>J Pharmacol Exp Ther</JournalTitle>
                  <VolumeID>311</VolumeID>
                  <FirstPage>441</FirstPage>
                  <LastPage>448</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15229230</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2cXptVKrt7k%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1124/jpet.104.069401</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Lichtman AH, Leung D, Shelton CC, et al. Reversible inhibitors of fatty acid amide hydrolase that promote analgesia: evidence for an unprecedented combination of potency and selectivity.<Emphasis Type="Italic">J Pharmacol Exp Ther</Emphasis>. 2004;311:441–448.</BibUnstructured>
              </Citation>
              <Citation ID="CR39">
                <CitationNumber>39.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>SM</Initials>
                    <FamilyName>Huang</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>T</Initials>
                    <FamilyName>Bisogno</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>TJ</Initials>
                    <FamilyName>Petros</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2001</Year>
                  <ArticleTitle Language="En">Identification of a new class of molecules, the arachidonyl amino acids, and characterization of one member that inhibits pain</ArticleTitle>
                  <JournalTitle>J Biol Chem</JournalTitle>
                  <VolumeID>276</VolumeID>
                  <FirstPage>42639</FirstPage>
                  <LastPage>42644</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11518719</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3MXptlemur8%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1074/jbc.M107351200</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Huang SM, Bisogno T, Petros TJ, et al. Identification of a new class of molecules, the arachidonyl amino acids, and characterization of one member that inhibits pain.<Emphasis Type="Italic">J Biol Chem</Emphasis>. 2001;276:42639–42644.</BibUnstructured>
              </Citation>
              <Citation ID="CR40">
                <CitationNumber>40.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>T</Initials>
                    <FamilyName>Bisogno</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>D</Initials>
                    <FamilyName>Melck</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>L</Initials>
                    <FamilyName>Petrocellis</FamilyName>
                    <Particle>De</Particle>
                  </BibAuthorName>
                  <Etal/>
                  <Year>1998</Year>
                  <ArticleTitle Language="En">Arachidonoylserotonin and other novel inhibitors of fatty acid amide hydrolase</ArticleTitle>
                  <JournalTitle>Biochem Biophys Res Commun</JournalTitle>
                  <VolumeID>248</VolumeID>
                  <FirstPage>515</FirstPage>
                  <LastPage>522</LastPage>
                  <Occurrence Type="PID">
                    <Handle>9703957</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK1cXlt1arsb0%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1006/bbrc.1998.8874</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Bisogno T, Melck D, De Petrocellis L, et al. Arachidonoylserotonin and other novel inhibitors of fatty acid amide hydrolase.<Emphasis Type="Italic">Biochem Biophys Res Commun</Emphasis>. 1998;248:515–522.</BibUnstructured>
              </Citation>
              <Citation ID="CR41">
                <CitationNumber>41.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Ligresti</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>T</Initials>
                    <FamilyName>Bisogno</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>I</Initials>
                    <FamilyName>Matias</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2003</Year>
                  <ArticleTitle Language="En">Possible endocannabinoid control of colorectal cancer growth</ArticleTitle>
                  <JournalTitle>Gastroenterology</JournalTitle>
                  <VolumeID>125</VolumeID>
                  <FirstPage>677</FirstPage>
                  <LastPage>687</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12949714</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3sXnvVSiurw%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0016-5085(03)00881-3</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Ligresti A, Bisogno T, Matias I, et al. Possible endocannabinoid control of colorectal cancer growth.<Emphasis Type="Italic">Gastroenterology</Emphasis>. 2003;125:677–687.</BibUnstructured>
              </Citation>
              <Citation ID="CR42">
                <CitationNumber>42.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>K-O</Initials>
                    <FamilyName>Jonsson</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Vandevoorde</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>DM</Initials>
                    <FamilyName>Lambert</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>G</Initials>
                    <FamilyName>Tiger</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>CJ</Initials>
                    <FamilyName>Fowler</FamilyName>
                  </BibAuthorName>
                  <Year>2001</Year>
                  <ArticleTitle Language="En">Effects of homologues and analogues of palmitoylethanolamide upon the inactivation of the endocannabinoid anandamide</ArticleTitle>
                  <JournalTitle>Br J Pharmacol</JournalTitle>
                  <VolumeID>133</VolumeID>
                  <FirstPage>1263</FirstPage>
                  <LastPage>1275</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11498512</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3MXmsFKhsbg%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1038/sj.bjp.0704199</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Jonsson K-O, Vandevoorde S, Lambert DM, Tiger G, Fowler CJ. Effects of homologues and analogues of palmitoylethanolamide upon the inactivation of the endocannabinoid anandamide.<Emphasis Type="Italic">Br J Pharmacol</Emphasis>. 2001;133:1263–1275.</BibUnstructured>
              </Citation>
              <Citation ID="CR43">
                <CitationNumber>43.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>AD</Initials>
                    <FamilyName>Khanolkar</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>V</Initials>
                    <FamilyName>Abadji</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Lin</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>1996</Year>
                  <ArticleTitle Language="En">Head group analogs of arachidonylethanolamide, the endogenous cannabinoid ligand</ArticleTitle>
                  <JournalTitle>J Med Chem</JournalTitle>
                  <VolumeID>39</VolumeID>
                  <FirstPage>4515</FirstPage>
                  <LastPage>4519</LastPage>
                  <Occurrence Type="PID">
                    <Handle>8893848</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK28XmtFyqs7w%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1021/jm960152y</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Khanolkar AD, Abadji V, Lin S, et al. Head group analogs of arachidonylethanolamide, the endogenous cannabinoid ligand.<Emphasis Type="Italic">J Med Chem</Emphasis>. 1996;39:4515–4519.</BibUnstructured>
              </Citation>
              <Citation ID="CR44">
                <CitationNumber>44.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Beltramo</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>N</Initials>
                    <FamilyName>Stella</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Calignano</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>SY</Initials>
                    <FamilyName>Lin</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Makriyannis</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>D</Initials>
                    <FamilyName>Piomelli</FamilyName>
                  </BibAuthorName>
                  <Year>1997</Year>
                  <ArticleTitle Language="En">Functional role of high-affinity anandamide transport, as revealed by selective inhibition</ArticleTitle>
                  <JournalTitle>Science</JournalTitle>
                  <VolumeID>277</VolumeID>
                  <FirstPage>1094</FirstPage>
                  <LastPage>1097</LastPage>
                  <Occurrence Type="PID">
                    <Handle>9262477</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK2sXlsFShs7k%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1126/science.277.5329.1094</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Beltramo M, Stella N, Calignano A, Lin SY, Makriyannis A, Piomelli D. Functional role of high-affinity anandamide transport, as revealed by selective inhibition.<Emphasis Type="Italic">Science</Emphasis>. 1997;277:1094–1097.</BibUnstructured>
              </Citation>
              <Citation ID="CR45">
                <CitationNumber>45.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Jarrahian</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Manna</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>WS</Initials>
                    <FamilyName>Edgemond</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>WB</Initials>
                    <FamilyName>Campbell</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>CJ</Initials>
                    <FamilyName>Hillard</FamilyName>
                  </BibAuthorName>
                  <Year>2000</Year>
                  <ArticleTitle Language="En">Structure-activity relationships among<Emphasis Type="Italic">N</Emphasis>-arachidonylethanolamine (anandamide) head group analogues for the anandamide transporter</ArticleTitle>
                  <JournalTitle>J Neurochem</JournalTitle>
                  <VolumeID>74</VolumeID>
                  <FirstPage>2597</FirstPage>
                  <LastPage>2606</LastPage>
                  <Occurrence Type="PID">
                    <Handle>10820223</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3cXjsVKrsb8%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1046/j.1471-4159.2000.0742597.x</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Jarrahian A, Manna S, Edgemond WS, Campbell WB, Hillard CJ. Structure-activity relationships among<Emphasis Type="Italic">N</Emphasis>-arachidonylethanolamine (anandamide) head group analogues for the anandamide transporter.<Emphasis Type="Italic">J Neurochem</Emphasis>. 2000;74:2597–2606.</BibUnstructured>
              </Citation>
              <Citation ID="CR46">
                <CitationNumber>46.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>PM</Initials>
                    <FamilyName>Zygmunt</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>H</Initials>
                    <FamilyName>Chuang</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>P</Initials>
                    <FamilyName>Movahed</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>D</Initials>
                    <FamilyName>Julius</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>ED</Initials>
                    <FamilyName>Högestätt</FamilyName>
                  </BibAuthorName>
                  <Year>2000</Year>
                  <ArticleTitle Language="En">The anandamide transport inhibitor AM404 activates vanilloid receptors</ArticleTitle>
                  <JournalTitle>Eur J Pharmacol</JournalTitle>
                  <VolumeID>396</VolumeID>
                  <FirstPage>39</FirstPage>
                  <LastPage>42</LastPage>
                  <Occurrence Type="PID">
                    <Handle>10822052</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3cXjsVGnt78%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0014-2999(00)00207-7</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Zygmunt PM, Chuang H, Movahed P, Julius D, Högestätt ED. The anandamide transport inhibitor AM404 activates vanilloid receptors.<Emphasis Type="Italic">Eur J Pharmacol</Emphasis>. 2000;396:39–42.</BibUnstructured>
              </Citation>
              <Citation ID="CR47">
                <CitationNumber>47.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>L</Initials>
                    <FamilyName>Petrocellis</FamilyName>
                    <Particle>De</Particle>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>T</Initials>
                    <FamilyName>Bisogno</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JB</Initials>
                    <FamilyName>Davis</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>RG</Initials>
                    <FamilyName>Pertwee</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>V</Initials>
                    <FamilyName>Marzo</FamilyName>
                    <Particle>Di</Particle>
                  </BibAuthorName>
                  <Year>2000</Year>
                  <ArticleTitle Language="En">Overlap between the ligand recognition properties of the anandamide transporter and the VR1 vanilloid receptor: inhibitors of anandamide uptake with negligible capsaicin-like activity</ArticleTitle>
                  <JournalTitle>FEBS Lett</JournalTitle>
                  <VolumeID>483</VolumeID>
                  <FirstPage>52</FirstPage>
                  <LastPage>56</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11033355</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0014-5793(00)02082-2</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>De Petrocellis L, Bisogno T, Davis JB, Pertwee RG, Di Marzo V. Overlap between the ligand recognition properties of the anandamide transporter and the VR1 vanilloid receptor: inhibitors of anandamide uptake with negligible capsaicin-like activity.<Emphasis Type="Italic">FEBS Lett</Emphasis>. 2000;483:52–56.</BibUnstructured>
              </Citation>
              <Citation ID="CR48">
                <CitationNumber>48.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>CJ</Initials>
                    <FamilyName>Fowler</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>G</Initials>
                    <FamilyName>Tiger</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Ligresti</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>ML</Initials>
                    <FamilyName>López-Rodríguez</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>V</Initials>
                    <FamilyName>Marzo</FamilyName>
                    <Particle>Di</Particle>
                  </BibAuthorName>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">Selective inhibition of anandamide cellular uptake versus enzymatic hydrolysis—a difficult issue to handle</ArticleTitle>
                  <JournalTitle>Eur J Pharmacol</JournalTitle>
                  <VolumeID>492</VolumeID>
                  <FirstPage>1</FirstPage>
                  <LastPage>11</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15145699</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2cXktVCqs74%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/j.ejphar.2004.03.048</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Fowler CJ, Tiger G, Ligresti A, López-Rodríguez ML, Di Marzo V. Selective inhibition of anandamide cellular uptake versus enzymatic hydrolysis—a difficult issue to handle.<Emphasis Type="Italic">Eur J Pharmacol</Emphasis>. 2004;492:1–11.</BibUnstructured>
              </Citation>
              <Citation ID="CR49">
                <CitationNumber>49.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>G</Initials>
                    <FamilyName>Ortar</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Ligresti</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>L</Initials>
                    <FamilyName>Petrocellis</FamilyName>
                    <Particle>De</Particle>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>E</Initials>
                    <FamilyName>Morera</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>V</Initials>
                    <FamilyName>Marzo</FamilyName>
                    <Particle>Di</Particle>
                  </BibAuthorName>
                  <Year>2003</Year>
                  <ArticleTitle Language="En">Novel selective and metabolically stable inhibitors of anandamide cellular uptake</ArticleTitle>
                  <JournalTitle>Biochem Pharmacol</JournalTitle>
                  <VolumeID>65</VolumeID>
                  <FirstPage>1473</FirstPage>
                  <LastPage>1481</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12732359</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3sXjsVeqsbo%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0006-2952(03)00109-6</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Ortar G, Ligresti A, De Petrocellis L, Morera E, Di Marzo V. Novel selective and metabolically stable inhibitors of anandamide cellular uptake.<Emphasis Type="Italic">Biochem Pharmacol</Emphasis>. 2003;65:1473–1481.</BibUnstructured>
              </Citation>
              <Citation ID="CR50">
                <CitationNumber>50.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>ML</Initials>
                    <FamilyName>López-Rodríguez</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Viso</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Ortega-Gutiérrez</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2003</Year>
                  <ArticleTitle Language="En">Design, synthesis and biological evaluation of new endocannabinoid transporter inhibitors</ArticleTitle>
                  <JournalTitle>Eur J Med Chem</JournalTitle>
                  <VolumeID>38</VolumeID>
                  <FirstPage>403</FirstPage>
                  <LastPage>412</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12750028</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0223-5234(03)00045-X</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3sXjs1CltL0%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>López-Rodríguez ML, Viso A, Ortega-Gutiérrez S, et al. Design, synthesis and biological evaluation of new endocannabinoid transporter inhibitors.<Emphasis Type="Italic">Eur J Med Chem</Emphasis>. 2003;38:403–412.</BibUnstructured>
              </Citation>
              <Citation ID="CR51">
                <CitationNumber>51.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>L</Initials>
                    <FamilyName>Ruiz-Llorente</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Ortega-Gutiérrez</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Viso</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">Characterization of an anandamide degradation system in prostate epithelial PC-3 cells: synthesis of new transporter inhibitors as tools for this study</ArticleTitle>
                  <JournalTitle>Br J Pharmacol</JournalTitle>
                  <VolumeID>141</VolumeID>
                  <FirstPage>457</FirstPage>
                  <LastPage>467</LastPage>
                  <Occurrence Type="PID">
                    <Handle>14718261</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2cXhvVOhu7w%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1038/sj.bjp.0705628</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Ruiz-Llorente L, Ortega-Gutiérrez S, Viso A, et al. Characterization of an anandamide degradation system in prostate epithelial PC-3 cells: synthesis of new transporter inhibitors as tools for this study.<Emphasis Type="Italic">Br J Pharmacol</Emphasis>. 2004;141:457–467.</BibUnstructured>
              </Citation>
              <Citation ID="CR52">
                <CitationNumber>52.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>C</Initials>
                    <FamilyName>Benito</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>E</Initials>
                    <FamilyName>Núñez</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>RM</Initials>
                    <FamilyName>Tolón</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2003</Year>
                  <ArticleTitle Language="En">Cannabinoid CB<Subscript>2</Subscript> receptors and fatty acid amide hydrolase are selectively overexpressed in neuritic plaque-associated glia in Alzheimer’s disease brains</ArticleTitle>
                  <JournalTitle>J Neurosci</JournalTitle>
                  <VolumeID>23</VolumeID>
                  <FirstPage>11136</FirstPage>
                  <LastPage>11141</LastPage>
                  <Occurrence Type="PID">
                    <Handle>14657172</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3sXpvV2gtbw%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Benito C, Núñez E, Tolón RM, et al. Cannabinoid CB<Subscript>2</Subscript> receptors and fatty acid amide hydrolase are selectively overexpressed in neuritic plaque-associated glia in Alzheimer’s disease brains.<Emphasis Type="Italic">J Neurosci</Emphasis>. 2003;23:11136–11141.</BibUnstructured>
              </Citation>
              <Citation ID="CR53">
                <CitationNumber>53.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>BG</Initials>
                    <FamilyName>Ramírez</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>C</Initials>
                    <FamilyName>Blázquez</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>T</Initials>
                    <FamilyName>Gómez del Pulgar</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>N</Initials>
                    <FamilyName>Guzmán</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>ML</Initials>
                    <FamilyName>Ceballos</FamilyName>
                    <Particle>de</Particle>
                  </BibAuthorName>
                  <Year>2005</Year>
                  <ArticleTitle Language="En">Prevention of Alzheimer’s disease pathology by cannabinoids: neuroprotection mediated by blockade of microglial activation</ArticleTitle>
                  <JournalTitle>J Neurosci</JournalTitle>
                  <VolumeID>25</VolumeID>
                  <FirstPage>1904</FirstPage>
                  <LastPage>1913</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15728830</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1523/JNEUROSCI.4540-04.2005</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2MXitVSnu7o%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Ramírez BG, Blázquez C, Gómez del Pulgar T, Guzmán N, de Ceballos ML. Prevention of Alzheimer’s disease pathology by cannabinoids: neuroprotection mediated by blockade of microglial activation.<Emphasis Type="Italic">J Neurosci</Emphasis>. 2005;25:1904–1913.</BibUnstructured>
              </Citation>
              <Citation ID="CR54">
                <CitationNumber>54.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Giuffrida</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>FM</Initials>
                    <FamilyName>Leweke</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>CW</Initials>
                    <FamilyName>Gerth</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">Cerebrospinal anandamide levels are elevated in acute schizophrenia and are inversely correlated with psychotic symptoms</ArticleTitle>
                  <JournalTitle>Neuropsychopharmacology</JournalTitle>
                  <VolumeID>29</VolumeID>
                  <FirstPage>2108</FirstPage>
                  <LastPage>2114</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15354183</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2cXoslSku7w%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1038/sj.npp.1300558</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Giuffrida A, Leweke FM, Gerth CW, et al. Cerebrospinal anandamide levels are elevated in acute schizophrenia and are inversely correlated with psychotic symptoms.<Emphasis Type="Italic">Neuropsychopharmacology</Emphasis>. 2004;29:2108–2114.</BibUnstructured>
              </Citation>
              <Citation ID="CR55">
                <CitationNumber>55.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>FM</Initials>
                    <FamilyName>Leweke</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Giuffrida</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>U</Initials>
                    <FamilyName>Wurster</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>HM</Initials>
                    <FamilyName>Emrich</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>D</Initials>
                    <FamilyName>Piomelli</FamilyName>
                  </BibAuthorName>
                  <Year>1999</Year>
                  <ArticleTitle Language="En">Elevated endogenous cannabinoids in schizophrenia</ArticleTitle>
                  <JournalTitle>Neuroreport</JournalTitle>
                  <VolumeID>10</VolumeID>
                  <FirstPage>1665</FirstPage>
                  <LastPage>1669</LastPage>
                  <Occurrence Type="PID">
                    <Handle>10501554</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK1MXksFaltLc%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1097/00001756-199906030-00008</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Leweke FM, Giuffrida A, Wurster U, Emrich HM, Piomelli D. Elevated endogenous cannabinoids in schizophrenia.<Emphasis Type="Italic">Neuroreport</Emphasis>. 1999;10:1665–1669.</BibUnstructured>
              </Citation>
              <Citation ID="CR56">
                <CitationNumber>56.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>B</Initials>
                    <FamilyName>Dean</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Sundram</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>R</Initials>
                    <FamilyName>Bradbury</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>E</Initials>
                    <FamilyName>Scarr</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>D</Initials>
                    <FamilyName>Copolov</FamilyName>
                  </BibAuthorName>
                  <Year>2001</Year>
                  <ArticleTitle Language="En">Studies on [<Superscript>3</Superscript>H]CP-55940 binding in the human central nervous system: regional specific changes in density of cannabinoid-1 receptors associated with schizophrenia and cannabis use</ArticleTitle>
                  <JournalTitle>Neuroscience</JournalTitle>
                  <VolumeID>103</VolumeID>
                  <FirstPage>9</FirstPage>
                  <LastPage>15</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11311783</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3MXislaqsrw%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0306-4522(00)00552-2</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Dean B, Sundram S, Bradbury R, Scarr E, Copolov D. Studies on [<Superscript>3</Superscript>H]CP-55940 binding in the human central nervous system: regional specific changes in density of cannabinoid-1 receptors associated with schizophrenia and cannabis use.<Emphasis Type="Italic">Neuroscience</Emphasis>. 2001;103:9–15.</BibUnstructured>
              </Citation>
              <Citation ID="CR57">
                <CitationNumber>57.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>K</Initials>
                    <FamilyName>Zavitsanou</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>T</Initials>
                    <FamilyName>Garrick</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>XF</Initials>
                    <FamilyName>Huang</FamilyName>
                  </BibAuthorName>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">Selective antagonist [<Superscript>3</Superscript>H]SR141716A binding to cannabinoid CB<Subscript>1</Subscript> receptors is increased in the anterior cingulate cortex in schizophrenia</ArticleTitle>
                  <JournalTitle>Prog Neuropsychopharmacol Biol Psychiatry</JournalTitle>
                  <VolumeID>28</VolumeID>
                  <FirstPage>355</FirstPage>
                  <LastPage>360</LastPage>
                  <Occurrence Type="PID">
                    <Handle>14751433</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2cXnvVOnsQ%3D%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/j.pnpbp.2003.11.005</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Zavitsanou K, Garrick T, Huang XF. Selective antagonist [<Superscript>3</Superscript>H]SR141716A binding to cannabinoid CB<Subscript>1</Subscript> receptors is increased in the anterior cingulate cortex in schizophrenia.<Emphasis Type="Italic">Prog Neuropsychopharmacol Biol Psychiatry</Emphasis>. 2004;28:355–360.</BibUnstructured>
              </Citation>
              <Citation ID="CR58">
                <CitationNumber>58.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>N</Initials>
                    <FamilyName>Marchi</FamilyName>
                    <Particle>De</Particle>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>L</Initials>
                    <FamilyName>Petrocellis</FamilyName>
                    <Particle>De</Particle>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>P</Initials>
                    <FamilyName>Orlando</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>F</Initials>
                    <FamilyName>Daniele</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>F</Initials>
                    <FamilyName>Fezza</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>V</Initials>
                    <FamilyName>Marzo</FamilyName>
                    <Particle>Di</Particle>
                  </BibAuthorName>
                  <Year>2003</Year>
                  <ArticleTitle Language="En">Endocannabinoid signalling in the blood of patients with schizophrenia</ArticleTitle>
                  <JournalTitle>Lipids Health Dis.</JournalTitle>
                  <VolumeID>2</VolumeID>
                  <FirstPage>1</FirstPage>
                  <LastPage>9</LastPage>
                  <Occurrence Type="DOI">
                    <Handle>10.1186/1476-511X-2-5</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>De Marchi N, De Petrocellis L, Orlando P, Daniele F, Fezza F, Di Marzo V. Endocannabinoid signalling in the blood of patients with schizophrenia.<Emphasis Type="Italic">Lipids Health Dis.</Emphasis> 2003;2:1–9.</BibUnstructured>
              </Citation>
              <Citation ID="CR59">
                <CitationNumber>59.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>BL</Initials>
                    <FamilyName>Hungund</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>KY</Initials>
                    <FamilyName>Vinod</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>SA</Initials>
                    <FamilyName>Kassir</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">Upregulation of CB<Subscript>1</Subscript> receptors and agonist-stimulated [<Superscript>35</Superscript>S]GTPγS binding in the prefrontal cortex of depressed suicide victims</ArticleTitle>
                  <JournalTitle>Mol Psychiatry</JournalTitle>
                  <VolumeID>9</VolumeID>
                  <FirstPage>184</FirstPage>
                  <LastPage>190</LastPage>
                  <Occurrence Type="PID">
                    <Handle>14966476</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2cXht1SjtLk%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1038/sj.mp.4001376</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Hungund BL, Vinod KY, Kassir SA, et al. Upregulation of CB<Subscript>1</Subscript> receptors and agonist-stimulated [<Superscript>35</Superscript>S]GTPγS binding in the prefrontal cortex of depressed suicide victims.<Emphasis Type="Italic">Mol Psychiatry</Emphasis>. 2004;9:184–190.</BibUnstructured>
              </Citation>
              <Citation ID="CR60">
                <CitationNumber>60.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>KY</Initials>
                    <FamilyName>Vinod</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>V</Initials>
                    <FamilyName>Arango</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Xie</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2005</Year>
                  <ArticleTitle Language="En">Elevated levels of endocannabinoids and CB<Subscript>1</Subscript> receptor-mediated G-protein signaling in the prefrontal cortex of alcoholic suicide victims</ArticleTitle>
                  <JournalTitle>Biol Psychiatry</JournalTitle>
                  <VolumeID>57</VolumeID>
                  <FirstPage>480</FirstPage>
                  <LastPage>486</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15737662</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2MXhslegs70%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/j.biopsych.2004.11.033</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Vinod KY, Arango V, Xie S, et al. Elevated levels of endocannabinoids and CB<Subscript>1</Subscript> receptor-mediated G-protein signaling in the prefrontal cortex of alcoholic suicide victims.<Emphasis Type="Italic">Biol Psychiatry</Emphasis>. 2005;57:480–486.</BibUnstructured>
              </Citation>
              <Citation ID="CR61">
                <CitationNumber>61.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>I</Initials>
                    <FamilyName>Lastres-Becker</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Cebeira</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>ML</Initials>
                    <FamilyName>Ceballos</FamilyName>
                    <Particle>de</Particle>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2001</Year>
                  <ArticleTitle Language="En">Increased cannabinoid CB<Subscript>1</Subscript> receptor binding and activation of GTP-binding proteins in the basal ganglia of patients with Parkinson’s syndrome and of MPTP-treated marmosets</ArticleTitle>
                  <JournalTitle>Eur J Neurosci</JournalTitle>
                  <VolumeID>14</VolumeID>
                  <FirstPage>1827</FirstPage>
                  <LastPage>1832</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11860478</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:DC%2BD387jvVSgsA%3D%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1046/j.0953-816x.2001.01812.x</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Lastres-Becker I, Cebeira M, de Ceballos ML, et al. Increased cannabinoid CB<Subscript>1</Subscript> receptor binding and activation of GTP-binding proteins in the basal ganglia of patients with Parkinson’s syndrome and of MPTP-treated marmosets.<Emphasis Type="Italic">Eur J Neurosci</Emphasis>. 2001;14:1827–1832.</BibUnstructured>
              </Citation>
              <Citation ID="CR62">
                <CitationNumber>62.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Glass</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>R</Initials>
                    <FamilyName>Faull</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Dragunow</FamilyName>
                  </BibAuthorName>
                  <Year>1993</Year>
                  <ArticleTitle Language="En">Loss of cannabinoid receptors in the substantia-nigra in Huntington’s disease</ArticleTitle>
                  <JournalTitle>Neurosci</JournalTitle>
                  <VolumeID>56</VolumeID>
                  <FirstPage>523</FirstPage>
                  <LastPage>527</LastPage>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:DyaK2c%2Fnslegsg%3D%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/0306-4522(93)90352-G</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Glass M, Faull R, Dragunow M. Loss of cannabinoid receptors in the substantia-nigra in Huntington’s disease.<Emphasis Type="Italic">Neurosci</Emphasis>. 1993;56:523–527.</BibUnstructured>
              </Citation>
              <Citation ID="CR63">
                <CitationNumber>63.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>EK</Initials>
                    <FamilyName>Richfield</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Herkenham</FamilyName>
                  </BibAuthorName>
                  <Year>1994</Year>
                  <ArticleTitle Language="En">Selective vulnerability in Huntington’s disease: preferential loss of cannabinoid receptors in lateral globus pallidus</ArticleTitle>
                  <JournalTitle>Ann Neurol</JournalTitle>
                  <VolumeID>36</VolumeID>
                  <FirstPage>577</FirstPage>
                  <LastPage>584</LastPage>
                  <Occurrence Type="PID">
                    <Handle>7944290</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:DyaK2M%2FjtV2msQ%3D%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1002/ana.410360406</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Richfield EK, Herkenham M. Selective vulnerability in Huntington’s disease: preferential loss of cannabinoid receptors in lateral globus pallidus.<Emphasis Type="Italic">Ann Neurol</Emphasis>. 1994;36:577–584.</BibUnstructured>
              </Citation>
              <Citation ID="CR64">
                <CitationNumber>64.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>W-R</Initials>
                    <FamilyName>Schäbitz</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Giuffrida</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>C</Initials>
                    <FamilyName>Berger</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">Release of fatty acid amides in a patient with hemispheric stroke: a microdialysis study</ArticleTitle>
                  <JournalTitle>Stroke</JournalTitle>
                  <VolumeID>33</VolumeID>
                  <FirstPage>2112</FirstPage>
                  <LastPage>2114</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12154273</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1161/01.STR.0000023491.63693.18</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD38XmvVeisrY%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Schäbitz W-R, Giuffrida A, Berger C, et al. Release of fatty acid amides in a patient with hemispheric stroke: a microdialysis study.<Emphasis Type="Italic">Stroke</Emphasis>. 2002;33:2112–2114.</BibUnstructured>
              </Citation>
              <Citation ID="CR65">
                <CitationNumber>65.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Maccarrone</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>H</Initials>
                    <FamilyName>Valensise</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Bari</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>N</Initials>
                    <FamilyName>Lazzarin</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>C</Initials>
                    <FamilyName>Romanini</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Finazzi-Agricò</FamilyName>
                  </BibAuthorName>
                  <Year>2000</Year>
                  <ArticleTitle Language="En">Relation between decreased anandamide hydrolase concentrations in human lymphocytes and miscarriage</ArticleTitle>
                  <JournalTitle>Lancet</JournalTitle>
                  <VolumeID>355</VolumeID>
                  <FirstPage>1326</FirstPage>
                  <LastPage>1329</LastPage>
                  <Occurrence Type="PID">
                    <Handle>10776746</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3cXivVCqsbk%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0140-6736(00)02115-2</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Maccarrone M, Valensise H, Bari M, Lazzarin N, Romanini C, Finazzi-Agricò A. Relation between decreased anandamide hydrolase concentrations in human lymphocytes and miscarriage.<Emphasis Type="Italic">Lancet</Emphasis>. 2000;355:1326–1329.</BibUnstructured>
              </Citation>
              <Citation ID="CR66">
                <CitationNumber>66.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Maccarrone</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>T</Initials>
                    <FamilyName>Bisogno</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>H</Initials>
                    <FamilyName>Valensise</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">Low fatty acid amide hydrolase and high anandamide levels are associated with failure to achieve an ongoing pregnancy after IVF and embryo transfer</ArticleTitle>
                  <JournalTitle>Mol Hum Reprod</JournalTitle>
                  <VolumeID>8</VolumeID>
                  <FirstPage>188</FirstPage>
                  <LastPage>195</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11818522</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD38XitFOgsrY%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1093/molehr/8.2.188</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Maccarrone M, Bisogno T, Valensise H, et al. Low fatty acid amide hydrolase and high anandamide levels are associated with failure to achieve an ongoing pregnancy after IVF and embryo transfer.<Emphasis Type="Italic">Mol Hum Reprod</Emphasis>. 2002;8:188–195.</BibUnstructured>
              </Citation>
              <Citation ID="CR67">
                <CitationNumber>67.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>Y</Initials>
                    <FamilyName>Wang</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>Y</Initials>
                    <FamilyName>Liu</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>Y</Initials>
                    <FamilyName>Ito</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2001</Year>
                  <ArticleTitle Language="En">Simultaneous measurement of anandamide and 2-arachidonoylglycerol by polymyxin B-selective adsorption and subsequent high-performance liquid chromatography analysis: increase in endogenous cannabinoids in the sera of patients with endotoxic shock</ArticleTitle>
                  <JournalTitle>Anal Biochem</JournalTitle>
                  <VolumeID>294</VolumeID>
                  <FirstPage>73</FirstPage>
                  <LastPage>82</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11412008</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3MXksVWqsLs%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1006/abio.2001.5015</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Wang Y, Liu Y, Ito Y, et al. Simultaneous measurement of anandamide and 2-arachidonoylglycerol by polymyxin B-selective adsorption and subsequent high-performance liquid chromatography analysis: increase in endogenous cannabinoids in the sera of patients with endotoxic shock.<Emphasis Type="Italic">Anal Biochem</Emphasis>. 2001;294:73–82.</BibUnstructured>
              </Citation>
              <Citation ID="CR68">
                <CitationNumber>68.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Bátkai</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>Z</Initials>
                    <FamilyName>Járai</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JA</Initials>
                    <FamilyName>Wagner</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2001</Year>
                  <ArticleTitle Language="En">Endocannabinoids acting at vascular CB<Subscript>1</Subscript> receptors mediate the vasodilated state in advanced liver cirrhosis</ArticleTitle>
                  <JournalTitle>Nat Med</JournalTitle>
                  <VolumeID>7</VolumeID>
                  <FirstPage>827</FirstPage>
                  <LastPage>832</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11433348</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1038/89953</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Bátkai S, Járai Z, Wagner JA, et al. Endocannabinoids acting at vascular CB<Subscript>1</Subscript> receptors mediate the vasodilated state in advanced liver cirrhosis.<Emphasis Type="Italic">Nat Med</Emphasis>. 2001;7:827–832.</BibUnstructured>
              </Citation>
              <Citation ID="CR69">
                <CitationNumber>69.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>CM</Initials>
                    <FamilyName>Fernández-Rodriguez</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Romero</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>TJ</Initials>
                    <FamilyName>Petros</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">Circulating endogenous cannabinoid anandamide and portal, systemic and renal hemodynamics in cirrhosis</ArticleTitle>
                  <JournalTitle>Liver Int</JournalTitle>
                  <VolumeID>24</VolumeID>
                  <FirstPage>477</FirstPage>
                  <LastPage>483</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15482346</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1111/j.1478-3231.2004.0945.x</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2cXhtVaktrzL</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Fernández-Rodriguez CM, Romero J, Petros TJ, et al. Circulating endogenous cannabinoid anandamide and portal, systemic and renal hemodynamics in cirrhosis.<Emphasis Type="Italic">Liver Int</Emphasis>. 2004;24:477–483.</BibUnstructured>
              </Citation>
              <Citation ID="CR70">
                <CitationNumber>70.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>B</Initials>
                    <FamilyName>Julien</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>P</Initials>
                    <FamilyName>Grenard</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>F</Initials>
                    <FamilyName>Teixeira-Clerc</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2005</Year>
                  <ArticleTitle Language="En">Antifibrogenic role of the cannabinoid receptor CB<Subscript>2</Subscript> in the liver</ArticleTitle>
                  <JournalTitle>Gastroenterology</JournalTitle>
                  <VolumeID>128</VolumeID>
                  <FirstPage>742</FirstPage>
                  <LastPage>755</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15765409</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2MXivFWntb8%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1053/j.gastro.2004.12.050</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Julien B, Grenard P, Teixeira-Clerc F, et al. Antifibrogenic role of the cannabinoid receptor CB<Subscript>2</Subscript> in the liver.<Emphasis Type="Italic">Gastroenterology</Emphasis>. 2005;128:742–755.</BibUnstructured>
              </Citation>
              <Citation ID="CR71">
                <CitationNumber>71.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Steffens</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>NR</Initials>
                    <FamilyName>Veillard</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>C</Initials>
                    <FamilyName>Arnaud</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2005</Year>
                  <ArticleTitle Language="En">Low dose oral cannabinoid therapy reduces progression of atherosclerosis in mice</ArticleTitle>
                  <JournalTitle>Nature</JournalTitle>
                  <VolumeID>434</VolumeID>
                  <FirstPage>782</FirstPage>
                  <LastPage>786</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15815632</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2MXivFCgtbs%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1038/nature03389</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Steffens S, Veillard NR, Arnaud C, et al. Low dose oral cannabinoid therapy reduces progression of atherosclerosis in mice.<Emphasis Type="Italic">Nature</Emphasis>. 2005;434:782–786.</BibUnstructured>
              </Citation>
              <Citation ID="CR72">
                <CitationNumber>72.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Maccarrone</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Attinà</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Cartoni</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Bari</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Finazzi-Agricò</FamilyName>
                  </BibAuthorName>
                  <Year>2001</Year>
                  <ArticleTitle Language="En">Gas chromatography-mass spectrometry analysis of endogenous cannabinoids in healthy and tumoral human brain and human cells in culture</ArticleTitle>
                  <JournalTitle>J Neurochem</JournalTitle>
                  <VolumeID>76</VolumeID>
                  <FirstPage>594</FirstPage>
                  <LastPage>601</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11208922</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3MXhtVGktb8%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1046/j.1471-4159.2001.00092.x</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Maccarrone M, Attinà M, Cartoni A, Bari M, Finazzi-Agricò A. Gas chromatography-mass spectrometry analysis of endogenous cannabinoids in healthy and tumoral human brain and human cells in culture.<Emphasis Type="Italic">J Neurochem</Emphasis>. 2001;76:594–601.</BibUnstructured>
              </Citation>
              <Citation ID="CR73">
                <CitationNumber>73.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>G</Initials>
                    <FamilyName>Petersen</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>B</Initials>
                    <FamilyName>Moesgaard</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>PC</Initials>
                    <FamilyName>Schmid</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2005</Year>
                  <ArticleTitle Language="En">Endocannabinoid metabolism in human glioblastomas and meningiomas compared to human non-tumour brain tissue</ArticleTitle>
                  <JournalTitle>J Neurochem</JournalTitle>
                  <VolumeID>93</VolumeID>
                  <FirstPage>299</FirstPage>
                  <LastPage>309</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15816853</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2MXjslWqurc%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1111/j.1471-4159.2005.03013.x</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Petersen G, Moesgaard B, Schmid PC, et al. Endocannabinoid metabolism in human glioblastomas and meningiomas compared to human non-tumour brain tissue.<Emphasis Type="Italic">J Neurochem</Emphasis>. 2005;93:299–309.</BibUnstructured>
              </Citation>
              <Citation ID="CR74">
                <CitationNumber>74.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>U</Initials>
                    <FamilyName>Pagotto</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>G</Initials>
                    <FamilyName>Marsicano</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>F</Initials>
                    <FamilyName>Fezza</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2001</Year>
                  <ArticleTitle Language="En">Normal human pituitary gland and pituitary adenomas express cannabinoid receptor type 1 and synthesize endogenous cannabinoids: first evidence for a direct role of cannabinoids on hormone modulation at the human pituitary level</ArticleTitle>
                  <JournalTitle>J Clin Endocrinol Metab</JournalTitle>
                  <VolumeID>86</VolumeID>
                  <FirstPage>2687</FirstPage>
                  <LastPage>2696</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11397872</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3MXktlKiuro%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1210/jc.86.6.2687</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Pagotto U, Marsicano G, Fezza F, et al. Normal human pituitary gland and pituitary adenomas express cannabinoid receptor type 1 and synthesize endogenous cannabinoids: first evidence for a direct role of cannabinoids on hormone modulation at the human pituitary level.<Emphasis Type="Italic">J Clin Endocrinol Metab</Emphasis>. 2001;86:2687–2696.</BibUnstructured>
              </Citation>
              <Citation ID="CR75">
                <CitationNumber>75.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Sarfaraz</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>F</Initials>
                    <FamilyName>Afaq</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>VM</Initials>
                    <FamilyName>Adhami</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>H</Initials>
                    <FamilyName>Mukhtar</FamilyName>
                  </BibAuthorName>
                  <Year>2005</Year>
                  <ArticleTitle Language="En">Cannabinoid receptor as a novel target for the treatment of prostate cancer</ArticleTitle>
                  <JournalTitle>Cancer Res</JournalTitle>
                  <VolumeID>65</VolumeID>
                  <FirstPage>1635</FirstPage>
                  <LastPage>1641</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15753356</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2MXitVOjs70%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1158/0008-5472.CAN-04-3410</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Sarfaraz S, Afaq F, Adhami VM, Mukhtar H. Cannabinoid receptor as a novel target for the treatment of prostate cancer.<Emphasis Type="Italic">Cancer Res</Emphasis>. 2005;65:1635–1641.</BibUnstructured>
              </Citation>
              <Citation ID="CR76">
                <CitationNumber>76.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>T</Initials>
                    <FamilyName>Motobe</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>T</Initials>
                    <FamilyName>Hashiguchi</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>T</Initials>
                    <FamilyName>Uchimura</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">Endogenous cannbinoids are candidates for lipid mediators of bone cement implantation syndrome</ArticleTitle>
                  <JournalTitle>Shock</JournalTitle>
                  <VolumeID>21</VolumeID>
                  <FirstPage>8</FirstPage>
                  <LastPage>12</LastPage>
                  <Occurrence Type="PID">
                    <Handle>14676677</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2cXjtVWru7c%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1097/01.SHK.0000094766.36694.49</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Motobe T, Hashiguchi T, Uchimura T, et al. Endogenous cannbinoids are candidates for lipid mediators of bone cement implantation syndrome.<Emphasis Type="Italic">Shock</Emphasis>. 2004;21:8–12.</BibUnstructured>
              </Citation>
              <Citation ID="CR77">
                <CitationNumber>77.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>D</Initials>
                    <FamilyName>Baker</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>G</Initials>
                    <FamilyName>Pryce</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JL</Initials>
                    <FamilyName>Croxford</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2001</Year>
                  <ArticleTitle Language="En">Endocannabinoids control spasticity in a multiple sclerosis model</ArticleTitle>
                  <JournalTitle>FASEB J</JournalTitle>
                  <VolumeID>15</VolumeID>
                  <FirstPage>300</FirstPage>
                  <LastPage>302</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11156943</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3MXhsFenurk%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Baker D, Pryce G, Croxford JL, et al. Endocannabinoids control spasticity in a multiple sclerosis model.<Emphasis Type="Italic">FASEB J</Emphasis>. 2001;15:300–302.</BibUnstructured>
              </Citation>
              <Citation ID="CR78">
                <CitationNumber>78.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>F</Initials>
                    <FamilyName>Berrendero</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Sánchez</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Cabranes</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2001</Year>
                  <ArticleTitle Language="En">Changes in cannabinoid CB<Subscript>1</Subscript> receptors in striatal and cortical regions of rats with experimental allergic encephalomyelitis, an animal model of multiple sclerosis</ArticleTitle>
                  <JournalTitle>Synapse</JournalTitle>
                  <VolumeID>41</VolumeID>
                  <FirstPage>195</FirstPage>
                  <LastPage>202</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11391780</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3MXlslSgtrc%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1002/syn.1075</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Berrendero F, Sánchez A, Cabranes A, et al. Changes in cannabinoid CB<Subscript>1</Subscript> receptors in striatal and cortical regions of rats with experimental allergic encephalomyelitis, an animal model of multiple sclerosis.<Emphasis Type="Italic">Synapse</Emphasis>. 2001;41:195–202.</BibUnstructured>
              </Citation>
              <Citation ID="CR79">
                <CitationNumber>79.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>BC</Initials>
                    <FamilyName>Cheng</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>H</Initials>
                    <FamilyName>Xu</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>L</Initials>
                    <FamilyName>Calbay</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>RG</Initials>
                    <FamilyName>Pertwee</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Coutts</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JV</Initials>
                    <FamilyName>Forrester</FamilyName>
                  </BibAuthorName>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">Specific CB<Subscript>2</Subscript> receptor agonist suppresses the murine model of experimental autoimmune uveitis</ArticleTitle>
                  <JournalTitle>Invest Ophthalmol Vis Sci</JournalTitle>
                  <VolumeID>45</VolumeID>
                  <FirstPage>552</FirstPage>
                  <LastPage>552</LastPage>
                  <Occurrence Type="DOI">
                    <Handle>10.1167/iovs.03-0749</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Cheng BC, Xu H, Calbay L, Pertwee RG, Coutts A, Forrester JV. Specific CB<Subscript>2</Subscript> receptor agonist suppresses the murine model of experimental autoimmune uveitis.<Emphasis Type="Italic">Invest Ophthalmol Vis Sci</Emphasis>. 2004;45:552.</BibUnstructured>
              </Citation>
              <Citation ID="CR80">
                <CitationNumber>80.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Witting</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>P</Initials>
                    <FamilyName>Weydt</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Hong</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Kliot</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>T</Initials>
                    <FamilyName>Möller</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>N</Initials>
                    <FamilyName>Stella</FamilyName>
                  </BibAuthorName>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">Endocannabinoids accumulate in spinal cord of SOD1<Superscript>G93A</Superscript> transgenic mice</ArticleTitle>
                  <JournalTitle>J Neurochem</JournalTitle>
                  <VolumeID>89</VolumeID>
                  <FirstPage>1555</FirstPage>
                  <LastPage>1557</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15189359</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2cXlsVOhu74%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1111/j.1471-4159.2004.02544.x</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Witting A, Weydt P, Hong S, Kliot M, Möller T, Stella N. Endocannabinoids accumulate in spinal cord of SOD1<Superscript>G93A</Superscript> transgenic mice.<Emphasis Type="Italic">J Neurochem</Emphasis>. 2004;89:1555–1557.</BibUnstructured>
              </Citation>
              <Citation ID="CR81">
                <CitationNumber>81.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>C</Initials>
                    <FamilyName>Benito</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>W-K</Initials>
                    <FamilyName>Kim</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>I</Initials>
                    <FamilyName>Chavarria</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2005</Year>
                  <ArticleTitle Language="En">A glial endogenous cannabinoid system is upregulated in the brains of macaques with simian immunodeficiency virus-induced encephalitis</ArticleTitle>
                  <JournalTitle>J Neurosci</JournalTitle>
                  <VolumeID>25</VolumeID>
                  <FirstPage>2530</FirstPage>
                  <LastPage>2536</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15758162</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2MXis1ygs74%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1523/JNEUROSCI.3923-04.2005</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Benito C, Kim W-K, Chavarria I, et al. A glial endogenous cannabinoid system is upregulated in the brains of macaques with simian immunodeficiency virus-induced encephalitis.<Emphasis Type="Italic">J Neurosci</Emphasis>. 2005;25:2530–2536.</BibUnstructured>
              </Citation>
              <Citation ID="CR82">
                <CitationNumber>82.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>W</Initials>
                    <FamilyName>Adriani</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Caprioli</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>O</Initials>
                    <FamilyName>Granstrem</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Carli</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>G</Initials>
                    <FamilyName>Laviola</FamilyName>
                  </BibAuthorName>
                  <Year>2003</Year>
                  <ArticleTitle Language="En">The spontaneously hypertensive-rat as an animal model of ADHD evidence for impulsive and non-impulsive subpopulations</ArticleTitle>
                  <JournalTitle>Neurosci Biobehav Rev</JournalTitle>
                  <VolumeID>27</VolumeID>
                  <FirstPage>639</FirstPage>
                  <LastPage>651</LastPage>
                  <Occurrence Type="PID">
                    <Handle>14624808</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/j.neubiorev.2003.08.007</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Adriani W, Caprioli A, Granstrem O, Carli M, Laviola G. The spontaneously hypertensive-rat as an animal model of ADHD evidence for impulsive and non-impulsive subpopulations.<Emphasis Type="Italic">Neurosci Biobehav Rev</Emphasis>. 2003;27:639–651.</BibUnstructured>
              </Citation>
              <Citation ID="CR83">
                <CitationNumber>83.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>V</Initials>
                    <FamilyName>Marzo</FamilyName>
                    <Particle>Di</Particle>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>MP</Initials>
                    <FamilyName>Hill</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>T</Initials>
                    <FamilyName>Bisogno</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>AR</Initials>
                    <FamilyName>Crossman</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JM</Initials>
                    <FamilyName>Brotchie</FamilyName>
                  </BibAuthorName>
                  <Year>2000</Year>
                  <ArticleTitle Language="En">Enhanced levels of endogenous cannabinoids in the globus pallidus are associated with a reduction in movement in an animal model of Parkinson’s disease</ArticleTitle>
                  <JournalTitle>FASEB J</JournalTitle>
                  <VolumeID>14</VolumeID>
                  <FirstPage>1432</FirstPage>
                  <LastPage>1438</LastPage>
                  <Occurrence Type="PID">
                    <Handle>10877836</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1096/fj.14.10.1432</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Di Marzo V, Hill MP, Bisogno T, Crossman AR, Brotchie JM. Enhanced levels of endogenous cannabinoids in the globus pallidus are associated with a reduction in movement in an animal model of Parkinson’s disease.<Emphasis Type="Italic">FASEB J</Emphasis>. 2000;14:1432–1438.</BibUnstructured>
              </Citation>
              <Citation ID="CR84">
                <CitationNumber>84.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>P</Initials>
                    <FamilyName>Gubellini</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>B</Initials>
                    <FamilyName>Picconi</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Bari</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">Experimental parkinsonism alters endocannabinoid degradation: implications for striatal glutamatergic transmission</ArticleTitle>
                  <JournalTitle>J Neurosci</JournalTitle>
                  <VolumeID>22</VolumeID>
                  <FirstPage>6900</FirstPage>
                  <LastPage>6907</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12177188</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD38XmsF2gsrY%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Gubellini P, Picconi B, Bari M, et al. Experimental parkinsonism alters endocannabinoid degradation: implications for striatal glutamatergic transmission.<Emphasis Type="Italic">J Neurosci</Emphasis>. 2002;22:6900–6907.</BibUnstructured>
              </Citation>
              <Citation ID="CR85">
                <CitationNumber>85.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Maccarrone</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>P</Initials>
                    <FamilyName>Gubellini</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Bari</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2003</Year>
                  <ArticleTitle Language="En">Levodopa treatment reverses endocannabinoid system abnormalities in experimental parkinsonism</ArticleTitle>
                  <JournalTitle>J Neurochem</JournalTitle>
                  <VolumeID>85</VolumeID>
                  <FirstPage>1018</FirstPage>
                  <LastPage>1025</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12716433</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3sXktVGhu7w%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1046/j.1471-4159.2003.01759.x</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Maccarrone M, Gubellini P, Bari M, et al. Levodopa treatment reverses endocannabinoid system abnormalities in experimental parkinsonism.<Emphasis Type="Italic">J Neurochem</Emphasis>. 2003;85:1018–1025.</BibUnstructured>
              </Citation>
              <Citation ID="CR86">
                <CitationNumber>86.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>E</Initials>
                    <FamilyName>Fernandez-Espejo</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>I</Initials>
                    <FamilyName>Caraballo</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>F</Initials>
                    <FamilyName>Rodriguez de Fonseca</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">Experimental parkinsonism alters anandamide precursor synthesis, and functional deficits are improved by AM404: a modulator of endocannabinoid function</ArticleTitle>
                  <JournalTitle>Neuropsychopharmacology</JournalTitle>
                  <VolumeID>29</VolumeID>
                  <FirstPage>1134</FirstPage>
                  <LastPage>1142</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15010694</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2cXktV2ku7w%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1038/sj.npp.1300407</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Fernandez-Espejo E, Caraballo I, Rodriguez de Fonseca F, et al. Experimental parkinsonism alters anandamide precursor synthesis, and functional deficits are improved by AM404: a modulator of endocannabinoid function.<Emphasis Type="Italic">Neuropsychopharmacology</Emphasis>. 2004;29:1134–1142.</BibUnstructured>
              </Citation>
              <Citation ID="CR87">
                <CitationNumber>87.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>B</Initials>
                    <FamilyName>Ferrer</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>N</Initials>
                    <FamilyName>Asbrock</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Kathuria</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>D</Initials>
                    <FamilyName>Piomelli</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Giuffrida</FamilyName>
                  </BibAuthorName>
                  <Year>2003</Year>
                  <ArticleTitle Language="En">Effects of levodopa on endocannabinoid levels in rat basal ganglia: implications for the treatment of levodopa-induced dyskinesias</ArticleTitle>
                  <JournalTitle>Eur J Neurosci</JournalTitle>
                  <VolumeID>18</VolumeID>
                  <FirstPage>1607</FirstPage>
                  <LastPage>1614</LastPage>
                  <Occurrence Type="PID">
                    <Handle>14511339</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1046/j.1460-9568.2003.02896.x</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Ferrer B, Asbrock N, Kathuria S, Piomelli D, Giuffrida A Effects of levodopa on endocannabinoid levels in rat basal ganglia: implications for the treatment of levodopa-induced dyskinesias.<Emphasis Type="Italic">Eur J Neurosci</Emphasis>. 2003;18:1607–1614.</BibUnstructured>
              </Citation>
              <Citation ID="CR88">
                <CitationNumber>88.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Herkenham</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>AB</Initials>
                    <FamilyName>Lynn</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>BR</Initials>
                    <FamilyName>Costa</FamilyName>
                    <Particle>de</Particle>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>EK</Initials>
                    <FamilyName>Richfield</FamilyName>
                  </BibAuthorName>
                  <Year>1991</Year>
                  <ArticleTitle Language="En">Neuronal localization of cannabinoid receptors in the basal ganglia of the rat</ArticleTitle>
                  <JournalTitle>Brain Res</JournalTitle>
                  <VolumeID>547</VolumeID>
                  <FirstPage>267</FirstPage>
                  <LastPage>274</LastPage>
                  <Occurrence Type="PID">
                    <Handle>1909204</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK3MXkt1ais7g%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/0006-8993(91)90970-7</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Herkenham M, Lynn AB, de Costa BR, Richfield EK. Neuronal localization of cannabinoid receptors in the basal ganglia of the rat.<Emphasis Type="Italic">Brain Res</Emphasis>. 1991;547:267–274.</BibUnstructured>
              </Citation>
              <Citation ID="CR89">
                <CitationNumber>89.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Romero</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>F</Initials>
                    <FamilyName>Berrendero</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Pérez-Rosado</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2000</Year>
                  <ArticleTitle Language="En">Unilateral 6-hydroxydopamine lesions of nigrostriatal dopaminergic neurons increased CB<Subscript>1</Subscript> receptor mRNA levels in the caudate-putamen</ArticleTitle>
                  <JournalTitle>Life Sci</JournalTitle>
                  <VolumeID>66</VolumeID>
                  <FirstPage>485</FirstPage>
                  <LastPage>494</LastPage>
                  <Occurrence Type="PID">
                    <Handle>10794065</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3cXlsFKqug%3D%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0024-3205(99)00618-9</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Romero J, Berrendero F, Pérez-Rosado A, et al. Unilateral 6-hydroxydopamine lesions of nigrostriatal dopaminergic neurons increased CB<Subscript>1</Subscript> receptor mRNA levels in the caudate-putamen.<Emphasis Type="Italic">Life Sci</Emphasis>. 2000;66:485–494.</BibUnstructured>
              </Citation>
              <Citation ID="CR90">
                <CitationNumber>90.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>P</Initials>
                    <FamilyName>Mailleux</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J-J</Initials>
                    <FamilyName>Vanderhaeghen</FamilyName>
                  </BibAuthorName>
                  <Year>1993</Year>
                  <ArticleTitle Language="En">Dopaminergic regulation of cannabinoid receptor mRNA levels in the rat caudate-putamen: an in situ hybridization study</ArticleTitle>
                  <JournalTitle>J Neurochem</JournalTitle>
                  <VolumeID>61</VolumeID>
                  <FirstPage>1705</FirstPage>
                  <LastPage>1712</LastPage>
                  <Occurrence Type="PID">
                    <Handle>7901331</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK2cXisVSmsA%3D%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1111/j.1471-4159.1993.tb09807.x</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Mailleux P, Vanderhaeghen J-J. Dopaminergic regulation of cannabinoid receptor mRNA levels in the rat caudate-putamen: an in situ hybridization study.<Emphasis Type="Italic">J Neurochem</Emphasis>. 1993;61:1705–1712.</BibUnstructured>
              </Citation>
              <Citation ID="CR91">
                <CitationNumber>91.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>B-Y</Initials>
                    <FamilyName>Zeng</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>B</Initials>
                    <FamilyName>Dass</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Owen</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>1999</Year>
                  <ArticleTitle Language="En">Chronic L-DOPA treatment increases striatal cannabinoid CB<Subscript>1</Subscript> receptor mRNA expression in 6-hydroxydopamine-lesioned rats</ArticleTitle>
                  <JournalTitle>Neurosci Lett</JournalTitle>
                  <VolumeID>276</VolumeID>
                  <FirstPage>71</FirstPage>
                  <LastPage>74</LastPage>
                  <Occurrence Type="PID">
                    <Handle>10624794</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK1MXntlemur8%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0304-3940(99)00762-4</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Zeng B-Y, Dass B, Owen A, et al. Chronic L-DOPA treatment increases striatal cannabinoid CB<Subscript>1</Subscript> receptor mRNA expression in 6-hydroxydopamine-lesioned rats.<Emphasis Type="Italic">Neurosci Lett</Emphasis>. 1999;276:71–74.</BibUnstructured>
              </Citation>
              <Citation ID="CR92">
                <CitationNumber>92.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>EA</Initials>
                    <FamilyName>McCaw</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>H</Initials>
                    <FamilyName>Hu</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>GT</Initials>
                    <FamilyName>Gomez</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>ALO</Initials>
                    <FamilyName>Hebb</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>MEM</Initials>
                    <FamilyName>Kelly</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>EM</Initials>
                    <FamilyName>Denovan-Wright</FamilyName>
                  </BibAuthorName>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">Structure, expression and regulation of the cannabinoid receptor gene (<Emphasis Type="Italic">CB1</Emphasis>) in Huntington’s disease transgenic mice</ArticleTitle>
                  <JournalTitle>Eur J Biochem</JournalTitle>
                  <VolumeID>271</VolumeID>
                  <FirstPage>4909</FirstPage>
                  <LastPage>4920</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15606779</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2MXjvFCrtg%3D%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1111/j.1432-1033.2004.04460.x</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>McCaw EA, Hu H, Gomez GT, Hebb ALO, Kelly MEM, Denovan-Wright EM. Structure, expression and regulation of the cannabinoid receptor gene (<Emphasis Type="Italic">CB1</Emphasis>) in Huntington’s disease transgenic mice.<Emphasis Type="Italic">Eur J Biochem</Emphasis>. 2004;271:4909–4920.</BibUnstructured>
              </Citation>
              <Citation ID="CR93">
                <CitationNumber>93.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>KJ</Initials>
                    <FamilyName>Page</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>L</Initials>
                    <FamilyName>Besret</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Jain</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>EM</Initials>
                    <FamilyName>Monagham</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>SB</Initials>
                    <FamilyName>Dunnett</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>BJ</Initials>
                    <FamilyName>Everitt</FamilyName>
                  </BibAuthorName>
                  <Year>2000</Year>
                  <ArticleTitle Language="En">Effects of systemic 3-nitropropionic acid-induced lesions of the dorsal striatum on cannabinoid and μ-opioid receptor binding in the basal ganglia</ArticleTitle>
                  <JournalTitle>Exp Brain Res</JournalTitle>
                  <VolumeID>130</VolumeID>
                  <FirstPage>142</FirstPage>
                  <LastPage>150</LastPage>
                  <Occurrence Type="PID">
                    <Handle>10672467</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3cXjs1CitQ%3D%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1007/s002210050016</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Page KJ, Besret L, Jain M, Monagham EM, Dunnett SB, Everitt BJ. Effects of systemic 3-nitropropionic acid-induced lesions of the dorsal striatum on cannabinoid and μ-opioid receptor binding in the basal ganglia.<Emphasis Type="Italic">Exp Brain Res</Emphasis>. 2000;130:142–150.</BibUnstructured>
              </Citation>
              <Citation ID="CR94">
                <CitationNumber>94.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>I</Initials>
                    <FamilyName>Lastres-Becker</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>F</Initials>
                    <FamilyName>Fezza</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Cebeira</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2001</Year>
                  <ArticleTitle Language="En">Changes in endocannabinoid transmission in the basal ganglia in a rat model of Huntington’s disease</ArticleTitle>
                  <JournalTitle>Neuroreport</JournalTitle>
                  <VolumeID>12</VolumeID>
                  <FirstPage>2125</FirstPage>
                  <LastPage>2129</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11447320</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3MXls1enu7s%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1097/00001756-200107200-00017</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Lastres-Becker I, Fezza F, Cebeira M, et al. Changes in endocannabinoid transmission in the basal ganglia in a rat model of Huntington’s disease.<Emphasis Type="Italic">Neuroreport</Emphasis>. 2001;12:2125–2129.</BibUnstructured>
              </Citation>
              <Citation ID="CR95">
                <CitationNumber>95.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>I</Initials>
                    <FamilyName>Lastres-Becker</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>N</Initials>
                    <FamilyName>Bizat</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>F</Initials>
                    <FamilyName>Boyer</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>P</Initials>
                    <FamilyName>Hantraye</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Fernández-Ruiz</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>E</Initials>
                    <FamilyName>Brouillet</FamilyName>
                  </BibAuthorName>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">Potential involvement of cannabinoid receptors in 3-nitropropionic acid toxicity<Emphasis Type="Italic">in vivo</Emphasis>
                  </ArticleTitle>
                  <JournalTitle>Neuroreport</JournalTitle>
                  <VolumeID>15</VolumeID>
                  <FirstPage>2375</FirstPage>
                  <LastPage>2379</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15640759</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2cXhtVOqt7vJ</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1097/00001756-200410250-00015</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Lastres-Becker I, Bizat N, Boyer F, Hantraye P, Fernández-Ruiz J, Brouillet E. Potential involvement of cannabinoid receptors in 3-nitropropionic acid toxicity<Emphasis Type="Italic">in vivo</Emphasis>.<Emphasis Type="Italic">Neuroreport</Emphasis>. 2004;15:2375–2379.</BibUnstructured>
              </Citation>
              <Citation ID="CR96">
                <CitationNumber>96.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>I</Initials>
                    <FamilyName>Lastres-Becker</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>HH</Initials>
                    <FamilyName>Hansen</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>F</Initials>
                    <FamilyName>Berrendero</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">Alleviation of motor hyperactivity and neurochemical deficits by endocannabinoid uptake inhibition in a rat model of Huntington’s disease</ArticleTitle>
                  <JournalTitle>Synapse</JournalTitle>
                  <VolumeID>44</VolumeID>
                  <FirstPage>23</FirstPage>
                  <LastPage>35</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11842443</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD38XitV2rtLc%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1002/syn.10054</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Lastres-Becker I, Hansen HH, Berrendero F, et al. Alleviation of motor hyperactivity and neurochemical deficits by endocannabinoid uptake inhibition in a rat model of Huntington’s disease.<Emphasis Type="Italic">Synapse</Emphasis>. 2002;44:23–35.</BibUnstructured>
              </Citation>
              <Citation ID="CR97">
                <CitationNumber>97.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>I</Initials>
                    <FamilyName>Lastres-Becker</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>F</Initials>
                    <FamilyName>Berrendero</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JJ</Initials>
                    <FamilyName>Lucas</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">Loss of mRNA levels, binding and activation of GTP-binding proteins for cannabinoid CB<Subscript>1</Subscript> receptors in the basal ganglia of a transgenic model of Huntington’s disease</ArticleTitle>
                  <JournalTitle>Brain Res</JournalTitle>
                  <VolumeID>929</VolumeID>
                  <FirstPage>236</FirstPage>
                  <LastPage>242</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11864629</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD38XhsFaksLc%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0006-8993(01)03403-5</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Lastres-Becker I, Berrendero F, Lucas JJ, et al. Loss of mRNA levels, binding and activation of GTP-binding proteins for cannabinoid CB<Subscript>1</Subscript> receptors in the basal ganglia of a transgenic model of Huntington’s disease.<Emphasis Type="Italic">Brain Res</Emphasis>. 2002;929:236–242.</BibUnstructured>
              </Citation>
              <Citation ID="CR98">
                <CitationNumber>98.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>JM</Initials>
                    <FamilyName>Walker</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>SM</Initials>
                    <FamilyName>Huang</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>NM</Initials>
                    <FamilyName>Strangman</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>K</Initials>
                    <FamilyName>Tsou</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>MC</Initials>
                    <FamilyName>Sañudo-Peña</FamilyName>
                  </BibAuthorName>
                  <Year>1999</Year>
                  <ArticleTitle Language="En">Pain modulation by release of the endogenous cannabinoid anandamide</ArticleTitle>
                  <JournalTitle>Proc Natl Acad Sci USA</JournalTitle>
                  <VolumeID>96</VolumeID>
                  <FirstPage>12198</FirstPage>
                  <LastPage>12203</LastPage>
                  <Occurrence Type="PID">
                    <Handle>10518599</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK1MXmvVGjtLw%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1073/pnas.96.21.12198</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Walker JM, Huang SM, Strangman NM, Tsou K, Sañudo-Peña MC. Pain modulation by release of the endogenous cannabinoid anandamide.<Emphasis Type="Italic">Proc Natl Acad Sci USA</Emphasis>. 1999;96:12198–12203.</BibUnstructured>
              </Citation>
              <Citation ID="CR99">
                <CitationNumber>99.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>G</Initials>
                    <FamilyName>Lim</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>B</Initials>
                    <FamilyName>Sung</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>R-R</Initials>
                    <FamilyName>Ji</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Mao</FamilyName>
                  </BibAuthorName>
                  <Year>2003</Year>
                  <ArticleTitle Language="En">Upregulation of spinal cannabinoid-1-receptors following nerve injury enhances the effects of Win 55,212-2 on neuropathic pain behaviors in rats</ArticleTitle>
                  <JournalTitle>Pain</JournalTitle>
                  <VolumeID>105</VolumeID>
                  <FirstPage>275</FirstPage>
                  <LastPage>283</LastPage>
                  <Occurrence Type="PID">
                    <Handle>14499445</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3sXnt1Cksr4%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0304-3959(03)00242-2</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Lim G, Sung B, Ji R-R, Mao J. Upregulation of spinal cannabinoid-1-receptors following nerve injury enhances the effects of Win 55,212-2 on neuropathic pain behaviors in rats.<Emphasis Type="Italic">Pain</Emphasis>. 2003;105:275–283.</BibUnstructured>
              </Citation>
              <Citation ID="CR100">
                <CitationNumber>100.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Zhang</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>C</Initials>
                    <FamilyName>Hoffert</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>HK</Initials>
                    <FamilyName>Vu</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>T</Initials>
                    <FamilyName>Groblewski</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Ahmad</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>D</Initials>
                    <FamilyName>O’Donnell</FamilyName>
                  </BibAuthorName>
                  <Year>2003</Year>
                  <ArticleTitle Language="En">Induction of CB<Subscript>2</Subscript> receptor expression in the rat spinal cord of neuropathic but not inflammatory chronic pain models</ArticleTitle>
                  <JournalTitle>Eur J Neurosci</JournalTitle>
                  <VolumeID>17</VolumeID>
                  <FirstPage>2750</FirstPage>
                  <LastPage>2754</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12823482</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1046/j.1460-9568.2003.02704.x</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Zhang J, Hoffert C, Vu HK, Groblewski T, Ahmad S, O’Donnell D. Induction of CB<Subscript>2</Subscript> receptor expression in the rat spinal cord of neuropathic but not inflammatory chronic pain models.<Emphasis Type="Italic">Eur J Neurosci</Emphasis>. 2003;17:2750–2754.</BibUnstructured>
              </Citation>
              <Citation ID="CR101">
                <CitationNumber>101.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>P</Initials>
                    <FamilyName>Dinis</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Charrua</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Avelino</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">Anandamide-evoked activation of vanilloid receptor 1 contributes to the development of bladder hyperreflexia and nociceptive transmission to spinal dorsal horn neurons in cystitis</ArticleTitle>
                  <JournalTitle>J Neurosci</JournalTitle>
                  <VolumeID>24</VolumeID>
                  <FirstPage>11253</FirstPage>
                  <LastPage>11263</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15601931</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2MXjtVWrtw%3D%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1523/JNEUROSCI.2657-04.2004</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Dinis P, Charrua A, Avelino A, et al. Anandamide-evoked activation of vanilloid receptor 1 contributes to the development of bladder hyperreflexia and nociceptive transmission to spinal dorsal horn neurons in cystitis.<Emphasis Type="Italic">J Neurosci</Emphasis>. 2004;24:11253–11263.</BibUnstructured>
              </Citation>
              <Citation ID="CR102">
                <CitationNumber>102.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>V</Initials>
                    <FamilyName>Marzo</FamilyName>
                    <Particle>Di</Particle>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>SK</Initials>
                    <FamilyName>Goparaju</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>L</Initials>
                    <FamilyName>Wang</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2001</Year>
                  <ArticleTitle Language="En">Leptin-regulated endocannabinoids are involved in maintaining food intake</ArticleTitle>
                  <JournalTitle>Nature</JournalTitle>
                  <VolumeID>410</VolumeID>
                  <FirstPage>822</FirstPage>
                  <LastPage>825</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11298451</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1038/35071088</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Di Marzo V, Goparaju SK, Wang L, et al. Leptin-regulated endocannabinoids are involved in maintaining food intake.<Emphasis Type="Italic">Nature</Emphasis>. 2001;410:822–825.</BibUnstructured>
              </Citation>
              <Citation ID="CR103">
                <CitationNumber>103.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Bensaid</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Gary-Bobo</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Esclangon</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2003</Year>
                  <ArticleTitle Language="En">The cannabinoid CB<Subscript>1</Subscript> receptor antagonist SR141716 increases Acrp30 mRNA expression in adipose tissue of obese fa/fa rats and in cultured adipocyte cells</ArticleTitle>
                  <JournalTitle>Mol Pharmacol</JournalTitle>
                  <VolumeID>63</VolumeID>
                  <FirstPage>908</FirstPage>
                  <LastPage>914</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12644592</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3sXisFeksb0%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1124/mol.63.4.908</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Bensaid M, Gary-Bobo M, Esclangon A, et al. The cannabinoid CB<Subscript>1</Subscript> receptor antagonist SR141716 increases Acrp30 mRNA expression in adipose tissue of obese fa/fa rats and in cultured adipocyte cells.<Emphasis Type="Italic">Mol Pharmacol</Emphasis>. 2003;63:908–914.</BibUnstructured>
              </Citation>
              <Citation ID="CR104">
                <CitationNumber>104.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Maccarrone</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>E</Initials>
                    <FamilyName>Fride</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>T</Initials>
                    <FamilyName>Bisogno</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2005</Year>
                  <ArticleTitle Language="En">Up-regulation of the endocannabinoid system in the uterus of leptin knockout (<Emphasis Type="Italic">ob/ob</Emphasis>) mice and implications for fertility</ArticleTitle>
                  <JournalTitle>Mol Hum Reprod</JournalTitle>
                  <VolumeID>11</VolumeID>
                  <FirstPage>21</FirstPage>
                  <LastPage>28</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15563449</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2MXkt1ahtQ%3D%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1093/molehr/gah130</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Maccarrone M, Fride E, Bisogno T, et al. Up-regulation of the endocannabinoid system in the uterus of leptin knockout (<Emphasis Type="Italic">ob/ob</Emphasis>) mice and implications for fertility.<Emphasis Type="Italic">Mol Hum Reprod</Emphasis>. 2005;11:21–28.</BibUnstructured>
              </Citation>
              <Citation ID="CR105">
                <CitationNumber>105.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>TC</Initials>
                    <FamilyName>Kirkham</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>CM</Initials>
                    <FamilyName>Williams</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>F</Initials>
                    <FamilyName>Fezza</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>V</Initials>
                    <FamilyName>Marzo</FamilyName>
                    <Particle>Di</Particle>
                  </BibAuthorName>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">Endocannabinoid levels in rat limbic forebrain and hypothalamus in relation to fasting, feeding and satiation: stimulation of eating by 2-arachidonoyl glycerol</ArticleTitle>
                  <JournalTitle>Br J Pharmacol</JournalTitle>
                  <VolumeID>136</VolumeID>
                  <FirstPage>550</FirstPage>
                  <LastPage>557</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12055133</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD38XlsFWqtro%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1038/sj.bjp.0704767</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Kirkham TC, Williams CM, Fezza F, Di Marzo V. Endocannabinoid levels in rat limbic forebrain and hypothalamus in relation to fasting, feeding and satiation: stimulation of eating by 2-arachidonoyl glycerol.<Emphasis Type="Italic">Br J Pharmacol</Emphasis>. 2002;136:550–557.</BibUnstructured>
              </Citation>
              <Citation ID="CR106">
                <CitationNumber>106.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>MN</Initials>
                    <FamilyName>Hill</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Patel</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>EJ</Initials>
                    <FamilyName>Carrier</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2005</Year>
                  <ArticleTitle Language="En">Downregulation of endocannabinoid signaling in the hippocampus following chronic unpredictable stress</ArticleTitle>
                  <JournalTitle>Neuropsychopharmacology</JournalTitle>
                  <VolumeID>30</VolumeID>
                  <FirstPage>508</FirstPage>
                  <LastPage>515</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15525997</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2MXhtlOrsbc%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1038/sj.npp.1300601</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Hill MN, Patel S, Carrier EJ, et al. Downregulation of endocannabinoid signaling in the hippocampus following chronic unpredictable stress.<Emphasis Type="Italic">Neuropsychopharmacology</Emphasis>. 2005;30:508–515.</BibUnstructured>
              </Citation>
              <Citation ID="CR107">
                <CitationNumber>107.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Patel</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>CT</Initials>
                    <FamilyName>Roelke</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>DJ</Initials>
                    <FamilyName>Rademacher</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>CJ</Initials>
                    <FamilyName>Hillard</FamilyName>
                  </BibAuthorName>
                  <Year>2005</Year>
                  <ArticleTitle Language="En">Inhibition of restraint stress-induced neural and behavioural activation by endogenous cannabinoid signalling</ArticleTitle>
                  <JournalTitle>Eur J Neurosci</JournalTitle>
                  <VolumeID>21</VolumeID>
                  <FirstPage>1057</FirstPage>
                  <LastPage>1069</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15787710</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1111/j.1460-9568.2005.03916.x</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Patel S, Roelke CT, Rademacher DJ, Hillard CJ. Inhibition of restraint stress-induced neural and behavioural activation by endogenous cannabinoid signalling.<Emphasis Type="Italic">Eur J Neurosci</Emphasis>. 2005;21:1057–1069.</BibUnstructured>
              </Citation>
              <Citation ID="CR108">
                <CitationNumber>108.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>G</Initials>
                    <FamilyName>Marsicano</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>CT</Initials>
                    <FamilyName>Wotjak</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>SC</Initials>
                    <FamilyName>Azad</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">The endogenous cannabinoid system controls extinction of aversive memories</ArticleTitle>
                  <JournalTitle>Nature</JournalTitle>
                  <VolumeID>418</VolumeID>
                  <FirstPage>530</FirstPage>
                  <LastPage>534</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12152079</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD38Xls12nur4%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1038/nature00839</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Marsicano G, Wotjak CT, Azad SC, et al. The endogenous cannabinoid system controls extinction of aversive memories.<Emphasis Type="Italic">Nature</Emphasis>. 2002;418:530–534.</BibUnstructured>
              </Citation>
              <Citation ID="CR109">
                <CitationNumber>109.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>P</Initials>
                    <FamilyName>Liu</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>DK</Initials>
                    <FamilyName>Bilkey</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>CL</Initials>
                    <FamilyName>Darlington</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>PF</Initials>
                    <FamilyName>Smith</FamilyName>
                  </BibAuthorName>
                  <Year>2003</Year>
                  <ArticleTitle Language="En">Cannabinoid CB<Subscript>1</Subscript> receptor protein expression in the rat hippocampus and entorhinal, perirhinal, postrhinal and temporal cortices: regional variations and agerelated changes</ArticleTitle>
                  <JournalTitle>Brain Res</JournalTitle>
                  <VolumeID>979</VolumeID>
                  <FirstPage>235</FirstPage>
                  <LastPage>239</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12850592</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3sXlt1WntbY%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0006-8993(03)02872-5</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Liu P, Bilkey DK, Darlington CL, Smith PF. Cannabinoid CB<Subscript>1</Subscript> receptor protein expression in the rat hippocampus and entorhinal, perirhinal, postrhinal and temporal cortices: regional variations and agerelated changes.<Emphasis Type="Italic">Brain Res</Emphasis>. 2003;979:235–239.</BibUnstructured>
              </Citation>
              <Citation ID="CR110">
                <CitationNumber>110.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>PB</Initials>
                    <FamilyName>Sparling</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Giuffrida</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>D</Initials>
                    <FamilyName>Piomelli</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>L</Initials>
                    <FamilyName>Rosskopf</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Dietrich</FamilyName>
                  </BibAuthorName>
                  <Year>2003</Year>
                  <ArticleTitle Language="En">Exercise activates the endocannabinoid system</ArticleTitle>
                  <JournalTitle>Neuroreport</JournalTitle>
                  <VolumeID>14</VolumeID>
                  <FirstPage>2209</FirstPage>
                  <LastPage>2211</LastPage>
                  <Occurrence Type="PID">
                    <Handle>14625449</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3sXptVCqurY%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1097/00001756-200312020-00015</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Sparling PB, Giuffrida A, Piomelli D, Rosskopf L, Dietrich A. Exercise activates the endocannabinoid system.<Emphasis Type="Italic">Neuroreport</Emphasis>. 2003;14:2209–2211.</BibUnstructured>
              </Citation>
              <Citation ID="CR111">
                <CitationNumber>111.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Bátkai</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>P</Initials>
                    <FamilyName>Pacher</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>D</Initials>
                    <FamilyName>Osei-Hyiaman</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">Endocannabinoids acting at cannabinoid-1 receptors regulate cardiovascular function in hypertension</ArticleTitle>
                  <JournalTitle>Circulation</JournalTitle>
                  <VolumeID>110</VolumeID>
                  <FirstPage>1996</FirstPage>
                  <LastPage>2002</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15451779</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1161/01.CIR.0000143230.23252.D2</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2cXnvFams74%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Bátkai S, Pacher P, Osei-Hyiaman D, et al. Endocannabinoids acting at cannabinoid-1 receptors regulate cardiovascular function in hypertension.<Emphasis Type="Italic">Circulation</Emphasis>. 2004;110:1996–2002.</BibUnstructured>
              </Citation>
              <Citation ID="CR112">
                <CitationNumber>112.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Domenicali</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Ros</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>G</Initials>
                    <FamilyName>Fernández-Varo</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2005</Year>
                  <ArticleTitle Language="En">Increased anandamide induced relaxation in mesenteric arteries of cirrhotic rats: role of cannabinoid and vanilloid receptors</ArticleTitle>
                  <JournalTitle>Gut</JournalTitle>
                  <VolumeID>54</VolumeID>
                  <FirstPage>522</FirstPage>
                  <LastPage>527</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15753538</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2MXjtFams74%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1136/gut.2004.051599</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Domenicali M, Ros J, Fernández-Varo G, et al. Increased anandamide induced relaxation in mesenteric arteries of cirrhotic rats: role of cannabinoid and vanilloid receptors.<Emphasis Type="Italic">Gut</Emphasis>. 2005;54:522–527.</BibUnstructured>
              </Citation>
              <Citation ID="CR113">
                <CitationNumber>113.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>K</Initials>
                    <FamilyName>Varga</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JA</Initials>
                    <FamilyName>Wagner</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>DT</Initials>
                    <FamilyName>Bridgen</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>G</Initials>
                    <FamilyName>Kunos</FamilyName>
                  </BibAuthorName>
                  <Year>1998</Year>
                  <ArticleTitle Language="En">Platelet- and macrophage-derived endogenous cannabinoids are involved in endotoxin-induced hypotension</ArticleTitle>
                  <JournalTitle>FASEB J</JournalTitle>
                  <VolumeID>12</VolumeID>
                  <FirstPage>1035</FirstPage>
                  <LastPage>1044</LastPage>
                  <Occurrence Type="PID">
                    <Handle>9707176</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK1cXlt1Chs7o%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Varga K, Wagner JA, Bridgen DT, Kunos G. Platelet- and macrophage-derived endogenous cannabinoids are involved in endotoxin-induced hypotension.<Emphasis Type="Italic">FASEB J</Emphasis>. 1998;12:1035–1044.</BibUnstructured>
              </Citation>
              <Citation ID="CR114">
                <CitationNumber>114.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Liu</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Bátkai</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>P</Initials>
                    <FamilyName>Pacher</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2003</Year>
                  <ArticleTitle Language="En">Lipopolysaccharide induces anandamide synthesis in macrophages via CD14/MAPK/phosphoinositide 3-kinase/NF-κB independently of platelet-activating factor</ArticleTitle>
                  <JournalTitle>J Biol Chem</JournalTitle>
                  <VolumeID>278</VolumeID>
                  <FirstPage>45034</FirstPage>
                  <LastPage>45039</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12949078</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3sXoslWlt7k%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1074/jbc.M306062200</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Liu J, Bátkai S, Pacher P, et al. Lipopolysaccharide induces anandamide synthesis in macrophages via CD14/MAPK/phosphoinositide 3-kinase/NF-κB independently of platelet-activating factor.<Emphasis Type="Italic">J Biol Chem</Emphasis>. 2003;278:45034–45039.</BibUnstructured>
              </Citation>
              <Citation ID="CR115">
                <CitationNumber>115.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Maccarrone</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>L</Initials>
                    <FamilyName>Petrocellis</FamilyName>
                    <Particle>De</Particle>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Bari</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2001</Year>
                  <ArticleTitle Language="En">Lipopolysaccharide downregulates fatty acid amide hydrolase expression and increases anandamide levels in human peripheral lymphocytes</ArticleTitle>
                  <JournalTitle>Arch Biochem Biophys</JournalTitle>
                  <VolumeID>393</VolumeID>
                  <FirstPage>321</FirstPage>
                  <LastPage>328</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11556820</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3MXmslGhurw%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1006/abbi.2001.2500</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Maccarrone M, De Petrocellis L, Bari M, et al. Lipopolysaccharide downregulates fatty acid amide hydrolase expression and increases anandamide levels in human peripheral lymphocytes.<Emphasis Type="Italic">Arch Biochem Biophys</Emphasis>. 2001;393:321–328.</BibUnstructured>
              </Citation>
              <Citation ID="CR116">
                <CitationNumber>116.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>JA</Initials>
                    <FamilyName>Wagner</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>K</Initials>
                    <FamilyName>Hu</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Bauersachs</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2001</Year>
                  <ArticleTitle Language="En">Endogenous cannabinoids mediate hypotension after experimental myocardial infarction</ArticleTitle>
                  <JournalTitle>J Am Coll Cardiol</JournalTitle>
                  <VolumeID>38</VolumeID>
                  <FirstPage>2048</FirstPage>
                  <LastPage>2054</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11738314</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD38XisFaksg%3D%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0735-1097(01)01671-0</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Wagner JA, Hu K, Bauersachs J, et al. Endogenous cannabinoids mediate hypotension after experimental myocardial infarction.<Emphasis Type="Italic">J Am Coll Cardiol</Emphasis>. 2001;38:2048–2054.</BibUnstructured>
              </Citation>
              <Citation ID="CR117">
                <CitationNumber>117.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>AA</Initials>
                    <FamilyName>Izzo</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>F</Initials>
                    <FamilyName>Fezza</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>R</Initials>
                    <FamilyName>Capasso</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2001</Year>
                  <ArticleTitle Language="En">Cannabinoid CB<Subscript>1</Subscript>-receptor mediated regulation of gastrointestinal motility in mice in a model of intestinal inflammation</ArticleTitle>
                  <JournalTitle>Br J Pharmacol</JournalTitle>
                  <VolumeID>134</VolumeID>
                  <FirstPage>563</FirstPage>
                  <LastPage>570</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11588110</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3MXnvV2kur4%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1038/sj.bjp.0704293</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Izzo AA, Fezza F, Capasso R, et al. Cannabinoid CB<Subscript>1</Subscript>-receptor mediated regulation of gastrointestinal motility in mice in a model of intestinal inflammation.<Emphasis Type="Italic">Br J Pharmacol</Emphasis>. 2001;134:563–570.</BibUnstructured>
              </Citation>
              <Citation ID="CR118">
                <CitationNumber>118.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>F</Initials>
                    <FamilyName>Massa</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>G</Initials>
                    <FamilyName>Marsicano</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>H</Initials>
                    <FamilyName>Hermann</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">The endogenous cannabinoid system protects against colonic inflammation</ArticleTitle>
                  <JournalTitle>J Clin Invest</JournalTitle>
                  <VolumeID>113</VolumeID>
                  <FirstPage>1202</FirstPage>
                  <LastPage>1209</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15085199</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2cXjt1yisL0%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Massa F, Marsicano G, Hermann H, et al. The endogenous cannabinoid system protects against colonic inflammation.<Emphasis Type="Italic">J Clin Invest</Emphasis>. 2004;113:1202–1209.</BibUnstructured>
              </Citation>
              <Citation ID="CR119">
                <CitationNumber>119.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>AA</Initials>
                    <FamilyName>Izzo</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>F</Initials>
                    <FamilyName>Capasso</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Costagliola</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2003</Year>
                  <ArticleTitle Language="En">An endogenous cannabinoid tone attenuates cholera toxin-induced fluid accumulation in mice</ArticleTitle>
                  <JournalTitle>Gastroenterology</JournalTitle>
                  <VolumeID>125</VolumeID>
                  <FirstPage>765</FirstPage>
                  <LastPage>774</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12949722</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3sXnvVSiurY%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0016-5085(03)00892-8</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Izzo AA, Capasso F, Costagliola A, et al. An endogenous cannabinoid tone attenuates cholera toxin-induced fluid accumulation in mice.<Emphasis Type="Italic">Gastroenterology</Emphasis>. 2003;125:765–774.</BibUnstructured>
              </Citation>
              <Citation ID="CR120">
                <CitationNumber>120.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>DC</Initials>
                    <FamilyName>McVey</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>PC</Initials>
                    <FamilyName>Schmid</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>HHO</Initials>
                    <FamilyName>Schmid</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>SR</Initials>
                    <FamilyName>Vigna</FamilyName>
                  </BibAuthorName>
                  <Year>2003</Year>
                  <ArticleTitle Language="En">Endocannabinoids induce ileitis in rats via the capsaicin receptor (VR1)</ArticleTitle>
                  <JournalTitle>J Pharmacol Exp Ther</JournalTitle>
                  <VolumeID>304</VolumeID>
                  <FirstPage>713</FirstPage>
                  <LastPage>722</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12538826</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3sXpvVCmsA%3D%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1124/jpet.102.043893</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>McVey DC, Schmid PC, Schmid HHO, Vigna SR. Endocannabinoids induce ileitis in rats via the capsaicin receptor (VR1).<Emphasis Type="Italic">J Pharmacol Exp Ther</Emphasis>. 2003;304:713–722.</BibUnstructured>
              </Citation>
              <Citation ID="CR121">
                <CitationNumber>121.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>N</Initials>
                    <FamilyName>Mascolo</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>AA</Initials>
                    <FamilyName>Izzo</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Ligresti</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">The endocannabinoid system and the molecular basis of paralytic ileus in mice</ArticleTitle>
                  <JournalTitle>FASEB J</JournalTitle>
                  <VolumeID>16</VolumeID>
                  <FirstPage>U131</FirstPage>
                  <LastPage>U51</LastPage>
                </BibArticle>
                <BibUnstructured>Mascolo N, Izzo AA, Ligresti A, et al. The endocannabinoid system and the molecular basis of paralytic ileus in mice.<Emphasis Type="Italic">FASEB J</Emphasis>. 2002;16:U131-U51.</BibUnstructured>
              </Citation>
              <Citation ID="CR122">
                <CitationNumber>122.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>KL</Initials>
                    <FamilyName>Jin</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>XO</Initials>
                    <FamilyName>Mao</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>PC</Initials>
                    <FamilyName>Goldsmith</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>DA</Initials>
                    <FamilyName>Greenberg</FamilyName>
                  </BibAuthorName>
                  <Year>2000</Year>
                  <ArticleTitle Language="En">CB<Subscript>1</Subscript> cannabinoid receptor induction in experimental stroke</ArticleTitle>
                  <JournalTitle>Ann Neurol</JournalTitle>
                  <VolumeID>48</VolumeID>
                  <FirstPage>257</FirstPage>
                  <LastPage>261</LastPage>
                  <Occurrence Type="PID">
                    <Handle>10939579</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3cXlvFKhtbY%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1002/1531-8249(200008)48:2&lt;257::AID-ANA18&gt;3.0.CO;2-P</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Jin KL, Mao XO, Goldsmith PC, Greenberg DA. CB<Subscript>1</Subscript> cannabinoid receptor induction in experimental stroke.<Emphasis Type="Italic">Ann Neurol</Emphasis>. 2000;48:257–261.</BibUnstructured>
              </Citation>
              <Citation ID="CR123">
                <CitationNumber>123.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Muthian</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>DJ</Initials>
                    <FamilyName>Rademacher</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>CT</Initials>
                    <FamilyName>Roelke</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>GJ</Initials>
                    <FamilyName>Gross</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>CJ</Initials>
                    <FamilyName>Hillard</FamilyName>
                  </BibAuthorName>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">Anandamide content is increased and CB<Subscript>1</Subscript> cannabinoid receptor blockade is protective during transient, focal cerebral ischemia</ArticleTitle>
                  <JournalTitle>Neuroscience</JournalTitle>
                  <VolumeID>129</VolumeID>
                  <FirstPage>743</FirstPage>
                  <LastPage>750</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15541895</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2cXpslWgtL4%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/j.neuroscience.2004.08.044</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Muthian S, Rademacher DJ, Roelke CT, Gross GJ, Hillard CJ. Anandamide content is increased and CB<Subscript>1</Subscript> cannabinoid receptor blockade is protective during transient, focal cerebral ischemia.<Emphasis Type="Italic">Neuroscience</Emphasis>. 2004;129:743–750.</BibUnstructured>
              </Citation>
              <Citation ID="CR124">
                <CitationNumber>124.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Kurabayashi</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>I</Initials>
                    <FamilyName>Takeyoshi</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>D</Initials>
                    <FamilyName>Yoshinari</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>K</Initials>
                    <FamilyName>Matsumoto</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>I</Initials>
                    <FamilyName>Maruyama</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>Y</Initials>
                    <FamilyName>Morishita</FamilyName>
                  </BibAuthorName>
                  <Year>2005</Year>
                  <ArticleTitle Language="En">2-Arachidonoylglycerol increases in ischemia-reperfusion injury of the rat liver</ArticleTitle>
                  <JournalTitle>J Invest Surg</JournalTitle>
                  <VolumeID>18</VolumeID>
                  <FirstPage>25</FirstPage>
                  <LastPage>31</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15804949</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1080/08941930590905189</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Kurabayashi M, Takeyoshi I, Yoshinari D, Matsumoto K, Maruyama I, Morishita Y. 2-Arachidonoylglycerol increases in ischemia-reperfusion injury of the rat liver.<Emphasis Type="Italic">J Invest Surg</Emphasis>. 2005;18:25–31.</BibUnstructured>
              </Citation>
              <Citation ID="CR125">
                <CitationNumber>125.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>HH</Initials>
                    <FamilyName>Hansen</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>PC</Initials>
                    <FamilyName>Schmid</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>P</Initials>
                    <FamilyName>Bittigau</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2001</Year>
                  <ArticleTitle Language="En">Anandamide, but not 2-arachidonoylglycerol, accumulates during<Emphasis Type="Italic">in vivo</Emphasis> neurodegeneration</ArticleTitle>
                  <JournalTitle>J Neurochem</JournalTitle>
                  <VolumeID>78</VolumeID>
                  <FirstPage>1415</FirstPage>
                  <LastPage>1427</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11579150</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3MXnt12isLw%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1046/j.1471-4159.2001.00542.x</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Hansen HH, Schmid PC, Bittigau P, et al. Anandamide, but not 2-arachidonoylglycerol, accumulates during<Emphasis Type="Italic">in vivo</Emphasis> neurodegeneration.<Emphasis Type="Italic">J Neurochem</Emphasis>. 2001;78:1415–1427.</BibUnstructured>
              </Citation>
              <Citation ID="CR126">
                <CitationNumber>126.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>D</Initials>
                    <FamilyName>Panikashvili</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>C</Initials>
                    <FamilyName>Simeonidou</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Ben-Shabat</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2001</Year>
                  <ArticleTitle Language="En">An endogenous cannabinoid (2-AG) is neuroprotective after brain injury</ArticleTitle>
                  <JournalTitle>Nature</JournalTitle>
                  <VolumeID>413</VolumeID>
                  <FirstPage>527</FirstPage>
                  <LastPage>531</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11586361</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:DC%2BD3MrjvFegsQ%3D%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1038/35097089</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Panikashvili D, Simeonidou C, Ben-Shabat S, et al. An endogenous cannabinoid (2-AG) is neuroprotective after brain injury.<Emphasis Type="Italic">Nature</Emphasis>. 2001;413:527–531.</BibUnstructured>
              </Citation>
              <Citation ID="CR127">
                <CitationNumber>127.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>T</Initials>
                    <FamilyName>Sugiura</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>N</Initials>
                    <FamilyName>Yoshinaga</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Kondo</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>K</Initials>
                    <FamilyName>Waku</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>Y</Initials>
                    <FamilyName>Ishima</FamilyName>
                  </BibAuthorName>
                  <Year>2000</Year>
                  <ArticleTitle Language="En">Generation of 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand, in picrotoxinin-administered rat brain</ArticleTitle>
                  <JournalTitle>Biochem Biophys Res Commun</JournalTitle>
                  <VolumeID>271</VolumeID>
                  <FirstPage>654</FirstPage>
                  <LastPage>658</LastPage>
                  <Occurrence Type="PID">
                    <Handle>10814517</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3cXjt1Sjsb4%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1006/bbrc.2000.2686</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Sugiura T, Yoshinaga N, Kondo S, Waku K, Ishima Y. Generation of 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand, in picrotoxinin-administered rat brain.<Emphasis Type="Italic">Biochem Biophys Res Commun</Emphasis>. 2000;271:654–658.</BibUnstructured>
              </Citation>
              <Citation ID="CR128">
                <CitationNumber>128.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>G</Initials>
                    <FamilyName>Marsicano</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Goodenough</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>K</Initials>
                    <FamilyName>Monory</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2003</Year>
                  <ArticleTitle Language="En">CB<Subscript>1</Subscript> cannabinoid receptors and on-demand defense against excitotoxicity</ArticleTitle>
                  <JournalTitle>Science</JournalTitle>
                  <VolumeID>302</VolumeID>
                  <FirstPage>84</FirstPage>
                  <LastPage>88</LastPage>
                  <Occurrence Type="PID">
                    <Handle>14526074</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3sXnslSjs78%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1126/science.1088208</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Marsicano G, Goodenough S, Monory K, et al. CB<Subscript>1</Subscript> cannabinoid receptors and on-demand defense against excitotoxicity.<Emphasis Type="Italic">Science</Emphasis>. 2003;302:84–88.</BibUnstructured>
              </Citation>
              <Citation ID="CR129">
                <CitationNumber>129.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>K</Initials>
                    <FamilyName>Chen</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Ratzliff</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>L</Initials>
                    <FamilyName>Hilgenberg</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2003</Year>
                  <ArticleTitle Language="En">Long-term plasticity of endocannabinoid signaling induced by developmental febrile seizures</ArticleTitle>
                  <JournalTitle>Neuron</JournalTitle>
                  <VolumeID>39</VolumeID>
                  <FirstPage>599</FirstPage>
                  <LastPage>611</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12925275</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3sXmslOmurY%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0896-6273(03)00499-9</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Chen K, Ratzliff A, Hilgenberg L, et al. Long-term plasticity of endocannabinoid signaling induced by developmental febrile seizures.<Emphasis Type="Italic">Neuron</Emphasis>. 2003;39:599–611.</BibUnstructured>
              </Citation>
              <Citation ID="CR130">
                <CitationNumber>130.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Maccarrone</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Piccirilli</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>N</Initials>
                    <FamilyName>Battista</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">Enhanced anandamide degradation is associated with neuronal apoptosis induced by the HIV-1 coat glycoprotein gp120 in the rat neocortex</ArticleTitle>
                  <JournalTitle>J Neurochem</JournalTitle>
                  <VolumeID>89</VolumeID>
                  <FirstPage>1293</FirstPage>
                  <LastPage>1300</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15147522</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2cXkvFOku74%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1111/j.1471-4159.2004.02430.x</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Maccarrone M, Piccirilli S, Battista N, et al. Enhanced anandamide degradation is associated with neuronal apoptosis induced by the HIV-1 coat glycoprotein gp120 in the rat neocortex.<Emphasis Type="Italic">J Neurochem</Emphasis>. 2004;89:1293–1300.</BibUnstructured>
              </Citation>
              <Citation ID="CR131">
                <CitationNumber>131.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>C</Initials>
                    <FamilyName>Sánchez</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>ML</Initials>
                    <FamilyName>Ceballos</FamilyName>
                    <Particle>de</Particle>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>T</Initials>
                    <FamilyName>Gómez del Pulgar</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2001</Year>
                  <ArticleTitle Language="En">Inhibition of glioma growth in vivo by selective activation of the CB<Subscript>2</Subscript> cannabinoid receptor</ArticleTitle>
                  <JournalTitle>Cancer Res</JournalTitle>
                  <VolumeID>61</VolumeID>
                  <FirstPage>5784</FirstPage>
                  <LastPage>5789</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11479216</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Sánchez C, de Ceballos ML, Gómez del Pulgar T, et al. Inhibition of glioma growth in vivo by selective activation of the CB<Subscript>2</Subscript> cannabinoid receptor.<Emphasis Type="Italic">Cancer Res</Emphasis>. 2001;61:5784–5789.</BibUnstructured>
              </Citation>
              <Citation ID="CR132">
                <CitationNumber>132.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>SH</Initials>
                    <FamilyName>Burstein</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>RG</Initials>
                    <FamilyName>Rossetti</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>B</Initials>
                    <FamilyName>Yagen</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>RB</Initials>
                    <FamilyName>Zurier</FamilyName>
                  </BibAuthorName>
                  <Year>2000</Year>
                  <ArticleTitle Language="En">Oxidative metabolism of anandamide</ArticleTitle>
                  <JournalTitle>Prostaglandins Other Lipid Mediat</JournalTitle>
                  <VolumeID>61</VolumeID>
                  <FirstPage>29</FirstPage>
                  <LastPage>41</LastPage>
                  <Occurrence Type="PID">
                    <Handle>10785540</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3cXjt1CltLo%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0090-6980(00)00053-8</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Burstein SH, Rossetti RG, Yagen B, Zurier RB. Oxidative metabolism of anandamide.<Emphasis Type="Italic">Prostaglandins Other Lipid Mediat</Emphasis>. 2000;61:29–41.</BibUnstructured>
              </Citation>
              <Citation ID="CR133">
                <CitationNumber>133.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>E</Initials>
                    <FamilyName>Lago</FamilyName>
                    <Particle>de</Particle>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Ligresti</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>G</Initials>
                    <FamilyName>Ortar</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">In vivo pharmacological actions of 2 novel inhibitors of anandamide cellular uptake</ArticleTitle>
                  <JournalTitle>Eur J Pharmacol</JournalTitle>
                  <VolumeID>484</VolumeID>
                  <FirstPage>249</FirstPage>
                  <LastPage>257</LastPage>
                  <Occurrence Type="PID">
                    <Handle>14744610</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/j.ejphar.2003.11.027</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2cXnvVOltw%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>de Lago E, Ligresti A, Ortar G, et al. In vivo pharmacological actions of 2 novel inhibitors of anandamide cellular uptake.<Emphasis Type="Italic">Eur J Pharmacol</Emphasis>. 2004;484:249–257.</BibUnstructured>
              </Citation>
              <Citation ID="CR134">
                <CitationNumber>134.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>SH</Initials>
                    <FamilyName>Burstein</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>SM</Initials>
                    <FamilyName>Huang</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>TJ</Initials>
                    <FamilyName>Petros</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>RG</Initials>
                    <FamilyName>Rossetti</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JM</Initials>
                    <FamilyName>Walker</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>RB</Initials>
                    <FamilyName>Zurier</FamilyName>
                  </BibAuthorName>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">Regulation of anandamide tissue levels by<Emphasis Type="Italic">N</Emphasis>-arachidonylglycine</ArticleTitle>
                  <JournalTitle>Biochem Pharmacol</JournalTitle>
                  <VolumeID>64</VolumeID>
                  <FirstPage>1147</FirstPage>
                  <LastPage>1150</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12234618</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD38XntVWqsbw%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0006-2952(02)01301-1</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Burstein SH, Huang SM, Petros TJ, Rossetti RG, Walker JM, Zurier RB. Regulation of anandamide tissue levels by<Emphasis Type="Italic">N</Emphasis>-arachidonylglycine.<Emphasis Type="Italic">Biochem Pharmacol</Emphasis>. 2002;64:1147–1150.</BibUnstructured>
              </Citation>
              <Citation ID="CR135">
                <CitationNumber>135.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>BF</Initials>
                    <FamilyName>Cravatt</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>K</Initials>
                    <FamilyName>Demarest</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>MP</Initials>
                    <FamilyName>Patricelli</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2001</Year>
                  <ArticleTitle Language="En">Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase</ArticleTitle>
                  <JournalTitle>Proc Natl Acad Sci USA</JournalTitle>
                  <VolumeID>98</VolumeID>
                  <FirstPage>9371</FirstPage>
                  <LastPage>9376</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11470906</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3MXlvFSrsbo%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1073/pnas.161191698</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Cravatt BF, Demarest K, Patricelli MP, et al. Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase.<Emphasis Type="Italic">Proc Natl Acad Sci USA</Emphasis>. 2001;98:9371–9376.</BibUnstructured>
              </Citation>
              <Citation ID="CR136">
                <CitationNumber>136.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>AH</Initials>
                    <FamilyName>Lichtman</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>CC</Initials>
                    <FamilyName>Shelton</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>T</Initials>
                    <FamilyName>Advani</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>BF</Initials>
                    <FamilyName>Cravatt</FamilyName>
                  </BibAuthorName>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">Mice lacking fatty acid amide hydrolase exhibit a cannabinoid receptor-mediated phenotypic hypoalgesia</ArticleTitle>
                  <JournalTitle>Pain</JournalTitle>
                  <VolumeID>109</VolumeID>
                  <FirstPage>319</FirstPage>
                  <LastPage>327</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15157693</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2cXkt1SltL4%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/j.pain.2004.01.022</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Lichtman AH, Shelton CC, Advani T, Cravatt BF. Mice lacking fatty acid amide hydrolase exhibit a cannabinoid receptor-mediated phenotypic hypoalgesia.<Emphasis Type="Italic">Pain</Emphasis>. 2004;109:319–327.</BibUnstructured>
              </Citation>
              <Citation ID="CR137">
                <CitationNumber>137.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>BF</Initials>
                    <FamilyName>Cravatt</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Saghatelian</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>EG</Initials>
                    <FamilyName>Hawkins</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>AB</Initials>
                    <FamilyName>Clement</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>MH</Initials>
                    <FamilyName>Bracey</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>AH</Initials>
                    <FamilyName>Lichtman</FamilyName>
                  </BibAuthorName>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">Functional disassociation of the central and peripheral fatty acid amide signaling systems</ArticleTitle>
                  <JournalTitle>Proc Natl Acad Sci USA</JournalTitle>
                  <VolumeID>101</VolumeID>
                  <FirstPage>10821</FirstPage>
                  <LastPage>10826</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15247426</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2cXmtFWmtLY%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1073/pnas.0401292101</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Cravatt BF, Saghatelian A, Hawkins EG, Clement AB, Bracey MH, Lichtman AH. Functional disassociation of the central and peripheral fatty acid amide signaling systems.<Emphasis Type="Italic">Proc Natl Acad Sci USA</Emphasis>. 2004;101:10821–10826.</BibUnstructured>
              </Citation>
              <Citation ID="CR138">
                <CitationNumber>138.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>BR</Initials>
                    <FamilyName>Martin</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>AH</Initials>
                    <FamilyName>Lichtman</FamilyName>
                  </BibAuthorName>
                  <Year>1998</Year>
                  <ArticleTitle Language="En">Cannabinoid transmission and pain perception</ArticleTitle>
                  <JournalTitle>Neurobiol Dis</JournalTitle>
                  <VolumeID>5</VolumeID>
                  <FirstPage>447</FirstPage>
                  <LastPage>461</LastPage>
                  <Occurrence Type="PID">
                    <Handle>9974177</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK1MXhtFSqsLg%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1006/nbdi.1998.0218</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Martin BR, Lichtman AH. Cannabinoid transmission and pain perception.<Emphasis Type="Italic">Neurobiol Dis</Emphasis>. 1998;5:447–461.</BibUnstructured>
              </Citation>
              <Citation ID="CR139">
                <CitationNumber>139.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>RG</Initials>
                    <FamilyName>Pertwee</FamilyName>
                  </BibAuthorName>
                  <Year>2001</Year>
                  <ArticleTitle Language="En">Cannabinoid receptors and pain</ArticleTitle>
                  <JournalTitle>Prog Neurobiol</JournalTitle>
                  <VolumeID>63</VolumeID>
                  <FirstPage>569</FirstPage>
                  <LastPage>611</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11164622</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3MXntlOksA%3D%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0301-0082(00)00031-9</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Pertwee RG. Cannabinoid receptors and pain.<Emphasis Type="Italic">Prog Neurobiol</Emphasis>. 2001;63:569–611.</BibUnstructured>
              </Citation>
              <Citation ID="CR140">
                <CitationNumber>140.</CitationNumber>
                <BibChapter>
                  <BibAuthorName>
                    <Initials>JM</Initials>
                    <FamilyName>Walker</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>AG</Initials>
                    <FamilyName>Hohman</FamilyName>
                  </BibAuthorName>
                  <Year>2005</Year>
                  <ChapterTitle Language="En">Cannabinoid mechanisms of pain suppression</ChapterTitle>
                  <BibEditorName>
                    <Initials>RG</Initials>
                    <FamilyName>Pertwee</FamilyName>
                  </BibEditorName>
                  <Eds/>
                  <BookTitle>Cannabinoids, Handbook of Experimental Pharmacolology</BookTitle>
                  <PublisherName>Springer-Verlag</PublisherName>
                  <PublisherLocation>Heidelberg, Germany</PublisherLocation>
                  <FirstPage>509</FirstPage>
                  <LastPage>54</LastPage>
                </BibChapter>
                <BibUnstructured>Walker JM, Hohman AG. Cannabinoid mechanisms of pain suppression. In: Pertwee RG, ed.<Emphasis Type="Italic">Cannabinoids, Handbook of Experimental Pharmacolology</Emphasis>. Heidelberg, Germany: Springer-Verlag; 2005;168:509–54.</BibUnstructured>
              </Citation>
              <Citation ID="CR141">
                <CitationNumber>141.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>U</Initials>
                    <FamilyName>Herzberg</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>E</Initials>
                    <FamilyName>Eliav</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>GJ</Initials>
                    <FamilyName>Bennett</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>IJ</Initials>
                    <FamilyName>Kopin</FamilyName>
                  </BibAuthorName>
                  <Year>1997</Year>
                  <ArticleTitle Language="En">The analgesic effects of<Emphasis Type="Italic">R</Emphasis>(+)-WIN 55,212-2 mesylate, a high affinity cannabinoid agonist, in a rat model of neuropathic pain</ArticleTitle>
                  <JournalTitle>Neurosci Lett</JournalTitle>
                  <VolumeID>221</VolumeID>
                  <FirstPage>157</FirstPage>
                  <LastPage>160</LastPage>
                  <Occurrence Type="PID">
                    <Handle>9121688</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK2sXns1ehtA%3D%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0304-3940(96)13308-5</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Herzberg U, Eliav E, Bennett GJ, Kopin IJ. The analgesic effects of<Emphasis Type="Italic">R</Emphasis>(+)-WIN 55,212-2 mesylate, a high affinity cannabinoid agonist, in a rat model of neuropathic pain.<Emphasis Type="Italic">Neurosci Lett</Emphasis>. 1997;221:157–160.</BibUnstructured>
              </Citation>
              <Citation ID="CR142">
                <CitationNumber>142.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>SA</Initials>
                    <FamilyName>Edsall</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>RJ</Initials>
                    <FamilyName>Knapp</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>TW</Initials>
                    <FamilyName>Vanderah</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>WR</Initials>
                    <FamilyName>Roeske</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>P</Initials>
                    <FamilyName>Consroe</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>HI</Initials>
                    <FamilyName>Yamamura</FamilyName>
                  </BibAuthorName>
                  <Year>1996</Year>
                  <ArticleTitle Language="En">Antisense oligodeoxynucleotide treatment to the brain cannabinoid receptor inhibits antinociception</ArticleTitle>
                  <JournalTitle>Neuroreport</JournalTitle>
                  <VolumeID>7</VolumeID>
                  <FirstPage>593</FirstPage>
                  <LastPage>596</LastPage>
                  <Occurrence Type="PID">
                    <Handle>8730837</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK28XisVCmsLo%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1097/00001756-199601310-00052</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Edsall SA, Knapp RJ, Vanderah TW, Roeske WR, Consroe P, Yamamura HI. Antisense oligodeoxynucleotide treatment to the brain cannabinoid receptor inhibits antinociception.<Emphasis Type="Italic">Neuroreport</Emphasis>. 1996;7:593–596.</BibUnstructured>
              </Citation>
              <Citation ID="CR143">
                <CitationNumber>143.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>JD</Initials>
                    <FamilyName>Richardson</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>L</Initials>
                    <FamilyName>Aanonsen</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>KM</Initials>
                    <FamilyName>Hargreaves</FamilyName>
                  </BibAuthorName>
                  <Year>1998</Year>
                  <ArticleTitle Language="En">Hypoactivity of the spinal cannabinoid system results in NMDA-dependent hyperalgesia</ArticleTitle>
                  <JournalTitle>J Neurosci</JournalTitle>
                  <VolumeID>18</VolumeID>
                  <FirstPage>451</FirstPage>
                  <LastPage>457</LastPage>
                  <Occurrence Type="PID">
                    <Handle>9412521</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK1cXjtVOiuw%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Richardson JD, Aanonsen L, Hargreaves KM. Hypoactivity of the spinal cannabinoid system results in NMDA-dependent hyperalgesia.<Emphasis Type="Italic">J Neurosci</Emphasis>. 1998;18:451–457.</BibUnstructured>
              </Citation>
              <Citation ID="CR144">
                <CitationNumber>144.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Dogrul</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>LR</Initials>
                    <FamilyName>Gardell</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Ma</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>MH</Initials>
                    <FamilyName>Ossipov</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>F</Initials>
                    <FamilyName>Porreca</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Lai</FamilyName>
                  </BibAuthorName>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">‘Knock-down’ of spinal CB<Subscript>1</Subscript> receptors produces abnormal pain and elevates spinal dynorphin content in mice</ArticleTitle>
                  <JournalTitle>Pain</JournalTitle>
                  <VolumeID>100</VolumeID>
                  <FirstPage>203</FirstPage>
                  <LastPage>209</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12435473</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD38XosFCks74%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0304-3959(02)00302-0</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Dogrul A, Gardell LR, Ma S, Ossipov MH, Porreca F, Lai J. ‘Knock-down’ of spinal CB<Subscript>1</Subscript> receptors produces abnormal pain and elevates spinal dynorphin content in mice.<Emphasis Type="Italic">Pain</Emphasis>. 2002;100:203–209.</BibUnstructured>
              </Citation>
              <Citation ID="CR145">
                <CitationNumber>145.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>O</Initials>
                    <FamilyName>Valverde</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>C</Initials>
                    <FamilyName>Ledent</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>F</Initials>
                    <FamilyName>Beslot</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Parmentier</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>BP</Initials>
                    <FamilyName>Roques</FamilyName>
                  </BibAuthorName>
                  <Year>2000</Year>
                  <ArticleTitle Language="En">Reduction of stress-induced analgesia but not of exogenous opioid effects in mice lacking CB<Subscript>1</Subscript> receptors</ArticleTitle>
                  <JournalTitle>Eur J Neurosci</JournalTitle>
                  <VolumeID>12</VolumeID>
                  <FirstPage>533</FirstPage>
                  <LastPage>539</LastPage>
                  <Occurrence Type="PID">
                    <Handle>10712632</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:DC%2BD3c7nslKhug%3D%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1046/j.1460-9568.2000.00929.x</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Valverde O, Ledent C, Beslot F, Parmentier M, Roques BP. Reduction of stress-induced analgesia but not of exogenous opioid effects in mice lacking CB<Subscript>1</Subscript> receptors.<Emphasis Type="Italic">Eur J Neurosci</Emphasis>. 2000;12:533–539.</BibUnstructured>
              </Citation>
              <Citation ID="CR146">
                <CitationNumber>146.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>MM</Initials>
                    <FamilyName>Ibrahim</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>H</Initials>
                    <FamilyName>Deng</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Zvonok</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2003</Year>
                  <ArticleTitle Language="En">Activation of CB<Subscript>2</Subscript> cannabinoid receptors by AM1241 inhibits experimental neuropathic pain: pain inhibition by receptors not present in the CNS</ArticleTitle>
                  <JournalTitle>Proc Natl Acad Sci USA</JournalTitle>
                  <VolumeID>100</VolumeID>
                  <FirstPage>10529</FirstPage>
                  <LastPage>10533</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12917492</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3sXntFynsb4%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1073/pnas.1834309100</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Ibrahim MM, Deng H, Zvonok A, et al. Activation of CB<Subscript>2</Subscript> cannabinoid receptors by AM1241 inhibits experimental neuropathic pain: pain inhibition by receptors not present in the CNS.<Emphasis Type="Italic">Proc Natl Acad Sci USA</Emphasis>. 2003;100:10529–10533.</BibUnstructured>
              </Citation>
              <Citation ID="CR147">
                <CitationNumber>147.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>C</Initials>
                    <FamilyName>Ledent</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>O</Initials>
                    <FamilyName>Valverde</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>G</Initials>
                    <FamilyName>Cossu</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>1999</Year>
                  <ArticleTitle Language="En">Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB<Subscript>1</Subscript> receptor knockout mice</ArticleTitle>
                  <JournalTitle>Science</JournalTitle>
                  <VolumeID>283</VolumeID>
                  <FirstPage>401</FirstPage>
                  <LastPage>404</LastPage>
                  <Occurrence Type="PID">
                    <Handle>9888857</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK1MXns1Ciug%3D%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1126/science.283.5400.401</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Ledent C, Valverde O, Cossu G, et al. Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB<Subscript>1</Subscript> receptor knockout mice.<Emphasis Type="Italic">Science</Emphasis>. 1999;283:401–404.</BibUnstructured>
              </Citation>
              <Citation ID="CR148">
                <CitationNumber>148.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Zimmer</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>AM</Initials>
                    <FamilyName>Zimmer</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>AG</Initials>
                    <FamilyName>Hohmann</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Herkenham</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>TI</Initials>
                    <FamilyName>Bonner</FamilyName>
                  </BibAuthorName>
                  <Year>1999</Year>
                  <ArticleTitle Language="En">Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB<Subscript>1</Subscript> receptor knockout mice</ArticleTitle>
                  <JournalTitle>Proc Natl Acad Sci USA</JournalTitle>
                  <VolumeID>96</VolumeID>
                  <FirstPage>5780</FirstPage>
                  <LastPage>5785</LastPage>
                  <Occurrence Type="PID">
                    <Handle>10318961</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK1MXjtFCnuro%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1073/pnas.96.10.5780</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Zimmer A, Zimmer AM, Hohmann AG, Herkenham M, Bonner TI. Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB<Subscript>1</Subscript> receptor knockout mice.<Emphasis Type="Italic">Proc Natl Acad Sci USA</Emphasis>. 1999;96:5780–5785.</BibUnstructured>
              </Citation>
              <Citation ID="CR149">
                <CitationNumber>149.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>L</Initials>
                    <FamilyName>Hanus</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Breuer</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Tchilibon</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>1999</Year>
                  <ArticleTitle Language="En">HU-308: a specific agonist for CB<Subscript>2</Subscript>, a peripheral cannabinoid receptor</ArticleTitle>
                  <JournalTitle>Proc Natl Acad Sci USA</JournalTitle>
                  <VolumeID>96</VolumeID>
                  <FirstPage>14228</FirstPage>
                  <LastPage>14233</LastPage>
                  <Occurrence Type="PID">
                    <Handle>10588688</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK1MXnvFKltLs%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1073/pnas.96.25.14228</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Hanus L, Breuer A, Tchilibon S, et al. HU-308: a specific agonist for CB<Subscript>2</Subscript>, a peripheral cannabinoid receptor.<Emphasis Type="Italic">Proc Natl Acad Sci USA</Emphasis>. 1999;96:14228–14233.</BibUnstructured>
              </Citation>
              <Citation ID="CR150">
                <CitationNumber>150.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>N</Initials>
                    <FamilyName>Clayton</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>FH</Initials>
                    <FamilyName>Marshall</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>C</Initials>
                    <FamilyName>Bountra</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>CT</Initials>
                    <FamilyName>O’Shaughnessy</FamilyName>
                  </BibAuthorName>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">CB<Subscript>1</Subscript> and CB<Subscript>2</Subscript> cannabinoid receptors are implicated in inflammatory pain</ArticleTitle>
                  <JournalTitle>Pain</JournalTitle>
                  <VolumeID>96</VolumeID>
                  <FirstPage>253</FirstPage>
                  <LastPage>260</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11972997</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD38XjtVSgsrw%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0304-3959(01)00454-7</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Clayton N, Marshall FH, Bountra C, O’Shaughnessy CT. CB<Subscript>1</Subscript> and CB<Subscript>2</Subscript> cannabinoid receptors are implicated in inflammatory pain.<Emphasis Type="Italic">Pain</Emphasis>. 2002;96:253–260.</BibUnstructured>
              </Citation>
              <Citation ID="CR151">
                <CitationNumber>151.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>KJ</Initials>
                    <FamilyName>Valenzano</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>L</Initials>
                    <FamilyName>Tafesse</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>G</Initials>
                    <FamilyName>Lee</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2005</Year>
                  <ArticleTitle Language="En">Pharmacological and pharmacokinetic characterization of the cannabinoid receptor 2 agonist, GW 405833, utilizing rodent models of acute and chronic pain, anxiety, ataxia and catalepsy</ArticleTitle>
                  <JournalTitle>Neuropharmacology</JournalTitle>
                  <VolumeID>48</VolumeID>
                  <FirstPage>658</FirstPage>
                  <LastPage>672</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15814101</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2MXivF2isLg%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/j.neuropharm.2004.12.008</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Valenzano KJ, Tafesse L, Lee G, et al. Pharmacological and pharmacokinetic characterization of the cannabinoid receptor 2 agonist, GW 405833, utilizing rodent models of acute and chronic pain, anxiety, ataxia and catalepsy.<Emphasis Type="Italic">Neuropharmacology</Emphasis>. 2005;48:658–672.</BibUnstructured>
              </Citation>
              <Citation ID="CR152">
                <CitationNumber>152.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>TP</Initials>
                    <FamilyName>Malan</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>MM</Initials>
                    <FamilyName>Ibrahim</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>H</Initials>
                    <FamilyName>Deng</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2001</Year>
                  <ArticleTitle Language="En">CB<Subscript>2</Subscript> cannabinoid receptor-mediated peripheral antinociception</ArticleTitle>
                  <JournalTitle>Pain</JournalTitle>
                  <VolumeID>93</VolumeID>
                  <FirstPage>239</FirstPage>
                  <LastPage>245</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11514083</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3MXmtFWis7Y%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0304-3959(01)00321-9</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Malan TP, Ibrahim MM, Deng H, et al. CB<Subscript>2</Subscript> cannabinoid receptor-mediated peripheral antinociception.<Emphasis Type="Italic">Pain</Emphasis>. 2001;93:239–245.</BibUnstructured>
              </Citation>
              <Citation ID="CR153">
                <CitationNumber>153.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>AG</Initials>
                    <FamilyName>Nackley</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Makriyannis</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>AG</Initials>
                    <FamilyName>Hohmann</FamilyName>
                  </BibAuthorName>
                  <Year>2003</Year>
                  <ArticleTitle Language="En">Selective activation of cannabinoid CB<Subscript>2</Subscript> receptors suppresses spinal Fos protein expression and pain behavior in a rat model of inflammation</ArticleTitle>
                  <JournalTitle>Neuroscience</JournalTitle>
                  <VolumeID>119</VolumeID>
                  <FirstPage>747</FirstPage>
                  <LastPage>757</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12809695</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3sXksValtbw%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0306-4522(03)00126-X</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Nackley AG, Makriyannis A, Hohmann AG. Selective activation of cannabinoid CB<Subscript>2</Subscript> receptors suppresses spinal Fos protein expression and pain behavior in a rat model of inflammation.<Emphasis Type="Italic">Neuroscience</Emphasis>. 2003;119:747–757.</BibUnstructured>
              </Citation>
              <Citation ID="CR154">
                <CitationNumber>154.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Quartilho</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>HP</Initials>
                    <FamilyName>Mata</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>MM</Initials>
                    <FamilyName>Ibrahim</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2003</Year>
                  <ArticleTitle Language="En">Inhibition of inflammatory hyperalgesia by activation of peripheral CB<Subscript>2</Subscript> cannabinoid receptors</ArticleTitle>
                  <JournalTitle>Anesthesiology</JournalTitle>
                  <VolumeID>99</VolumeID>
                  <FirstPage>955</FirstPage>
                  <LastPage>960</LastPage>
                  <Occurrence Type="PID">
                    <Handle>14508331</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3sXnsFantbw%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1097/00000542-200310000-00031</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Quartilho A, Mata HP, Ibrahim MM, et al. Inhibition of inflammatory hyperalgesia by activation of peripheral CB<Subscript>2</Subscript> cannabinoid receptors.<Emphasis Type="Italic">Anesthesiology</Emphasis>. 2003;99:955–960.</BibUnstructured>
              </Citation>
              <Citation ID="CR155">
                <CitationNumber>155.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>AG</Initials>
                    <FamilyName>Hohmann</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JN</Initials>
                    <FamilyName>Farthing</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>AM</Initials>
                    <FamilyName>Zvonok</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Makriyannis</FamilyName>
                  </BibAuthorName>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">Selective activation of cannabinoid CB<Subscript>2</Subscript> receptors suppresses hyperalgesia evoked by intradermal capsaicin</ArticleTitle>
                  <JournalTitle>J Pharmacol Exp Ther</JournalTitle>
                  <VolumeID>308</VolumeID>
                  <FirstPage>446</FirstPage>
                  <LastPage>453</LastPage>
                  <Occurrence Type="PID">
                    <Handle>14610224</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2cXhtlSqtL0%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1124/jpet.103.060079</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Hohmann AG, Farthing JN, Zvonok AM, Makriyannis A. Selective activation of cannabinoid CB<Subscript>2</Subscript> receptors suppresses hyperalgesia evoked by intradermal capsaicin.<Emphasis Type="Italic">J Pharmacol Exp Ther</Emphasis>. 2004;308:446–453.</BibUnstructured>
              </Citation>
              <Citation ID="CR156">
                <CitationNumber>156.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>MM</Initials>
                    <FamilyName>Ibrahim</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>F</Initials>
                    <FamilyName>Porreca</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Lai</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2005</Year>
                  <ArticleTitle Language="En">CB<Subscript>2</Subscript> cannabinoid receptor activation produces antinociception by stimulating peripheral release of endogenous opioids</ArticleTitle>
                  <JournalTitle>Proc Natl Acad Sci USA</JournalTitle>
                  <VolumeID>102</VolumeID>
                  <FirstPage>3093</FirstPage>
                  <LastPage>3098</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15705714</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2MXitVSktb0%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1073/pnas.0409888102</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Ibrahim MM, Porreca F, Lai J, et al. CB<Subscript>2</Subscript> cannabinoid receptor activation produces antinociception by stimulating peripheral release of endogenous opioids.<Emphasis Type="Italic">Proc Natl Acad Sci USA</Emphasis>. 2005;102:3093–3098.</BibUnstructured>
              </Citation>
              <Citation ID="CR157">
                <CitationNumber>157.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>RA</Initials>
                    <FamilyName>Ross</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>AA</Initials>
                    <FamilyName>Coutts</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>SM</Initials>
                    <FamilyName>McFarlane</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2001</Year>
                  <ArticleTitle Language="En">Actions of cannabinoid receptor ligands on rat cultured sensory neurones: implications for antinociception</ArticleTitle>
                  <JournalTitle>Neuropharmacology</JournalTitle>
                  <VolumeID>40</VolumeID>
                  <FirstPage>221</FirstPage>
                  <LastPage>232</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11114401</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3cXoslCksrs%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0028-3908(00)00135-0</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Ross RA, Coutts AA, McFarlane SM, et al. Actions of cannabinoid receptor ligands on rat cultured sensory neurones: implications for antinociception.<Emphasis Type="Italic">Neuropharmacology</Emphasis>. 2001;40:221–232.</BibUnstructured>
              </Citation>
              <Citation ID="CR158">
                <CitationNumber>158.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Holt</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>F</Initials>
                    <FamilyName>Comelli</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>B</Initials>
                    <FamilyName>Costa</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>CJ</Initials>
                    <FamilyName>Fowler</FamilyName>
                  </BibAuthorName>
                  <Year>2005</Year>
                  <ArticleTitle Language="En">Inhibitors of fatty acid amide hydrolase reduce carrageenan induced hind paw inflammation in pentobarbital-treated mice: comparison with indomethacin and possible involvement of cannabinoid receptors</ArticleTitle>
                  <JournalTitle>Br J Pharmacol</JournalTitle>
                  <VolumeID>146</VolumeID>
                  <FirstPage>467</FirstPage>
                  <LastPage>476</LastPage>
                  <Occurrence Type="PID">
                    <Handle>16100529</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2MXhtVGrurrK</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1038/sj.bjp.0706348</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Holt S, Comelli F, Costa B, Fowler CJ. Inhibitors of fatty acid amide hydrolase reduce carrageenan induced hind paw inflammation in pentobarbital-treated mice: comparison with indomethacin and possible involvement of cannabinoid receptors.<Emphasis Type="Italic">Br J Pharmacol</Emphasis>. 2005;146:467–476.</BibUnstructured>
              </Citation>
              <Citation ID="CR159">
                <CitationNumber>159.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Calignano</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>G</Initials>
                    <FamilyName>Rana</FamilyName>
                    <Particle>La</Particle>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Giuffrida</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>D</Initials>
                    <FamilyName>Piomelli</FamilyName>
                  </BibAuthorName>
                  <Year>1998</Year>
                  <ArticleTitle Language="En">Control of pain initiation by endogenous cannabinoids</ArticleTitle>
                  <JournalTitle>Nature</JournalTitle>
                  <VolumeID>394</VolumeID>
                  <FirstPage>277</FirstPage>
                  <LastPage>281</LastPage>
                  <Occurrence Type="PID">
                    <Handle>9685157</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK1cXkvVKjt7w%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1038/28393</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Calignano A, La Rana G, Giuffrida A, Piomelli D. Control of pain initiation by endogenous cannabinoids.<Emphasis Type="Italic">Nature</Emphasis>. 1998;394:277–281.</BibUnstructured>
              </Citation>
              <Citation ID="CR160">
                <CitationNumber>160.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>P</Initials>
                    <FamilyName>Beaulieu</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>T</Initials>
                    <FamilyName>Bisogno</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Punwar</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2000</Year>
                  <ArticleTitle Language="En">Role of the endogenous cannabinoid system in the formalin test of persistent pain in the rat</ArticleTitle>
                  <JournalTitle>Eur J Pharmacol</JournalTitle>
                  <VolumeID>396</VolumeID>
                  <FirstPage>85</FirstPage>
                  <LastPage>92</LastPage>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3cXjsVGnsbg%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0014-2999(00)00226-0</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Beaulieu P, Bisogno T, Punwar S, et al. Role of the endogenous cannabinoid system in the formalin test of persistent pain in the rat.<Emphasis Type="Italic">Eur J Pharmacol</Emphasis>. 2000;396:85–92.</BibUnstructured>
              </Citation>
              <Citation ID="CR161">
                <CitationNumber>161.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>W</Initials>
                    <FamilyName>Notcutt</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Price</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>R</Initials>
                    <FamilyName>Miller</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">Initial experiences with medicinal extracts of cannabis for chronic pain: results from 34 ‘N of 1’ studies</ArticleTitle>
                  <JournalTitle>Anaesthesia</JournalTitle>
                  <VolumeID>59</VolumeID>
                  <FirstPage>440</FirstPage>
                  <LastPage>452</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15096238</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1111/j.1365-2044.2004.03674.x</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Notcutt W, Price M, Miller R, et al. Initial experiences with medicinal extracts of cannabis for chronic pain: results from 34 ‘N of 1’ studies.<Emphasis Type="Italic">Anaesthesia</Emphasis>. 2004;59:440–452.</BibUnstructured>
              </Citation>
              <Citation ID="CR162">
                <CitationNumber>162.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>R</Initials>
                    <FamilyName>Noyes</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>SF</Initials>
                    <FamilyName>Brunk</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>DA</Initials>
                    <FamilyName>Baram</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Canter</FamilyName>
                  </BibAuthorName>
                  <Year>1975</Year>
                  <ArticleTitle Language="En">Analgesic effect of delta-9-tetrahydrocannabinol</ArticleTitle>
                  <JournalTitle>J Clin Pharmacol</JournalTitle>
                  <VolumeID>15</VolumeID>
                  <FirstPage>139</FirstPage>
                  <LastPage>143</LastPage>
                  <Occurrence Type="PID">
                    <Handle>1091664</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Noyes R, Brunk SF, Baram DA, Canter A. Analgesic effect of delta-9-tetrahydrocannabinol.<Emphasis Type="Italic">J Clin Pharmacol</Emphasis>. 1975;15:139–143.</BibUnstructured>
              </Citation>
              <Citation ID="CR163">
                <CitationNumber>163.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>R</Initials>
                    <FamilyName>Noyes</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>SF</Initials>
                    <FamilyName>Brunk</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>DH</Initials>
                    <FamilyName>Avery</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Canter</FamilyName>
                  </BibAuthorName>
                  <Year>1975</Year>
                  <ArticleTitle Language="En">Analgesic properties of delta-9-tetrahydrocannabinol and codeine</ArticleTitle>
                  <JournalTitle>Clin Pharmacol Ther</JournalTitle>
                  <VolumeID>18</VolumeID>
                  <FirstPage>84</FirstPage>
                  <LastPage>89</LastPage>
                  <Occurrence Type="PID">
                    <Handle>50159</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Noyes R, Brunk SF, Avery DH, Canter A. Analgesic properties of delta-9-tetrahydrocannabinol and codeine.<Emphasis Type="Italic">Clin Pharmacol Ther</Emphasis>. 1975;18:84–89.</BibUnstructured>
              </Citation>
              <Citation ID="CR164">
                <CitationNumber>164.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>RG</Initials>
                    <FamilyName>Pertwee</FamilyName>
                  </BibAuthorName>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">Cannabinoids and multiple sclerosis</ArticleTitle>
                  <JournalTitle>Pharmacol Ther</JournalTitle>
                  <VolumeID>95</VolumeID>
                  <FirstPage>165</FirstPage>
                  <LastPage>174</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12182963</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD38XmtlKjsr8%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0163-7258(02)00255-3</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Pertwee RG. Cannabinoids and multiple sclerosis<Emphasis Type="Italic">Pharmacol Ther</Emphasis>. 2002;95:165–174.</BibUnstructured>
              </Citation>
              <Citation ID="CR165">
                <CitationNumber>165.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>DT</Initials>
                    <FamilyName>Wade</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>P</Initials>
                    <FamilyName>Robson</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>H</Initials>
                    <FamilyName>House</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>P</Initials>
                    <FamilyName>Makela</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Aram</FamilyName>
                  </BibAuthorName>
                  <Year>2003</Year>
                  <ArticleTitle Language="En">A preliminary controlled study to determine whether whole-plant cannabis extracts can improve intractable neurogenic symptoms</ArticleTitle>
                  <JournalTitle>Clin Rehabil</JournalTitle>
                  <VolumeID>17</VolumeID>
                  <FirstPage>21</FirstPage>
                  <LastPage>29</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12617376</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1191/0269215503cr581oa</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Wade DT, Robson P, House H, Makela P, Aram J. A preliminary controlled study to determine whether whole-plant cannabis extracts can improve intractable neurogenic symptoms.<Emphasis Type="Italic">Clin Rehabil</Emphasis>. 2003;17:21–29.</BibUnstructured>
              </Citation>
              <Citation ID="CR166">
                <CitationNumber>166.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Zajicek</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>P</Initials>
                    <FamilyName>Fox</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>H</Initials>
                    <FamilyName>Sanders</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2003</Year>
                  <ArticleTitle Language="En">Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS study): multicentre randomised placebo-controlled trial</ArticleTitle>
                  <JournalTitle>Lancet</JournalTitle>
                  <VolumeID>362</VolumeID>
                  <FirstPage>1517</FirstPage>
                  <LastPage>1526</LastPage>
                  <Occurrence Type="PID">
                    <Handle>14615106</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3sXovVWlsr0%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0140-6736(03)14738-1</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Zajicek J, Fox P, Sanders H, et al. Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS study): multicentre randomised placebo-controlled trial.<Emphasis Type="Italic">Lancet</Emphasis>. 2003;362:1517–1526.</BibUnstructured>
              </Citation>
              <Citation ID="CR167">
                <CitationNumber>167.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>B</Initials>
                    <FamilyName>Gauter</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>R</Initials>
                    <FamilyName>Rukwied</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>C</Initials>
                    <FamilyName>Konrad</FamilyName>
                  </BibAuthorName>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">Cannabinoid agonists in the treatment of blepharospasm—a case report study</ArticleTitle>
                  <JournalTitle>Neuroendocrinol Lett</JournalTitle>
                  <VolumeID>25</VolumeID>
                  <FirstPage>45</FirstPage>
                  <LastPage>48</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15159681</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Gauter B, Rukwied R, Konrad C. Cannabinoid agonists in the treatment of blepharospasm—a case report study.<Emphasis Type="Italic">Neuroendocrinol Lett</Emphasis>. 2004;25:45–48.</BibUnstructured>
              </Citation>
              <Citation ID="CR168">
                <CitationNumber>168.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>CM</Initials>
                    <FamilyName>Brady</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>R</Initials>
                    <FamilyName>DasGupta</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>C</Initials>
                    <FamilyName>Dalton</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>OJ</Initials>
                    <FamilyName>Wiseman</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>KJ</Initials>
                    <FamilyName>Berkley</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>CJ</Initials>
                    <FamilyName>Fowler</FamilyName>
                  </BibAuthorName>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">An open-label pilot study of cannabis-based extracts for bladder dysfunction in advanced multiple sclerosis</ArticleTitle>
                  <JournalTitle>Mult Scler</JournalTitle>
                  <VolumeID>10</VolumeID>
                  <FirstPage>425</FirstPage>
                  <LastPage>433</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15327041</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2cXnt1Sks78%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1191/1352458504ms1063oa</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Brady CM, DasGupta R, Dalton C, Wiseman OJ, Berkley KJ, Fowler CJ. An open-label pilot study of cannabis-based extracts for bladder dysfunction in advanced multiple sclerosis.<Emphasis Type="Italic">Mult Scler</Emphasis>. 2004;10:425–433.</BibUnstructured>
              </Citation>
              <Citation ID="CR169">
                <CitationNumber>169.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>KB</Initials>
                    <FamilyName>Svendsen</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>TS</Initials>
                    <FamilyName>Jensen</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>FW</Initials>
                    <FamilyName>Bach</FamilyName>
                  </BibAuthorName>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">Does the cannabinoid dronabinol reduce central pain in multiple sclerosis? Randomized double blind placebo controlled crossover trial</ArticleTitle>
                  <JournalTitle>BMJ</JournalTitle>
                  <VolumeID>329</VolumeID>
                  <FirstPage>253</FirstPage>
                  <LastPage>257</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15258006</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2cXnsV2rsLY%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1136/bmj.38149.566979.AE</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Svendsen KB, Jensen TS, Bach FW. Does the cannabinoid dronabinol reduce central pain in multiple sclerosis? Randomized double blind placebo controlled crossover trial.<Emphasis Type="Italic">BMJ</Emphasis>. 2004;329:253–257.</BibUnstructured>
              </Citation>
              <Citation ID="CR170">
                <CitationNumber>170.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>H</Initials>
                    <FamilyName>Iwamura</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>H</Initials>
                    <FamilyName>Suzuki</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>Y</Initials>
                    <FamilyName>Ueda</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>T</Initials>
                    <FamilyName>Kaya</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>T</Initials>
                    <FamilyName>Inaba</FamilyName>
                  </BibAuthorName>
                  <Year>2001</Year>
                  <ArticleTitle Language="En">In vitro and in vivo pharmacological characterization of JTE-907, a novel selective ligand for cannabinoid CB<Subscript>2</Subscript> receptor</ArticleTitle>
                  <JournalTitle>J Pharmacol Exp Ther</JournalTitle>
                  <VolumeID>296</VolumeID>
                  <FirstPage>420</FirstPage>
                  <LastPage>425</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11160626</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3MXoslaqsA%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Iwamura H, Suzuki H, Ueda Y, Kaya T, Inaba T. In vitro and in vivo pharmacological characterization of JTE-907, a novel selective ligand for cannabinoid CB<Subscript>2</Subscript> receptor.<Emphasis Type="Italic">J Pharmacol Exp Ther</Emphasis>. 2001;296:420–425.</BibUnstructured>
              </Citation>
              <Citation ID="CR171">
                <CitationNumber>171.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>BJ</Initials>
                    <FamilyName>Lavey</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JA</Initials>
                    <FamilyName>Kozlowski</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>RW</Initials>
                    <FamilyName>Hipkin</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2005</Year>
                  <ArticleTitle Language="En">Triaryl bis-sulfones as a new class of cannabinoid CB<Subscript>2</Subscript> receptor inhibitors: identification of a lead and initial SAR studies</ArticleTitle>
                  <JournalTitle>Bioorg Med Chem Lett</JournalTitle>
                  <VolumeID>15</VolumeID>
                  <FirstPage>783</FirstPage>
                  <LastPage>786</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15664857</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2MXnsVOjsQ%3D%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/j.bmcl.2004.11.007</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Lavey BJ, Kozlowski JA, Hipkin RW, et al. Triaryl bis-sulfones as a new class of cannabinoid CB<Subscript>2</Subscript> receptor inhibitors: identification of a lead and initial SAR studies.<Emphasis Type="Italic">Bioorg Med Chem Lett</Emphasis>. 2005;15:783–786.</BibUnstructured>
              </Citation>
              <Citation ID="CR172">
                <CitationNumber>172.</CitationNumber>
                <BibUnstructured>Lunn CA. Immune modulation by cannabinoids: targetting the cannabinoid CB<Subscript>2</Subscript> receptor. Symposium on cannabinoid receptors: pharmacological opportunities for obesity and inflammation: New York Academy of Sciences, 2004. Available at: http://www.nyas.org/ebriefreps/main.asp?intSubsectionID-1406 (Accessed).</BibUnstructured>
              </Citation>
              <Citation ID="CR173">
                <CitationNumber>173.</CitationNumber>
                <BibUnstructured>Costa B, Colleoni M, Trovato AE, Comelli F, Franke C, Giognoni G. Anandamide transport and hydrolysis as targets for the treatment of neuropathic pain: Effects of AM404 and URB597 in rats with chronic constriction injury of the sciatic nerve. 2005 Symposium on the Cannabinoids; June 24–27; Clearwater Beach, FL. Burlington, VT: International Cannabinoid Research Society; 2005:33.</BibUnstructured>
              </Citation>
              <Citation ID="CR174">
                <CitationNumber>174.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>L</Initials>
                    <FamilyName>Mestre</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>F</Initials>
                    <FamilyName>Correa</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Arévalo-Martin</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2005</Year>
                  <ArticleTitle Language="En">Pharmacological modulation of the endocannabinoid system in a viral model of multiple sclerosis</ArticleTitle>
                  <JournalTitle>J Neurochem</JournalTitle>
                  <VolumeID>92</VolumeID>
                  <FirstPage>1327</FirstPage>
                  <LastPage>1339</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15748152</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2MXislegsbg%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1111/j.1471-4159.2004.02979.x</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Mestre L, Correa F, Arévalo-Martin A, et al. Pharmacological modulation of the endocannabinoid system in a viral model of multiple sclerosis.<Emphasis Type="Italic">J Neurochem</Emphasis>. 2005;92:1327–1339.</BibUnstructured>
              </Citation>
              <Citation ID="CR175">
                <CitationNumber>175.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>G</Initials>
                    <FamilyName>Pryce</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>Z</Initials>
                    <FamilyName>Ahmed</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>DJR</Initials>
                    <FamilyName>Hankey</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2003</Year>
                  <ArticleTitle Language="En">Cannabinoids inhibit neurodegeneration in models of multiple sclerosis</ArticleTitle>
                  <JournalTitle>Brain</JournalTitle>
                  <VolumeID>126</VolumeID>
                  <FirstPage>2191</FirstPage>
                  <LastPage>2202</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12876144</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1093/brain/awg224</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Pryce G, Ahmed Z, Hankey DJR, et al. Cannabinoids inhibit neurodegeneration in models of multiple sclerosis.<Emphasis Type="Italic">Brain</Emphasis>. 2003;126:2191–2202.</BibUnstructured>
              </Citation>
              <Citation ID="CR176">
                <CitationNumber>176.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>D</Initials>
                    <FamilyName>Baker</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>G</Initials>
                    <FamilyName>Pryce</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JL</Initials>
                    <FamilyName>Croxford</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2000</Year>
                  <ArticleTitle Language="En">Cannabinoids control spasticity and tremor in a multiple sclerosis model</ArticleTitle>
                  <JournalTitle>Nature</JournalTitle>
                  <VolumeID>404</VolumeID>
                  <FirstPage>84</FirstPage>
                  <LastPage>87</LastPage>
                  <Occurrence Type="PID">
                    <Handle>10716447</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3cXhvVyqsb4%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1038/35003583</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Baker D, Pryce G, Croxford JL, et al. Cannabinoids control spasticity and tremor in a multiple sclerosis model.<Emphasis Type="Italic">Nature</Emphasis>. 2000;404:84–87.</BibUnstructured>
              </Citation>
              <Citation ID="CR177">
                <CitationNumber>177.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>JW</Initials>
                    <FamilyName>Brooks</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>G</Initials>
                    <FamilyName>Pryce</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>T</Initials>
                    <FamilyName>Bisogno</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">Arvanil-induced inhibition of spasticity and persistent pain: evidence for therapeutic sites of action different from the vanilloid VR1 receptor and cannabinoid CB<Subscript>1</Subscript>/CB<Subscript>2</Subscript> receptors</ArticleTitle>
                  <JournalTitle>Eur J Pharmacol</JournalTitle>
                  <VolumeID>439</VolumeID>
                  <FirstPage>83</FirstPage>
                  <LastPage>92</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11937096</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD38XisV2rsrw%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0014-2999(02)01369-9</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Brooks JW, Pryce G, Bisogno T, et al. Arvanil-induced inhibition of spasticity and persistent pain: evidence for therapeutic sites of action different from the vanilloid VR1 receptor and cannabinoid CB<Subscript>1</Subscript>/CB<Subscript>2</Subscript> receptors.<Emphasis Type="Italic">Eur J Pharmacol</Emphasis>. 2002;439:83–92.</BibUnstructured>
              </Citation>
              <Citation ID="CR178">
                <CitationNumber>178.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>JD</Initials>
                    <FamilyName>Wilkinson</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>BJ</Initials>
                    <FamilyName>Whalley</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>D</Initials>
                    <FamilyName>Baker</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2003</Year>
                  <ArticleTitle Language="En">Medicinal cannabis: is {ieE653-1} necessary for all its effects?</ArticleTitle>
                  <JournalTitle>J Pharm Pharmacol</JournalTitle>
                  <VolumeID>55</VolumeID>
                  <FirstPage>1687</FirstPage>
                  <LastPage>1694</LastPage>
                  <Occurrence Type="PID">
                    <Handle>14738597</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2cXnslKlug%3D%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1211/0022357022304</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Wilkinson JD, Whalley BJ, Baker D, et al. Medicinal cannabis: is {ieE653-1} necessary for all its effects?.<Emphasis Type="Italic">J Pharm Pharmacol</Emphasis>. 2003;55:1687–1694.</BibUnstructured>
              </Citation>
              <Citation ID="CR179">
                <CitationNumber>179.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>WD</Initials>
                    <FamilyName>Lyman</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JR</Initials>
                    <FamilyName>Sonett</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>CF</Initials>
                    <FamilyName>Brosnan</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>R</Initials>
                    <FamilyName>Elkin</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>MB</Initials>
                    <FamilyName>Bornstein</FamilyName>
                  </BibAuthorName>
                  <Year>1989</Year>
                  <ArticleTitle Language="En">{ieE653-2} a novel treatment for experimental autoimmune encephalomyelitis</ArticleTitle>
                  <JournalTitle>J Neuroimmunol</JournalTitle>
                  <VolumeID>23</VolumeID>
                  <FirstPage>73</FirstPage>
                  <LastPage>81</LastPage>
                  <Occurrence Type="PID">
                    <Handle>2542370</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaL1MXktlegs7s%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/0165-5728(89)90075-1</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Lyman WD, Sonett JR, Brosnan CF, Elkin R, Bornstein MB. {ieE653-2} a novel treatment for experimental autoimmune encephalomyelitis.<Emphasis Type="Italic">J Neuroimmunol</Emphasis>. 1989;23:73–81.</BibUnstructured>
              </Citation>
              <Citation ID="CR180">
                <CitationNumber>180.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>I</Initials>
                    <FamilyName>Wirguin</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>R</Initials>
                    <FamilyName>Mechoulam</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Breuer</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>E</Initials>
                    <FamilyName>Schezen</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Weidenfeld</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>T</Initials>
                    <FamilyName>Brenner</FamilyName>
                  </BibAuthorName>
                  <Year>1994</Year>
                  <ArticleTitle Language="En">Suppression of experimental autoimmune encephalomyelitis by cannabinoids</ArticleTitle>
                  <JournalTitle>Immunopharmacology</JournalTitle>
                  <VolumeID>28</VolumeID>
                  <FirstPage>209</FirstPage>
                  <LastPage>214</LastPage>
                  <Occurrence Type="PID">
                    <Handle>7852052</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK2cXmslajsbs%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/0162-3109(94)90056-6</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Wirguin I, Mechoulam R, Breuer A, Schezen E, Weidenfeld J, Brenner T. Suppression of experimental autoimmune encephalomyelitis by cannabinoids.<Emphasis Type="Italic">Immunopharmacology</Emphasis>. 1994;28:209–214.</BibUnstructured>
              </Citation>
              <Citation ID="CR181">
                <CitationNumber>181.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>JL</Initials>
                    <FamilyName>Croxford</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>SD</Initials>
                    <FamilyName>Miller</FamilyName>
                  </BibAuthorName>
                  <Year>2003</Year>
                  <ArticleTitle Language="En">Immunoregulation of a viral model of multiple sclerosis using the synthetic cannabinoid<Emphasis Type="Italic">R</Emphasis>(+)WIN55,212</ArticleTitle>
                  <JournalTitle>J Clin Invest</JournalTitle>
                  <VolumeID>111</VolumeID>
                  <FirstPage>1231</FirstPage>
                  <LastPage>1240</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12697742</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3sXjtFCrs7k%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Croxford JL, Miller SD. Immunoregulation of a viral model of multiple sclerosis using the synthetic cannabinoid<Emphasis Type="Italic">R</Emphasis>(+)WIN55,212.<Emphasis Type="Italic">J Clin Invest</Emphasis>. 2003;111:1231–1240.</BibUnstructured>
              </Citation>
              <Citation ID="CR182">
                <CitationNumber>182.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>N</Initials>
                    <FamilyName>Arévalo-Martin</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JM</Initials>
                    <FamilyName>Vela</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>E</Initials>
                    <FamilyName>Molina-Holgado</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Borrell</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>C</Initials>
                    <FamilyName>Guaza</FamilyName>
                  </BibAuthorName>
                  <Year>2003</Year>
                  <ArticleTitle Language="En">Therapeutic action of cannabinoids in a murine model of multiple sclerosis</ArticleTitle>
                  <JournalTitle>J Neurosci</JournalTitle>
                  <VolumeID>23</VolumeID>
                  <FirstPage>2511</FirstPage>
                  <LastPage>2516</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12684434</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Arévalo-Martin N, Vela JM, Molina-Holgado E, Borrell J, Guaza C. Therapeutic action of cannabinoids in a murine model of multiple sclerosis.<Emphasis Type="Italic">J Neurosci</Emphasis>. 2003;23:2511–2516.</BibUnstructured>
              </Citation>
              <Citation ID="CR183">
                <CitationNumber>183.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>C</Initials>
                    <FamilyName>Vaney</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Heinzel-Gutenbrunner</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>P</Initials>
                    <FamilyName>Jobin</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">Efficacy, safety and tolerability of an orally administered cannabis extract in the treatment of spasticity in patients with multiple sclerosis: a randomized, double-blind, placebo-controlled, crossover study</ArticleTitle>
                  <JournalTitle>Mult Scler</JournalTitle>
                  <VolumeID>10</VolumeID>
                  <FirstPage>417</FirstPage>
                  <LastPage>424</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15327040</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2cXnt1Sks74%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1191/1352458504ms1048oa</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Vaney C, Heinzel-Gutenbrunner M, Jobin P, et al. Efficacy, safety and tolerability of an orally administered cannabis extract in the treatment of spasticity in patients with multiple sclerosis: a randomized, double-blind, placebo-controlled, crossover study.<Emphasis Type="Italic">Mult Scler</Emphasis>. 2004;10:417–424.</BibUnstructured>
              </Citation>
              <Citation ID="CR184">
                <CitationNumber>184.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>DT</Initials>
                    <FamilyName>Wade</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>P</Initials>
                    <FamilyName>Makela</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>P</Initials>
                    <FamilyName>Robson</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>H</Initials>
                    <FamilyName>House</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>C</Initials>
                    <FamilyName>Bateman</FamilyName>
                  </BibAuthorName>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">Do cannabis-based medicinal extracts have general or specific effects on symptoms in multiple sclerosis? A double-blind, randomized, placebo-controlled study on 160 patients</ArticleTitle>
                  <JournalTitle>Mult Scler</JournalTitle>
                  <VolumeID>10</VolumeID>
                  <FirstPage>434</FirstPage>
                  <LastPage>441</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15327042</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2cXnt1Sks7w%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1191/1352458504ms1082oa</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Wade DT, Makela P, Robson P, House H, Bateman C. Do cannabis-based medicinal extracts have general or specific effects on symptoms in multiple sclerosis? A double-blind, randomized, placebo-controlled study on 160 patients.<Emphasis Type="Italic">Mult Scler</Emphasis>. 2004;10:434–441.</BibUnstructured>
              </Citation>
              <Citation ID="CR185">
                <CitationNumber>185.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Killestein</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>ELJ</Initials>
                    <FamilyName>Hoogervorst</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Reif</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">Safety, tolerability, and efficacy of orally administered cannabinoids in MS</ArticleTitle>
                  <JournalTitle>Neurology</JournalTitle>
                  <VolumeID>58</VolumeID>
                  <FirstPage>1404</FirstPage>
                  <LastPage>1407</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12011290</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD38Xktlyks7o%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Killestein J, Hoogervorst ELJ, Reif M, et al. Safety, tolerability, and efficacy of orally administered cannabinoids in MS.<Emphasis Type="Italic">Neurology</Emphasis>. 2002;58:1404–1407.</BibUnstructured>
              </Citation>
              <Citation ID="CR186">
                <CitationNumber>186.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Bifulco</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>C</Initials>
                    <FamilyName>Laezza</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Valenti</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Ligresti</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>G</Initials>
                    <FamilyName>Portella</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>V</Initials>
                    <FamilyName>Marzo</FamilyName>
                    <Particle>Di</Particle>
                  </BibAuthorName>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">A new strategy to block tumor growth by inhibiting endocannabinoid inactivation</ArticleTitle>
                  <JournalTitle>FASEB J</JournalTitle>
                  <VolumeID>18</VolumeID>
                  <FirstPage>U320</FirstPage>
                  <LastPage>U33</LastPage>
                </BibArticle>
                <BibUnstructured>Bifulco M, Laezza C, Valenti M, Ligresti A, Portella G, Di Marzo V. A new strategy to block tumor growth by inhibiting endocannabinoid inactivation.<Emphasis Type="Italic">FASEB J</Emphasis>. 2004;18:U320-U33.</BibUnstructured>
              </Citation>
              <Citation ID="CR187">
                <CitationNumber>187.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Bifulco</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>C</Initials>
                    <FamilyName>Laezza</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>G</Initials>
                    <FamilyName>Portella</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2001</Year>
                  <ArticleTitle Language="En">Control by the endogenous cannabinoid system of<Emphasis Type="Italic">ras</Emphasis> oncogene-dependent tumor growth</ArticleTitle>
                  <JournalTitle>FASEB J</JournalTitle>
                  <VolumeID>15</VolumeID>
                  <FirstPage>U100</FirstPage>
                  <LastPage>U16</LastPage>
                </BibArticle>
                <BibUnstructured>Bifulco M, Laezza C, Portella G, et al. Control by the endogenous cannabinoid system of<Emphasis Type="Italic">ras</Emphasis> oncogene-dependent tumor growth.<Emphasis Type="Italic">FASEB J</Emphasis>. 2001;15:U100-U16.</BibUnstructured>
              </Citation>
              <Citation ID="CR188">
                <CitationNumber>188.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Bifulco</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>V</Initials>
                    <FamilyName>Marzo</FamilyName>
                    <Particle>Di</Particle>
                  </BibAuthorName>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">Targeting the endocannabinoid system in cancer therapy: a call for further research</ArticleTitle>
                  <JournalTitle>Nat Med</JournalTitle>
                  <VolumeID>8</VolumeID>
                  <FirstPage>547</FirstPage>
                  <LastPage>550</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12042794</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD38XktVyisbs%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1038/nm0602-547</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Bifulco M, Di Marzo V. Targeting the endocannabinoid system in cancer therapy: a call for further research.<Emphasis Type="Italic">Nat Med</Emphasis>. 2002;8:547–550.</BibUnstructured>
              </Citation>
              <Citation ID="CR189">
                <CitationNumber>189.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>G</Initials>
                    <FamilyName>Portella</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>C</Initials>
                    <FamilyName>Laezza</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>P</Initials>
                    <FamilyName>Laccetti</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>L</Initials>
                    <FamilyName>Petrocellis</FamilyName>
                    <Particle>De</Particle>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>V</Initials>
                    <FamilyName>Marzo</FamilyName>
                    <Particle>Di</Particle>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Bifulco</FamilyName>
                  </BibAuthorName>
                  <Year>2003</Year>
                  <ArticleTitle Language="En">Inhibitory effects of cannabinoid CB<Subscript>1</Subscript> receptor stimulation on tumor growth and metastatic spreading: actions on signals involved in angiogenesis and metastasis</ArticleTitle>
                  <JournalTitle>FASEB J</JournalTitle>
                  <VolumeID>17</VolumeID>
                  <FirstPage>U458</FirstPage>
                  <LastPage>U74</LastPage>
                </BibArticle>
                <BibUnstructured>Portella G, Laezza C, Laccetti P, De Petrocellis L, Di Marzo V, Bifulco M. Inhibitory effects of cannabinoid CB<Subscript>1</Subscript> receptor stimulation on tumor growth and metastatic spreading: actions on signals involved in angiogenesis and metastasis.<Emphasis Type="Italic">FASEB J</Emphasis>. 2003;17:U458-U74.</BibUnstructured>
              </Citation>
              <Citation ID="CR190">
                <CitationNumber>190.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Guzmán</FamilyName>
                  </BibAuthorName>
                  <Year>2003</Year>
                  <ArticleTitle Language="En">Cannabinoids: potential anticancer agents</ArticleTitle>
                  <JournalTitle>Nat Rev Cancer</JournalTitle>
                  <VolumeID>3</VolumeID>
                  <FirstPage>745</FirstPage>
                  <LastPage>755</LastPage>
                  <Occurrence Type="PID">
                    <Handle>14570037</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1038/nrc1188</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3sXotFCiu7c%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Guzmán M. Cannabinoids: potential anticancer agents.<Emphasis Type="Italic">Nat Rev Cancer</Emphasis>. 2003;3:745–755.</BibUnstructured>
              </Citation>
              <Citation ID="CR191">
                <CitationNumber>191.</CitationNumber>
                <BibChapter>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Guzmán</FamilyName>
                  </BibAuthorName>
                  <Year>2005</Year>
                  <ChapterTitle Language="En">Effects on cell viability</ChapterTitle>
                  <BibEditorName>
                    <Initials>RG</Initials>
                    <FamilyName>Pertwee</FamilyName>
                  </BibEditorName>
                  <Eds/>
                  <BookTitle>Cannabinoids Handbook of Experimental Pharmacolology</BookTitle>
                  <PublisherName>Springer-Verlag</PublisherName>
                  <PublisherLocation>Heidelberg, Germany</PublisherLocation>
                  <FirstPage>627</FirstPage>
                  <LastPage>642</LastPage>
                </BibChapter>
                <BibUnstructured>Guzmán M. Effects on cell viability In: Pertwee RG, ed.<Emphasis Type="Italic">Cannabinoids Handbook of Experimental Pharmacolology</Emphasis>. Heidelberg, Germany: Springer-Verlag; 2005;168:627–642.</BibUnstructured>
              </Citation>
              <Citation ID="CR192">
                <CitationNumber>192.</CitationNumber>
                <BibChapter>
                  <BibAuthorName>
                    <Initials>AA</Initials>
                    <FamilyName>Izzo</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>AA</Initials>
                    <FamilyName>Coutts</FamilyName>
                  </BibAuthorName>
                  <Year>2005</Year>
                  <ChapterTitle Language="En">Cannabinoids and the digestive tract</ChapterTitle>
                  <BibEditorName>
                    <Initials>RG</Initials>
                    <FamilyName>Pertwee</FamilyName>
                  </BibEditorName>
                  <Eds/>
                  <BookTitle>Cannabinoids, Handbook of Experimental Pharmacolology</BookTitle>
                  <PublisherName>Springer-Verlag</PublisherName>
                  <PublisherLocation>Heidelberg, Germany</PublisherLocation>
                  <FirstPage>573</FirstPage>
                  <LastPage>598</LastPage>
                </BibChapter>
                <BibUnstructured>Izzo AA, Coutts AA. Cannabinoids and the digestive tract. In: Pertwee RG, ed.<Emphasis Type="Italic">Cannabinoids, Handbook of Experimental Pharmacolology</Emphasis>. Heidelberg, Germany: Springer-Verlag; 2005;168:573–598.</BibUnstructured>
              </Citation>
              <Citation ID="CR193">
                <CitationNumber>193.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>D</Initials>
                    <FamilyName>Panikashvili</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>R</Initials>
                    <FamilyName>Mechoulam</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>SM</Initials>
                    <FamilyName>Beni</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Alexandrovich</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>E</Initials>
                    <FamilyName>Shohami</FamilyName>
                  </BibAuthorName>
                  <Year>2005</Year>
                  <ArticleTitle Language="En">CB<Subscript>1</Subscript> cannabinoid receptors are involved in neuroprotection via NF-κB inhibition</ArticleTitle>
                  <JournalTitle>J Cereb Blood Flow Metab</JournalTitle>
                  <VolumeID>25</VolumeID>
                  <FirstPage>477</FirstPage>
                  <LastPage>484</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15729296</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2MXjvVyqur0%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1038/sj.jcbfm.9600047</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Panikashvili D, Mechoulam R, Beni SM, Alexandrovich A, Shohami E. CB<Subscript>1</Subscript> cannabinoid receptors are involved in neuroprotection via NF-κB inhibition.<Emphasis Type="Italic">J Cereb Blood Flow Metab</Emphasis>. 2005;25:477–484.</BibUnstructured>
              </Citation>
              <Citation ID="CR194">
                <CitationNumber>194.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>F</Initials>
                    <FamilyName>Banoua</FamilyName>
                    <Particle>El</Particle>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>I</Initials>
                    <FamilyName>Caraballo</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JA</Initials>
                    <FamilyName>Flores</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>B</Initials>
                    <FamilyName>Galan-Rodriguez</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>E</Initials>
                    <FamilyName>Fernandez-Espejo</FamilyName>
                  </BibAuthorName>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">Effects on turning of microinjections into basal ganglia of D<Subscript>1</Subscript> and D<Subscript>2</Subscript> dopamine receptors agonists and the cannabinoid CB<Subscript>1</Subscript> antagonist SR 141716A in a rat Parkinson’s model</ArticleTitle>
                  <JournalTitle>Neurobiol Dis</JournalTitle>
                  <VolumeID>16</VolumeID>
                  <FirstPage>377</FirstPage>
                  <LastPage>385</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15193294</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/j.nbd.2004.03.002</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2cXkvVegtrk%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>El Banoua F, Caraballo I, Flores JA, Galan-Rodriguez B, Fernandez-Espejo E. Effects on turning of microinjections into basal ganglia of D<Subscript>1</Subscript> and D<Subscript>2</Subscript> dopamine receptors agonists and the cannabinoid CB<Subscript>1</Subscript> antagonist SR 141716A in a rat Parkinson’s model.<Emphasis Type="Italic">Neurobiol Dis</Emphasis>. 2004;16:377–385.</BibUnstructured>
              </Citation>
              <Citation ID="CR195">
                <CitationNumber>195.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>E</Initials>
                    <FamilyName>Fernandez-Espejo</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>I</Initials>
                    <FamilyName>Caraballo</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>F</Initials>
                    <FamilyName>Rodriguez de Fonseca</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2005</Year>
                  <ArticleTitle Language="En">Cannabinoid CB<Subscript>1</Subscript> antagonists possess antiparkinsonian efficacy only in rats with very severe nigral lesion in experimental parkinsonism</ArticleTitle>
                  <JournalTitle>Neurobiol Dis</JournalTitle>
                  <VolumeID>18</VolumeID>
                  <FirstPage>591</FirstPage>
                  <LastPage>601</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15755685</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2MXhvFynsb8%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/j.nbd.2004.10.015</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Fernandez-Espejo E, Caraballo I, Rodriguez de Fonseca F, et al. Cannabinoid CB<Subscript>1</Subscript> antagonists possess antiparkinsonian efficacy only in rats with very severe nigral lesion in experimental parkinsonism.<Emphasis Type="Italic">Neurobiol Dis</Emphasis>. 2005;18:591–601.</BibUnstructured>
              </Citation>
              <Citation ID="CR196">
                <CitationNumber>196.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>JP</Initials>
                    <FamilyName>Meschler</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>AC</Initials>
                    <FamilyName>Howlett</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>BK</Initials>
                    <FamilyName>Madras</FamilyName>
                  </BibAuthorName>
                  <Year>2001</Year>
                  <ArticleTitle Language="En">Cannabinoid receptor agonist and antagonist effects on motor function in normal and 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP)-treated non-human primates</ArticleTitle>
                  <JournalTitle>Psychopharmacology (Berl)</JournalTitle>
                  <VolumeID>156</VolumeID>
                  <FirstPage>79</FirstPage>
                  <LastPage>85</LastPage>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3MXlsFamurs%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1007/s002130100728</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Meschler JP, Howlett AC, Madras BK. Cannabinoid receptor agonist and antagonist effects on motor function in normal and 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP)-treated non-human primates.<Emphasis Type="Italic">Psychopharmacology (Berl)</Emphasis>. 2001;156:79–85.</BibUnstructured>
              </Citation>
              <Citation ID="CR197">
                <CitationNumber>197.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>JA</Initials>
                    <FamilyName>Wagner</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>K</Initials>
                    <FamilyName>Varga</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>EF</Initials>
                    <FamilyName>Ellis</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>BA</Initials>
                    <FamilyName>Rzigalinski</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>BR</Initials>
                    <FamilyName>Martin</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>G</Initials>
                    <FamilyName>Kunos</FamilyName>
                  </BibAuthorName>
                  <Year>1997</Year>
                  <ArticleTitle Language="En">Activation of peripheral CB<Subscript>1</Subscript> cannabinoid receptors in haemorrhagic shock</ArticleTitle>
                  <JournalTitle>Nature</JournalTitle>
                  <VolumeID>390</VolumeID>
                  <FirstPage>518</FirstPage>
                  <LastPage>521</LastPage>
                  <Occurrence Type="PID">
                    <Handle>9394002</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK2sXnvF2nt7o%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1038/37371</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Wagner JA, Varga K, Ellis EF, Rzigalinski BA, Martin BR, Kunos G. Activation of peripheral CB<Subscript>1</Subscript> cannabinoid receptors in haemorrhagic shock.<Emphasis Type="Italic">Nature</Emphasis>. 1997;390:518–521.</BibUnstructured>
              </Citation>
              <Citation ID="CR198">
                <CitationNumber>198.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>Y</Initials>
                    <FamilyName>Kadoi</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>H</Initials>
                    <FamilyName>Hinohara</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>F</Initials>
                    <FamilyName>Kunimoto</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>H</Initials>
                    <FamilyName>Kuwano</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Saito</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>F</Initials>
                    <FamilyName>Goto</FamilyName>
                  </BibAuthorName>
                  <Year>2005</Year>
                  <ArticleTitle Language="En">Effects of AM281, a cannabinoid antagonist, on systemic haemodynamics, internal carotid artery blood flow and mortality in septic shock in rats</ArticleTitle>
                  <JournalTitle>Br J Anaesth</JournalTitle>
                  <VolumeID>94</VolumeID>
                  <FirstPage>563</FirstPage>
                  <LastPage>568</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15734782</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2MXjtFaltr0%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1093/bja/aei106</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Kadoi Y, Hinohara H, Kunimoto F, Kuwano H, Saito S, Goto F. Effects of AM281, a cannabinoid antagonist, on systemic haemodynamics, internal carotid artery blood flow and mortality in septic shock in rats.<Emphasis Type="Italic">Br J Anaesth</Emphasis>. 2005;94:563–568.</BibUnstructured>
              </Citation>
              <Citation ID="CR199">
                <CitationNumber>199.</CitationNumber>
                <BibChapter>
                  <BibAuthorName>
                    <Initials>PJ</Initials>
                    <FamilyName>Robson</FamilyName>
                  </BibAuthorName>
                  <Year>2005</Year>
                  <ChapterTitle Language="En">Human studies of cannabinoids and medicinal cannabis</ChapterTitle>
                  <BibEditorName>
                    <Initials>RG</Initials>
                    <FamilyName>Pertwee</FamilyName>
                  </BibEditorName>
                  <Eds/>
                  <BookTitle>Cannabinoids, Handbook Exp Pharmacol</BookTitle>
                  <PublisherName>Springer-Verlag</PublisherName>
                  <PublisherLocation>Heidelberg, Germany</PublisherLocation>
                  <FirstPage>719</FirstPage>
                  <LastPage>756</LastPage>
                </BibChapter>
                <BibUnstructured>Robson PJ. Human studies of cannabinoids and medicinal cannabis. In: Pertwee RG, ed.<Emphasis Type="Italic">Cannabinoids, Handbook Exp Pharmacol</Emphasis>. Heidelberg, Germany: Springer-Verlag; 2005:719–756.</BibUnstructured>
              </Citation>
              <Citation ID="CR200">
                <CitationNumber>200.</CitationNumber>
                <BibChapter>
                  <BibAuthorName>
                    <Initials>PJ</Initials>
                    <FamilyName>Robson</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>GW</Initials>
                    <FamilyName>Guy</FamilyName>
                  </BibAuthorName>
                  <Year>2005</Year>
                  <ChapterTitle Language="En">Clinical studies of cannabis-based medicines</ChapterTitle>
                  <BibEditorName>
                    <Initials>GW</Initials>
                    <FamilyName>Guy</FamilyName>
                  </BibEditorName>
                  <BibEditorName>
                    <Initials>BA</Initials>
                    <FamilyName>Whittle</FamilyName>
                  </BibEditorName>
                  <BibEditorName>
                    <Initials>PJ</Initials>
                    <FamilyName>Robson</FamilyName>
                  </BibEditorName>
                  <Eds/>
                  <BookTitle>The Medicinal Uses of Cannabis and Cannabinoids</BookTitle>
                  <PublisherName>Pharmaceutical Press</PublisherName>
                  <PublisherLocation>London, UK</PublisherLocation>
                  <FirstPage>229</FirstPage>
                  <LastPage>269</LastPage>
                </BibChapter>
                <BibUnstructured>Robson PJ, Guy GW. Clinical studies of cannabis-based medicines. In: Guy GW, Whittle BA, Robson PJ, eds.<Emphasis Type="Italic">The Medicinal Uses of Cannabis and Cannabinoids</Emphasis>. London, UK: Pharmaceutical Press; 2005:229–269.</BibUnstructured>
              </Citation>
              <Citation ID="CR201">
                <CitationNumber>201.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>P</Initials>
                    <FamilyName>Consroe</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>R</Initials>
                    <FamilyName>Musty</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Rein</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>W</Initials>
                    <FamilyName>Tillery</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>R</Initials>
                    <FamilyName>Pertwee</FamilyName>
                  </BibAuthorName>
                  <Year>1997</Year>
                  <ArticleTitle Language="En">The perceived effects of smoked cannabis on patients with multiple sclerosis</ArticleTitle>
                  <JournalTitle>Eur Neurol</JournalTitle>
                  <VolumeID>38</VolumeID>
                  <FirstPage>44</FirstPage>
                  <LastPage>48</LastPage>
                  <Occurrence Type="PID">
                    <Handle>9252798</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:DyaK2szps1Khtw%3D%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1159/000112901</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Consroe P, Musty R, Rein J, Tillery W, Pertwee R. The perceived effects of smoked cannabis on patients with multiple sclerosis.<Emphasis Type="Italic">Eur Neurol</Emphasis> 1997;38:44–48.</BibUnstructured>
              </Citation>
              <Citation ID="CR202">
                <CitationNumber>202.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>MA</Initials>
                    <FamilyName>Ware</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>H</Initials>
                    <FamilyName>Adams</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>GW</Initials>
                    <FamilyName>Guy</FamilyName>
                  </BibAuthorName>
                  <Year>2005</Year>
                  <ArticleTitle Language="En">The medicinal use of cannabis in the UK: results of a nationwide survey</ArticleTitle>
                  <JournalTitle>Int J Clin Pract</JournalTitle>
                  <VolumeID>59</VolumeID>
                  <FirstPage>291</FirstPage>
                  <LastPage>295</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15857325</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:DC%2BD2M3it1ylsA%3D%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1111/j.1742-1241.2004.00271.x</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Ware MA, Adams H, Guy GW. The medicinal use of cannabis in the UK: results of a nationwide survey.<Emphasis Type="Italic">Int J Clin Pract</Emphasis>. 2005;59:291–295.</BibUnstructured>
              </Citation>
              <Citation ID="CR203">
                <CitationNumber>203.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Vry</FamilyName>
                    <Particle>De</Particle>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>D</Initials>
                    <FamilyName>Denzer</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>E</Initials>
                    <FamilyName>Reissmueller</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">3-[2-cyano-3-(trifluoro methyl)phenoxy]phenyl-4,4,4-trifluoro-1-butanesulfonate (BAY 59-3074): a novel cannabinoid CB<Subscript>1</Subscript>/CB<Subscript>2</Subscript> receptor partial agonist with antihyperalgesic and antiallodynic effects</ArticleTitle>
                  <JournalTitle>J Pharmacol Exp Ther</JournalTitle>
                  <VolumeID>310</VolumeID>
                  <FirstPage>620</FirstPage>
                  <LastPage>632</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15140913</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1124/jpet.103.062836</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2cXmtVyksb8%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>De Vry J, Denzer D, Reissmueller E, et al. 3-[2-cyano-3-(trifluoro methyl)phenoxy]phenyl-4,4,4-trifluoro-1-butanesulfonate (BAY 59-3074): a novel cannabinoid CB<Subscript>1</Subscript>/CB<Subscript>2</Subscript> receptor partial agonist with antihyperalgesic and antiallodynic effects.<Emphasis Type="Italic">J Pharmacol Exp Ther</Emphasis>. 2004;310:620–632.</BibUnstructured>
              </Citation>
              <Citation ID="CR204">
                <CitationNumber>204.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>R</Initials>
                    <FamilyName>Rukwied</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Watkinson</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>F</Initials>
                    <FamilyName>McGlone</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Dvorak</FamilyName>
                  </BibAuthorName>
                  <Year>2003</Year>
                  <ArticleTitle Language="En">Cannabinoid agonists attenuate capsaicin-induced responses in human skin</ArticleTitle>
                  <JournalTitle>Pain</JournalTitle>
                  <VolumeID>102</VolumeID>
                  <FirstPage>283</FirstPage>
                  <LastPage>288</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12670670</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3sXisV2ltLo%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0304-3959(02)00401-3</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Rukwied R, Watkinson A, McGlone F, Dvorak M. Cannabinoid agonists attenuate capsaicin-induced responses in human skin.<Emphasis Type="Italic">Pain</Emphasis>. 2003;102:283–288.</BibUnstructured>
              </Citation>
              <Citation ID="CR205">
                <CitationNumber>205.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Dvorak</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Watkinson</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>F</Initials>
                    <FamilyName>McGlone</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>R</Initials>
                    <FamilyName>Rukwied</FamilyName>
                  </BibAuthorName>
                  <Year>2003</Year>
                  <ArticleTitle Language="En">Histamine-induced responses are attenuated by a cannabinoid receptor agonist in human skin</ArticleTitle>
                  <JournalTitle>Inflamm Res</JournalTitle>
                  <VolumeID>52</VolumeID>
                  <FirstPage>238</FirstPage>
                  <LastPage>245</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12835895</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3sXls1WlsLk%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Dvorak M, Watkinson A, McGlone F, Rukwied R. Histamine-induced responses are attenuated by a cannabinoid receptor agonist in human skin.<Emphasis Type="Italic">Inflamm Res</Emphasis>. 2003;52:238–245.</BibUnstructured>
              </Citation>
              <Citation ID="CR206">
                <CitationNumber>206.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>DL</Initials>
                    <FamilyName>Cichewicz</FamilyName>
                  </BibAuthorName>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">Synergistic interactions between cannabinoid and opioid analgesics</ArticleTitle>
                  <JournalTitle>Life Sci</JournalTitle>
                  <VolumeID>74</VolumeID>
                  <FirstPage>1317</FirstPage>
                  <LastPage>1324</LastPage>
                  <Occurrence Type="PID">
                    <Handle>14706563</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2cXptVyk</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/j.lfs.2003.09.038</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Cichewicz DL. Synergistic interactions between cannabinoid and opioid analgesics.<Emphasis Type="Italic">Life Sci</Emphasis>. 2004;74:1317–1324.</BibUnstructured>
              </Citation>
              <Citation ID="CR207">
                <CitationNumber>207.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Holdcroft</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Smith</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Jacklin</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>1997</Year>
                  <ArticleTitle Language="En">Pain relief with oral cannabinoids in familial Mediterranean fever</ArticleTitle>
                  <JournalTitle>Anaesthesia</JournalTitle>
                  <VolumeID>52</VolumeID>
                  <FirstPage>483</FirstPage>
                  <LastPage>488</LastPage>
                  <Occurrence Type="PID">
                    <Handle>9165969</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:DyaK2szgvVOkug%3D%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1111/j.1365-2044.1997.139-az0132.x</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Holdcroft A, Smith M, Jacklin A, et al. Pain relief with oral cannabinoids in familial Mediterranean fever.<Emphasis Type="Italic">Anaesthesia</Emphasis>. 1997;52:483–488.</BibUnstructured>
              </Citation>
              <Citation ID="CR208">
                <CitationNumber>208.</CitationNumber>
                <BibChapter>
                  <BibAuthorName>
                    <Initials>RG</Initials>
                    <FamilyName>Pertwee</FamilyName>
                  </BibAuthorName>
                  <Year>2004</Year>
                  <ChapterTitle Language="En">The pharmacology and therapeutic potential of cannabidiol</ChapterTitle>
                  <BibEditorName>
                    <Initials>V</Initials>
                    <FamilyName>Marzo</FamilyName>
                    <Particle>Di</Particle>
                  </BibEditorName>
                  <Eds/>
                  <BookTitle>Cannabinoids</BookTitle>
                  <PublisherName>Kluwer Academic/Plenum Publishers</PublisherName>
                  <PublisherLocation>New York, NY</PublisherLocation>
                  <FirstPage>32</FirstPage>
                  <LastPage>83</LastPage>
                </BibChapter>
                <BibUnstructured>Pertwee RG. The pharmacology and therapeutic potential of cannabidiol. In: Di Marzo V, ed.<Emphasis Type="Italic">Cannabinoids</Emphasis>. New York, NY: Kluwer Academic/Plenum Publishers; 2004:32–83.</BibUnstructured>
              </Citation>
              <Citation ID="CR209">
                <CitationNumber>209.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>WB</Initials>
                    <FamilyName>Mendelson</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>AS</Initials>
                    <FamilyName>Basile</FamilyName>
                  </BibAuthorName>
                  <Year>2001</Year>
                  <ArticleTitle Language="En">The hypnotic actions of the fatty acid amide, oleamide</ArticleTitle>
                  <JournalTitle>Neuropsychopharmacology</JournalTitle>
                  <VolumeID>25</VolumeID>
                  <FirstPage>S36</FirstPage>
                  <LastPage>S39</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11682271</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3MXnslCjtrY%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0893-133X(01)00341-4</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Mendelson WB, Basile AS. The hypnotic actions of the fatty acid amide, oleamide.<Emphasis Type="Italic">Neuropsychopharmacology</Emphasis>. 2001;25:S36-S39.</BibUnstructured>
              </Citation>
              <Citation ID="CR210">
                <CitationNumber>210.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>RG</Initials>
                    <FamilyName>Pertwee</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>RA</Initials>
                    <FamilyName>Ross</FamilyName>
                  </BibAuthorName>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">Cannabinoid receptors and their ligands</ArticleTitle>
                  <JournalTitle>Prostaglandins Leukot Essent Fatty Acids</JournalTitle>
                  <VolumeID>66</VolumeID>
                  <FirstPage>101</FirstPage>
                  <LastPage>121</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12052030</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD38Xlt1Klu7k%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1054/plef.2001.0341</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Pertwee RG, Ross RA. Cannabinoid receptors and their ligands.<Emphasis Type="Italic">Prostaglandins Leukot Essent Fatty Acids</Emphasis>. 2002;66:101–121.</BibUnstructured>
              </Citation>
              <Citation ID="CR211">
                <CitationNumber>211.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>LJ</Initials>
                    <FamilyName>Sim-Selley</FamilyName>
                  </BibAuthorName>
                  <Year>2003</Year>
                  <ArticleTitle Language="En">Regulation of cannabinoid CB<Subscript>1</Subscript> receptors in the central nervous system by chronic cannabinoids</ArticleTitle>
                  <JournalTitle>Crit Rev Neurobiol</JournalTitle>
                  <VolumeID>15</VolumeID>
                  <FirstPage>91</FirstPage>
                  <LastPage>119</LastPage>
                  <Occurrence Type="PID">
                    <Handle>14977366</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2cXhvVGlsro%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1615/CritRevNeurobiol.v15.i2.10</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Sim-Selley LJ. Regulation of cannabinoid CB<Subscript>1</Subscript> receptors in the central nervous system by chronic cannabinoids.<Emphasis Type="Italic">Crit Rev Neurobiol</Emphasis>. 2003;15:91–119.</BibUnstructured>
              </Citation>
              <Citation ID="CR212">
                <CitationNumber>212.</CitationNumber>
                <BibChapter>
                  <BibAuthorName>
                    <Initials>AH</Initials>
                    <FamilyName>Lichtman</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>BR</Initials>
                    <FamilyName>Martin</FamilyName>
                  </BibAuthorName>
                  <Year>2005</Year>
                  <ChapterTitle Language="En">Cannabinoid tolerance and dependence</ChapterTitle>
                  <BibEditorName>
                    <Initials>RG</Initials>
                    <FamilyName>Pertwee</FamilyName>
                  </BibEditorName>
                  <Eds/>
                  <BookTitle>Cannabinoids, Handbook of Experimental Pharmacolology</BookTitle>
                  <PublisherName>Springer-Verlag</PublisherName>
                  <PublisherLocation>Heidelberg, Germany</PublisherLocation>
                  <FirstPage>691</FirstPage>
                  <LastPage>717</LastPage>
                </BibChapter>
                <BibUnstructured>Lichtman AH, Martin BR. Cannabinoid tolerance and dependence. In: Pertwee RG, ed.<Emphasis Type="Italic">Cannabinoids, Handbook of Experimental Pharmacolology</Emphasis>. Heidelberg, Germany: Springer-Verlag; 2005;168:691–717.</BibUnstructured>
              </Citation>
              <Citation ID="CR213">
                <CitationNumber>213.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Vry</FamilyName>
                    <Particle>De</Particle>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>KR</Initials>
                    <FamilyName>Jentzsch</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>E</Initials>
                    <FamilyName>Kuhl</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>G</Initials>
                    <FamilyName>Eckel</FamilyName>
                  </BibAuthorName>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">Behavioral effects of cannabinoids show differential sensitivity to cannabinoid receptor blockade and tolerance development</ArticleTitle>
                  <JournalTitle>Behav Pharmacol</JournalTitle>
                  <VolumeID>15</VolumeID>
                  <FirstPage>1</FirstPage>
                  <LastPage>12</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15075621</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1097/00008877-200402000-00001</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>De Vry J, Jentzsch KR, Kuhl E, Eckel G. Behavioral effects of cannabinoids show differential sensitivity to cannabinoid receptor blockade and tolerance development.<Emphasis Type="Italic">Behav Pharmacol</Emphasis>. 2004;15:1–12.</BibUnstructured>
              </Citation>
              <Citation ID="CR214">
                <CitationNumber>214.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>BC</Initials>
                    <FamilyName>Paria</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>SK</Initials>
                    <FamilyName>Dey</FamilyName>
                  </BibAuthorName>
                  <Year>2000</Year>
                  <ArticleTitle Language="En">Ligand-receptor signaling with endocannabinoids in preimplantation embryo development and implantation</ArticleTitle>
                  <JournalTitle>Chem Phys Lipids</JournalTitle>
                  <VolumeID>108</VolumeID>
                  <FirstPage>211</FirstPage>
                  <LastPage>220</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11106792</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3cXosFeqtLk%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0009-3084(00)00197-3</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Paria BC, Dey SK. Ligand-receptor signaling with endocannabinoids in preimplantation embryo development and implantation.<Emphasis Type="Italic">Chem Phys Lipids</Emphasis>. 2000;108:211–220.</BibUnstructured>
              </Citation>
              <Citation ID="CR215">
                <CitationNumber>215.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>LF</Initials>
                    <FamilyName>Gaal</FamilyName>
                    <Particle>Van</Particle>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>AM</Initials>
                    <FamilyName>Rissanen</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>AJ</Initials>
                    <FamilyName>Scheen</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>O</Initials>
                    <FamilyName>Ziegler</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Rossner</FamilyName>
                  </BibAuthorName>
                  <Year>2005</Year>
                  <ArticleTitle Language="En">Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study</ArticleTitle>
                  <JournalTitle>Lancet</JournalTitle>
                  <VolumeID>365</VolumeID>
                  <FirstPage>1389</FirstPage>
                  <LastPage>1397</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15836887</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0140-6736(05)66374-X</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2MXjsVegtbo%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Van Gaal LF, Rissanen AM, Scheen AJ, Ziegler O, Rossner S. Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study.<Emphasis Type="Italic">Lancet</Emphasis>. 2005;365:1389–1397.</BibUnstructured>
              </Citation>
              <Citation ID="CR216">
                <CitationNumber>216.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>AI</Initials>
                    <FamilyName>Idris</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>RJ</Initials>
                    <FamilyName>Hof</FamilyName>
                    <Particle>van’t</Particle>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>IR</Initials>
                    <FamilyName>Greig</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>SA</Initials>
                    <FamilyName>Ridge</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>D</Initials>
                    <FamilyName>Baker</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>RA</Initials>
                    <FamilyName>Ross</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>SH</Initials>
                    <FamilyName>Ralston</FamilyName>
                  </BibAuthorName>
                  <Year>2005</Year>
                  <ArticleTitle Language="En">Regulation of bone mass, bone loss and osteoclast activity by cannabinoid receptors</ArticleTitle>
                  <JournalTitle>Nat Med</JournalTitle>
                  <VolumeID>11</VolumeID>
                  <FirstPage>774</FirstPage>
                  <LastPage>779</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15908955</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2MXmt1aju7g%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1038/nm1255</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Idris AI, van’t Hof RJ, Greig IR, Ridge SA, Baker D, Ross RA, Ralston SH. Regulation of bone mass, bone loss and osteoclast activity by cannabinoid receptors.<Emphasis Type="Italic">Nat Med</Emphasis>. 2005;11:774–779.</BibUnstructured>
              </Citation>
              <Citation ID="CR217">
                <CitationNumber>217.</CitationNumber>
                <BibBook>
                  <BibAuthorName>
                    <Initials>AJ</Initials>
                    <FamilyName>Brown</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Ueno</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>K</Initials>
                    <FamilyName>Suen</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>SJ</Initials>
                    <FamilyName>Dowell</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Wise</FamilyName>
                  </BibAuthorName>
                  <Year>2005</Year>
                  <BookTitle>Molecular identification of GPR55 as a third G protein-coupled receptor responsive to cannabinoid ligands</BookTitle>
                  <ConfEventName>Symposium on the Cannabinoids</ConfEventName>
                  <ConfEventLocation>Clearwater Beach, FL</ConfEventLocation>
                  <ConfEventDate>June 24–27</ConfEventDate>
                  <PublisherName>International Cannabinoid Research Society</PublisherName>
                  <PublisherLocation>Burlington, VT</PublisherLocation>
                  <FirstPage>16</FirstPage>
                  <LastPage>16</LastPage>
                </BibBook>
                <BibUnstructured>Brown AJ, Ueno S, Suen K, Dowell SJ, Wise A Molecular identification of GPR55 as a third G protein-coupled receptor responsive to cannabinoid ligands. Symposium on the Cannabinoids; June 24–27; Clearwater Beach, FL. Burlington, VT: International Cannabinoid Research Society; 2005, 16.</BibUnstructured>
              </Citation>
              <Citation ID="CR218">
                <CitationNumber>218.</CitationNumber>
                <BibBook>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Sjögren</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>E</Initials>
                    <FamilyName>Ryberg</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Lindblom</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2005</Year>
                  <BookTitle>A new receptor for cannabinoid ligands Symposium on the Cannabinoids; June 24–27; Clearwater Beach, FL</BookTitle>
                  <PublisherName>International Cannabinoid Research Society</PublisherName>
                  <PublisherLocation>Burlington, VT</PublisherLocation>
                  <FirstPage>106</FirstPage>
                  <LastPage>106</LastPage>
                </BibBook>
                <BibUnstructured>Sjögren S, Ryberg E, Lindblom A, et al. A new receptor for cannabinoid ligands Symposium on the Cannabinoids; June 24–27; Clearwater Beach, FL. Burlington, VT: International Cannabinoid Research Society; 2005, 106.</BibUnstructured>
              </Citation>
              <Citation ID="CR219">
                <CitationNumber>219.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>AG</Initials>
                    <FamilyName>Hohmann</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>RL</Initials>
                    <FamilyName>Suplita</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>NM</Initials>
                    <FamilyName>Bolton</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2005</Year>
                  <ArticleTitle Language="En">An endocannabinoid mechanism for stress-induced analgesia</ArticleTitle>
                  <JournalTitle>Nature</JournalTitle>
                  <VolumeID>435</VolumeID>
                  <FirstPage>1108</FirstPage>
                  <LastPage>1112</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15973410</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2MXltl2ntrY%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1038/nature03658</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Hohmann AG, Suplita RL, Bolton NM, et al. An endocannabinoid mechanism for stress-induced analgesia.<Emphasis Type="Italic">Nature</Emphasis>. 2005;435:1108–1112.</BibUnstructured>
              </Citation>
            </Bibliography>
          </ArticleBackmatter>
        </Article>
      </Issue>
    </Volume>
  </Journal>
</Publisher>
